<?xml version="1.0" encoding="utf-8"?><gexf version="1.1" xmlns="http://www.gexf.net/1.1draft" xmlns:viz="http://www.gexf.net/1.1draft/viz" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.w3.org/2001/XMLSchema-instance">
  <graph defaultedgetype="undirected" mode="static">
    <nodes>
      <node id="Pancreatic cancer, 260350 (3)" label="Pancreatic cancer, 260350 (3)" />
      <node id="Platelet Adhesion to exposed collagen" label="Platelet Adhesion to exposed collagen" />
      <node id="Glutamine deficiency, congenital, 610015 (3)" label="Glutamine deficiency, congenital, 610015 (3)" />
      <node id="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" label="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" />
      <node id="{?Amyloidosis, secondary, susceptibility to} (1)" label="{?Amyloidosis, secondary, susceptibility to} (1)" />
      <node id="{Cystic fibrosis lung disease, modifier of}, 219700 (3)" label="{Cystic fibrosis lung disease, modifier of}, 219700 (3)" />
      <node id="Transcriptional Regulation of White Adipocyte Differentiation" label="Transcriptional Regulation of White Adipocyte Differentiation" />
      <node id="HIV Infection" label="HIV Infection" />
      <node id="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" label="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" />
      <node id="MODY, type II, 125851 (3)" label="MODY, type II, 125851 (3)" />
      <node id="Frontometaphyseal dysplasia, 305620 (3)" label="Frontometaphyseal dysplasia, 305620 (3)" />
      <node id="Ovarian cancer, somatic, (3)" label="Ovarian cancer, somatic, (3)" />
      <node id="Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)" label="Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)" />
      <node id="Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)" label="Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)" />
      <node id="Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)" label="Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)" />
      <node id="Regulation of Signaling by NODAL" label="Regulation of Signaling by NODAL" />
      <node id="CREB phosphorylation through the activation of CaMKK" label="CREB phosphorylation through the activation of CaMKK" />
      <node id="Pseudopseudohypoparathyroidism, 612463 (3)" label="Pseudopseudohypoparathyroidism, 612463 (3)" />
      <node id="Meckel syndrome 4, 611134 (3)" label="Meckel syndrome 4, 611134 (3)" />
      <node id="Ras activation uopn Ca2+ infux through NMDA receptor" label="Ras activation uopn Ca2+ infux through NMDA receptor" />
      <node id="COPD, rate of decline of lung function in, 606963 (3)" label="COPD, rate of decline of lung function in, 606963 (3)" />
      <node id="Giant platelet disorder, isolated, 231200 (3)" label="Giant platelet disorder, isolated, 231200 (3)" />
      <node id="Adenocarcinoma of lung, somatic, 211980 (3)" label="Adenocarcinoma of lung, somatic, 211980 (3)" />
      <node id="Lhermitte-Duclos syndrome, 158350 (3)" label="Lhermitte-Duclos syndrome, 158350 (3)" />
      <node id="Hypobetalipoproteinemia, normotriglyceridemic (3)" label="Hypobetalipoproteinemia, normotriglyceridemic (3)" />
      <node id="VATER association with macrocephaly and ventriculomegaly, 276950 (3)" label="VATER association with macrocephaly and ventriculomegaly, 276950 (3)" />
      <node id="Bleeding disorder, platelet-type, 8, 609821 (3)" label="Bleeding disorder, platelet-type, 8, 609821 (3)" />
      <node id="Fanconi-Bickel syndrome, 227810 (3)" label="Fanconi-Bickel syndrome, 227810 (3)" />
      <node id="Mental retardation, X-linked, syndromic 14, 300676 (3)" label="Mental retardation, X-linked, syndromic 14, 300676 (3)" />
      <node id="ATP sensitive Potassium channels" label="ATP sensitive Potassium channels" />
      <node id="Fanconi anemia, complementation group 0, 613390 (3)" label="Fanconi anemia, complementation group 0, 613390 (3)" />
      <node id="Thalassemias, beta-, 613985 (3)" label="Thalassemias, beta-, 613985 (3)" />
      <node id="Noonan syndrome 5, 611553 (3)" label="Noonan syndrome 5, 611553 (3)" />
      <node id="Prolonged bleeding time, brachydactyly and mental retardation (3)" label="Prolonged bleeding time, brachydactyly and mental retardation (3)" />
      <node id="Microcephaly 9, primary, autosomal recessive, 614852 (3)" label="Microcephaly 9, primary, autosomal recessive, 614852 (3)" />
      <node id="Nuclear Events (kinase and transcription factor activation)" label="Nuclear Events (kinase and transcription factor activation)" />
      <node id="OI type II, 166210 (3)" label="OI type II, 166210 (3)" />
      <node id="Cardiomyopathy, dilated, 1N, 607487 (3)" label="Cardiomyopathy, dilated, 1N, 607487 (3)" />
      <node id="{Myocardial infarcation, susceptibility to}, 608446 (3)" label="{Myocardial infarcation, susceptibility to}, 608446 (3)" />
      <node id="CREB phosphorylation through the activation of Adenylate Cyclase" label="CREB phosphorylation through the activation of Adenylate Cyclase" />
      <node id="Hypofibrinogenemia, gamma type (3)" label="Hypofibrinogenemia, gamma type (3)" />
      <node id="Retinitis pigmentosa 38, 613862 (3)" label="Retinitis pigmentosa 38, 613862 (3)" />
      <node id="{Malaria, cerebral, susceptibility to}, 611162 (3)" label="{Malaria, cerebral, susceptibility to}, 611162 (3)" />
      <node id="Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells" label="Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells" />
      <node id="Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)" label="Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)" />
      <node id="Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)" label="Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)" />
      <node id="Retinitis pigmentosa 35, 610282 (3)" label="Retinitis pigmentosa 35, 610282 (3)" />
      <node id="Serotonin clearance from the synaptic cleft" label="Serotonin clearance from the synaptic cleft" />
      <node id="Post-Elongation Processing of the Transcript" label="Post-Elongation Processing of the Transcript" />
      <node id="Nef Mediated CD8 Down-regulation" label="Nef Mediated CD8 Down-regulation" />
      <node id="{Meningioma}, 607174 (3)" label="{Meningioma}, 607174 (3)" />
      <node id="Thrombocythemia 2, 601977 (3)" label="Thrombocythemia 2, 601977 (3)" />
      <node id="Leukemia, T-cell acute lymphoblastic (3)" label="Leukemia, T-cell acute lymphoblastic (3)" />
      <node id="Hemostasis" label="Hemostasis" />
      <node id="Myelodysplastic syndrome, preleukemic (3)" label="Myelodysplastic syndrome, preleukemic (3)" />
      <node id="Xeroderma pigmentosum, group B, 610651 (3)" label="Xeroderma pigmentosum, group B, 610651 (3)" />
      <node id="Myelogenous leukemia, acute (3)" label="Myelogenous leukemia, acute (3)" />
      <node id="Diamond-Blackfan anemia 1, 105650 (3)" label="Diamond-Blackfan anemia 1, 105650 (3)" />
      <node id="Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)" label="Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)" />
      <node id="Muscle contraction" label="Muscle contraction" />
      <node id="ERK1 activation" label="ERK1 activation" />
      <node id="Smooth Muscle Contraction" label="Smooth Muscle Contraction" />
      <node id="{Accelerated tumor formation, susceptibility to}, 614401 (3)" label="{Accelerated tumor formation, susceptibility to}, 614401 (3)" />
      <node id="NCAM signaling for neurite out-growth" label="NCAM signaling for neurite out-growth" />
      <node id="{Osteoporosis}, 166710 (3)" label="{Osteoporosis}, 166710 (3)" />
      <node id="Trafficking of AMPA receptors" label="Trafficking of AMPA receptors" />
      <node id="Corpus callosum, partial agenesis of, 304100 (3)" label="Corpus callosum, partial agenesis of, 304100 (3)" />
      <node id="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" label="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" />
      <node id="Extrinsic Pathway" label="Extrinsic Pathway" />
      <node id="Hypobetalipoproteinemia (3)" label="Hypobetalipoproteinemia (3)" />
      <node id="Osteogenesis imperfecta, type I, 166200 (3)" label="Osteogenesis imperfecta, type I, 166200 (3)" />
      <node id="Lissencephaly 3, 611603 (3)" label="Lissencephaly 3, 611603 (3)" />
      <node id="Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)" label="Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)" />
      <node id="Thalassemia, delta- (3)" label="Thalassemia, delta- (3)" />
      <node id="Mitotic Prophase" label="Mitotic Prophase" />
      <node id="Netrin-1 signaling" label="Netrin-1 signaling" />
      <node id="Mirror movements, congenital, 157600 (3)" label="Mirror movements, congenital, 157600 (3)" />
      <node id="Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)" label="Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)" />
      <node id="Degradation of GABA" label="Degradation of GABA" />
      <node id="Dopamine clearance from the synaptic cleft" label="Dopamine clearance from the synaptic cleft" />
      <node id="{Melanoma, cutaneous malignant, 3}, 609048 (3)" label="{Melanoma, cutaneous malignant, 3}, 609048 (3)" />
      <node id="Transcription of the HIV genome" label="Transcription of the HIV genome" />
      <node id="Plasma fibronectin deficiency, 614101 (1)" label="Plasma fibronectin deficiency, 614101 (1)" />
      <node id="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)" label="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)" />
      <node id="Aortic aneurysm, familial thoracic 7, 613780 (3)" label="Aortic aneurysm, familial thoracic 7, 613780 (3)" />
      <node id="Myogenesis" label="Myogenesis" />
      <node id="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" label="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" />
      <node id="Lethal congenital contractural syndrome 3, 611369 (3)" label="Lethal congenital contractural syndrome 3, 611369 (3)" />
      <node id="Meier-Gorlin syndrome 2, 613800 (3)" label="Meier-Gorlin syndrome 2, 613800 (3)" />
      <node id="Prolonged bleeding time, brachydactyly, and mental retardation (3)" label="Prolonged bleeding time, brachydactyly, and mental retardation (3)" />
      <node id="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" label="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" />
      <node id="Microcephaly 6, primary, autosomal recessive, 608393 (3)" label="Microcephaly 6, primary, autosomal recessive, 608393 (3)" />
      <node id="Thrombin signalling through proteinase activated receptors (PARs)" label="Thrombin signalling through proteinase activated receptors (PARs)" />
      <node id="Hypertrichotic osteochondrodysplasia, 239850 (3)" label="Hypertrichotic osteochondrodysplasia, 239850 (3)" />
      <node id="CRASH syndrome, 303350 (3)" label="CRASH syndrome, 303350 (3)" />
      <node id="Myopathy, myofibrillar, 1, 601419 (3)" label="Myopathy, myofibrillar, 1, 601419 (3)" />
      <node id="Ehlers-Danlos syndrome, type VIIB, 130060 (3)" label="Ehlers-Danlos syndrome, type VIIB, 130060 (3)" />
      <node id="Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)" label="Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)" />
      <node id="{Stroke, ischemic, susceptibility to}, 601367 (3)" label="{Stroke, ischemic, susceptibility to}, 601367 (3)" />
      <node id="[High molecular weight kininogen deficiency], 228960 (3)" label="[High molecular weight kininogen deficiency], 228960 (3)" />
      <node id="Interactions of Vpr with host cellular proteins" label="Interactions of Vpr with host cellular proteins" />
      <node id="Retrograde neurotrophin signalling" label="Retrograde neurotrophin signalling" />
      <node id="{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)" label="{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)" />
      <node id="DCC mediated attractive signaling" label="DCC mediated attractive signaling" />
      <node id="Formation of the HIV-1 Early Elongation Complex" label="Formation of the HIV-1 Early Elongation Complex" />
      <node id="Platelet degranulation" label="Platelet degranulation" />
      <node id="Pausing and recovery of Tat-mediated HIV-1 elongation" label="Pausing and recovery of Tat-mediated HIV-1 elongation" />
      <node id="Formation of HIV-1 elongation complex in the absence of HIV-1 Tat" label="Formation of HIV-1 elongation complex in the absence of HIV-1 Tat" />
      <node id="Methemoglobinemias, beta- (3)" label="Methemoglobinemias, beta- (3)" />
      <node id="Myeloproliferative disorder (2)" label="Myeloproliferative disorder (2)" />
      <node id="Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)" label="Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)" />
      <node id="Axon guidance" label="Axon guidance" />
      <node id="Osteogenesis imperfecta, type IV, 166220 (3)" label="Osteogenesis imperfecta, type IV, 166220 (3)" />
      <node id="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" label="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" />
      <node id="Leukemia, juvenile myelomonocytic, 607785 (3)" label="Leukemia, juvenile myelomonocytic, 607785 (3)" />
      <node id="GABA receptor activation" label="GABA receptor activation" />
      <node id="FG syndrome 2, 300321 (3)" label="FG syndrome 2, 300321 (3)" />
      <node id="{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)" label="{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)" />
      <node id="Developmental Biology" label="Developmental Biology" />
      <node id="Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)" label="Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)" />
      <node id="Platelet calcium homeostasis" label="Platelet calcium homeostasis" />
      <node id="Osseous heteroplasia, progressive, 166350 (3)" label="Osseous heteroplasia, progressive, 166350 (3)" />
      <node id="Elongation arrest and recovery" label="Elongation arrest and recovery" />
      <node id="Leukemia, acute myelogenous, 601626 (3)" label="Leukemia, acute myelogenous, 601626 (3)" />
      <node id="Mitotic Metaphase/Anaphase Transition" label="Mitotic Metaphase/Anaphase Transition" />
      <node id="Thrombocytopenia-absent radius syndrome, 274000 (3)" label="Thrombocytopenia-absent radius syndrome, 274000 (3)" />
      <node id="Plasminogen deficiency, types I and II (1)" label="Plasminogen deficiency, types I and II (1)" />
      <node id="Diabetes mellitus, permanent neonatal, 606176 (3)" label="Diabetes mellitus, permanent neonatal, 606176 (3)" />
      <node id="Renal cell carcinoma, papillary, familial and somatic, 605074 (3)" label="Renal cell carcinoma, papillary, familial and somatic, 605074 (3)" />
      <node id="Cowden syndrome 1, 158350 (3)" label="Cowden syndrome 1, 158350 (3)" />
      <node id="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" label="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" />
      <node id="Integration of provirus" label="Integration of provirus" />
      <node id="The role of Nef in HIV-1 replication and disease pathogenesis" label="The role of Nef in HIV-1 replication and disease pathogenesis" />
      <node id="Lujan-Fryns syndrome, 309520 (3)" label="Lujan-Fryns syndrome, 309520 (3)" />
      <node id="Basigin interactions" label="Basigin interactions" />
      <node id="Duchenne muscular dystrophy, 310200 (3)" label="Duchenne muscular dystrophy, 310200 (3)" />
      <node id="Erythremias, beta- (3)" label="Erythremias, beta- (3)" />
      <node id="Bleeding disorder, platelet-type, 11, 614201 (3)" label="Bleeding disorder, platelet-type, 11, 614201 (3)" />
      <node id="Acromegaly, 102200 (3)" label="Acromegaly, 102200 (3)" />
      <node id="Agammaglobulinemia 7, autosomal recessive, 615214 (3)" label="Agammaglobulinemia 7, autosomal recessive, 615214 (3)" />
      <node id="Pseudohypoparathyroidism Ia, 103580 (3)" label="Pseudohypoparathyroidism Ia, 103580 (3)" />
      <node id="Sema4D mediated inhibition of cell attachment and migration" label="Sema4D mediated inhibition of cell attachment and migration" />
      <node id="Quebec platelet disorder, 601709 (3)" label="Quebec platelet disorder, 601709 (3)" />
      <node id="Dysprothrombinemia, 613679 (3)" label="Dysprothrombinemia, 613679 (3)" />
      <node id="Otopalatodigital syndrome, type II, 304120 (3)" label="Otopalatodigital syndrome, type II, 304120 (3)" />
      <node id="{Multiple myeloma, resistance to}, 254500 (3)" label="{Multiple myeloma, resistance to}, 254500 (3)" />
      <node id="Gastric cancer, somatic, 613659 (3)" label="Gastric cancer, somatic, 613659 (3)" />
      <node id="Noonan syndrome 1, 163950 (3)" label="Noonan syndrome 1, 163950 (3)" />
      <node id="Leprechaunism, 246200 (3)" label="Leprechaunism, 246200 (3)" />
      <node id="Autointegration results in viral DNA circles" label="Autointegration results in viral DNA circles" />
      <node id="{Alzheimer disease, susceptibility to}, 104300 (3)" label="{Alzheimer disease, susceptibility to}, 104300 (3)" />
      <node id="Colorectal cancer with chromosomal instability (3)" label="Colorectal cancer with chromosomal instability (3)" />
      <node id="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" label="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" />
      <node id="[High density lipoprotein cholesterol level QTL 11] (3)" label="[High density lipoprotein cholesterol level QTL 11] (3)" />
      <node id="Thromboxane signalling through TP receptor" label="Thromboxane signalling through TP receptor" />
      <node id="Huntington disease-like 1, 603218 (3)" label="Huntington disease-like 1, 603218 (3)" />
      <node id="Parkinsonism-dystonia, infantile, 613135 (3)" label="Parkinsonism-dystonia, infantile, 613135 (3)" />
      <node id="Factor XI deficiency, autosomal dominant, 612416 (3)" label="Factor XI deficiency, autosomal dominant, 612416 (3)" />
      <node id="Cone-rod dystrophy 10, 610283 (3)" label="Cone-rod dystrophy 10, 610283 (3)" />
      <node id="GPVI-mediated activation cascade" label="GPVI-mediated activation cascade" />
      <node id="Lactase persistance/nonpersistance, 223100 (3)" label="Lactase persistance/nonpersistance, 223100 (3)" />
      <node id="Alcohol sensitivity, acute, 610251 (3)" label="Alcohol sensitivity, acute, 610251 (3)" />
      <node id="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" label="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" />
      <node id="ADP signalling through P2Y purinoceptor 1" label="ADP signalling through P2Y purinoceptor 1" />
      <node id="Otopalatodigital syndrome, type I, 311300 (3)" label="Otopalatodigital syndrome, type I, 311300 (3)" />
      <node id="Diarrhea 4, malabsorptive, congenital, 610370 (3)" label="Diarrhea 4, malabsorptive, congenital, 610370 (3)" />
      <node id="Metabolism of serotonin" label="Metabolism of serotonin" />
      <node id="Afibrinogenemia, congenital, 202400 (3)" label="Afibrinogenemia, congenital, 202400 (3)" />
      <node id="?Glycoprotein Ia deficiency, 614200 (1)" label="?Glycoprotein Ia deficiency, 614200 (1)" />
      <node id="Squamous cell carcinoma, head and neck, somatic, 275355 (3)" label="Squamous cell carcinoma, head and neck, somatic, 275355 (3)" />
      <node id="Complement component 4, partial deficiency of, 120790 (3)" label="Complement component 4, partial deficiency of, 120790 (3)" />
      <node id="Insomnia, fatal familial, 600072 (3)" label="Insomnia, fatal familial, 600072 (3)" />
      <node id="{Septic shock, susceptibility to} (3)" label="{Septic shock, susceptibility to} (3)" />
      <node id="Purpura, posttransfusion (3)" label="Purpura, posttransfusion (3)" />
      <node id="Lacticacidemia due to PDX1 deficiency, 245349 (3)" label="Lacticacidemia due to PDX1 deficiency, 245349 (3)" />
      <node id="Processing of Capped Intronless Pre-mRNA" label="Processing of Capped Intronless Pre-mRNA" />
      <node id="HIV-1 Transcription Elongation" label="HIV-1 Transcription Elongation" />
      <node id="PLC-gamma1 signalling" label="PLC-gamma1 signalling" />
      <node id="{Budd-Chiari syndrome}, 600880 (3)" label="{Budd-Chiari syndrome}, 600880 (3)" />
      <node id="ERK activation" label="ERK activation" />
      <node id="Common Pathway" label="Common Pathway" />
      <node id="Neurotransmitter Release Cycle" label="Neurotransmitter Release Cycle" />
      <node id="Rabson-Mendenhall syndrome, 262190 (3)" label="Rabson-Mendenhall syndrome, 262190 (3)" />
      <node id="Amyloids" label="Amyloids" />
      <node id="Tandem pore domain potassium channels" label="Tandem pore domain potassium channels" />
      <node id="Plasminogen activator inhibitor-1 deficiency, 613329 (3)" label="Plasminogen activator inhibitor-1 deficiency, 613329 (3)" />
      <node id="Hypoproteinemia, hypercatabolic, 241600 (3)" label="Hypoproteinemia, hypercatabolic, 241600 (3)" />
      <node id="CDO in myogenesis" label="CDO in myogenesis" />
      <node id="Cone-rod dystrophy 7, 603649 (3)" label="Cone-rod dystrophy 7, 603649 (3)" />
      <node id="{Reduced triglycerides, susceptibility to} (3)" label="{Reduced triglycerides, susceptibility to} (3)" />
      <node id="{Myocardial infarction, susceptibility to}, 608446 (3)" label="{Myocardial infarction, susceptibility to}, 608446 (3)" />
      <node id="Thrombocytopenia, congenital amegakaryocytic, 604498 (3)" label="Thrombocytopenia, congenital amegakaryocytic, 604498 (3)" />
      <node id="Oral-facial-digital syndrome 1, 311200 (3)" label="Oral-facial-digital syndrome 1, 311200 (3)" />
      <node id="Vif-mediated degradation of APOBEC3G" label="Vif-mediated degradation of APOBEC3G" />
      <node id="Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)" label="Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)" />
      <node id="{Bladder cancer, somatic}, 109800 (3)" label="{Bladder cancer, somatic}, 109800 (3)" />
      <node id="Glioblastoma, somatic, 137800 (3)" label="Glioblastoma, somatic, 137800 (3)" />
      <node id="Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)" label="Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)" />
      <node id="Nef mediated downregulation of MHC class I complex cell surface expression" label="Nef mediated downregulation of MHC class I complex cell surface expression" />
      <node id="Bernard-Soulier syndrome, type C, 231200 (3)" label="Bernard-Soulier syndrome, type C, 231200 (3)" />
      <node id="Norepinephrine Neurotransmitter Release Cycle" label="Norepinephrine Neurotransmitter Release Cycle" />
      <node id="ADP signalling through P2Y purinoceptor 12" label="ADP signalling through P2Y purinoceptor 12" />
      <node id="Cardiac valvular dysplasia, X-linked, 314400 (3)" label="Cardiac valvular dysplasia, X-linked, 314400 (3)" />
      <node id="Long QT syndrome-11, 611820 (3)" label="Long QT syndrome-11, 611820 (3)" />
      <node id="Role of second messengers in netrin-1 signaling" label="Role of second messengers in netrin-1 signaling" />
      <node id="Phospholipase A2, group IV A, deficiency of (3)" label="Phospholipase A2, group IV A, deficiency of (3)" />
      <node id="Ehlers-Danlos syndrome, type I, 130000 (3)" label="Ehlers-Danlos syndrome, type I, 130000 (3)" />
      <node id="Diabetes mellitus, gestational, 125851 (3)" label="Diabetes mellitus, gestational, 125851 (3)" />
      <node id="Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)" label="Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)" />
      <node id="Inwardly rectifying K+ channels" label="Inwardly rectifying K+ channels" />
      <node id="Caffey disease, 114000 (3)" label="Caffey disease, 114000 (3)" />
      <node id="Diamond-Blackfan anemia 6, 612561 (3)" label="Diamond-Blackfan anemia 6, 612561 (3)" />
      <node id="Venous malformations, multiple cutaneous and mucosal, 600195 (3)" label="Venous malformations, multiple cutaneous and mucosal, 600195 (3)" />
      <node id="von Willibrand disease, type 3, 277480 (3)" label="von Willibrand disease, type 3, 277480 (3)" />
      <node id="Cocoon syndrome, 613630 (3)" label="Cocoon syndrome, 613630 (3)" />
      <node id="{Venous thrombosis, protection against}, 188050 (3)" label="{Venous thrombosis, protection against}, 188050 (3)" />
      <node id="Camurati-Engelmann disease, 131300 (3)" label="Camurati-Engelmann disease, 131300 (3)" />
      <node id="Cardiomyopathy, dilated, 1G, 604145 (3)" label="Cardiomyopathy, dilated, 1G, 604145 (3)" />
      <node id="Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)" label="Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)" />
      <node id="Diabetes mellitus, transient neonatal 2, 610374 (3)" label="Diabetes mellitus, transient neonatal 2, 610374 (3)" />
      <node id="Interactions of Rev with host cellular proteins" label="Interactions of Rev with host cellular proteins" />
      <node id="Osteogenesis imperfecta, type II, 166210 (3)" label="Osteogenesis imperfecta, type II, 166210 (3)" />
      <node id="Heterotaxy, visceral, 5, 270100 (3)" label="Heterotaxy, visceral, 5, 270100 (3)" />
      <node id="Nonsmall cell lung cancer, somatic, 211980 (3)" label="Nonsmall cell lung cancer, somatic, 211980 (3)" />
      <node id="Nestor-Guillermo progeria syndrome, 614008 (3)" label="Nestor-Guillermo progeria syndrome, 614008 (3)" />
      <node id="RAF activation" label="RAF activation" />
      <node id="{Autism, susceptibility to, X-linked 5}, 300847 (3)" label="{Autism, susceptibility to, X-linked 5}, 300847 (3)" />
      <node id="{Nicotine dependence, protection against}, 188890 (3)" label="{Nicotine dependence, protection against}, 188890 (3)" />
      <node id="Cardiofaciocutaneous syndrome, 115150 (3)" label="Cardiofaciocutaneous syndrome, 115150 (3)" />
      <node id="Platelet sensitization by LDL" label="Platelet sensitization by LDL" />
      <node id="Enzymatic degradation of Dopamine by monoamine oxidase" label="Enzymatic degradation of Dopamine by monoamine oxidase" />
      <node id="Cardiomyopathy, dilated, 1W, 611407 (3)" label="Cardiomyopathy, dilated, 1W, 611407 (3)" />
      <node id="Bernard-Soulier syndrome, type B, 231200 (3)" label="Bernard-Soulier syndrome, type B, 231200 (3)" />
      <node id="HIV Life Cycle" label="HIV Life Cycle" />
      <node id="Leukemia, T-cell acute lymphoblastic (2)" label="Leukemia, T-cell acute lymphoblastic (2)" />
      <node id="Nuclear import of Rev protein" label="Nuclear import of Rev protein" />
      <node id="Striated Muscle Contraction" label="Striated Muscle Contraction" />
      <node id="Cornelia de Lange syndrome 4, 614701 (3)" label="Cornelia de Lange syndrome 4, 614701 (3)" />
      <node id="{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)" label="{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)" />
      <node id="LEOPARD syndrome 1, 151100 (3)" label="LEOPARD syndrome 1, 151100 (3)" />
      <node id="Factors involved in megakaryocyte development and platelet production" label="Factors involved in megakaryocyte development and platelet production" />
      <node id="Acetylcholine Neurotransmitter Release Cycle" label="Acetylcholine Neurotransmitter Release Cycle" />
      <node id="Potassium Channels" label="Potassium Channels" />
      <node id="Kinesins" label="Kinesins" />
      <node id="Prostate cancer, somatic, 176807 (3)" label="Prostate cancer, somatic, 176807 (3)" />
      <node id="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" label="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" />
      <node id="Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)" label="Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)" />
      <node id="Activation of CaMK IV" label="Activation of CaMK IV" />
      <node id="Osteosarcoma, 259500 (3)" label="Osteosarcoma, 259500 (3)" />
      <node id="Intrinsic Pathway" label="Intrinsic Pathway" />
      <node id="?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)" label="?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)" />
      <node id="{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)" label="{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)" />
      <node id="CHARGE syndrome, 214800 (3)" label="CHARGE syndrome, 214800 (3)" />
      <node id="Factor VII deficiency, 227500 (3)" label="Factor VII deficiency, 227500 (3)" />
      <node id="Thrombocythemia 3, 614521 (3)" label="Thrombocythemia 3, 614521 (3)" />
      <node id="McCune-Albright syndrome, 174800 (3)" label="McCune-Albright syndrome, 174800 (3)" />
      <node id="DNA ligase I deficiency (3)" label="DNA ligase I deficiency (3)" />
      <node id="Leber congenital amaurosis 10, 611755 (3)" label="Leber congenital amaurosis 10, 611755 (3)" />
      <node id="CRMPs in Sema3A signaling" label="CRMPs in Sema3A signaling" />
      <node id="Thrombophilia due to activated protein C resistance, 188055 (3)" label="Thrombophilia due to activated protein C resistance, 188055 (3)" />
      <node id="RAF phosphorylates MEK" label="RAF phosphorylates MEK" />
      <node id="Myopathy, tubular aggregate, 160565 (3)" label="Myopathy, tubular aggregate, 160565 (3)" />
      <node id="Regulation of gene expression in beta cells" label="Regulation of gene expression in beta cells" />
      <node id="Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity" label="Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity" />
      <node id="{Warfarin sensitivity}, 122700 (3)" label="{Warfarin sensitivity}, 122700 (3)" />
      <node id="Leukemia, acute myeloid, 601626 (3)" label="Leukemia, acute myeloid, 601626 (3)" />
      <node id="Melnick-Needles syndrome, 309350 (3)" label="Melnick-Needles syndrome, 309350 (3)" />
      <node id="{Coronary heart disease, susceptibility to, 7}, 610938 (3)" label="{Coronary heart disease, susceptibility to, 7}, 610938 (3)" />
      <node id="Tat-mediated elongation of the HIV-1 transcript" label="Tat-mediated elongation of the HIV-1 transcript" />
      <node id="NrCAM interactions" label="NrCAM interactions" />
      <node id="Enzymatic degradation of dopamine by COMT" label="Enzymatic degradation of dopamine by COMT" />
      <node id="Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)" label="Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)" />
      <node id="{Glioma susceptibility 1}, 137800 (3)" label="{Glioma susceptibility 1}, 137800 (3)" />
      <node id="Choroid plexus papilloma, 260500 (3)" label="Choroid plexus papilloma, 260500 (3)" />
      <node id="CHL1 interactions" label="CHL1 interactions" />
      <node id="{Malaria, cerebral, reduced risk of}, 611162 (3)" label="{Malaria, cerebral, reduced risk of}, 611162 (3)" />
      <node id="Myopathy, congenital, Compton-North, 612540 (3)" label="Myopathy, congenital, Compton-North, 612540 (3)" />
      <node id="Rubinstein-Taybi syndrome 2, 613684 (3)" label="Rubinstein-Taybi syndrome 2, 613684 (3)" />
      <node id="Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells" label="Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells" />
      <node id="Platelet Aggregation (Plug Formation)" label="Platelet Aggregation (Plug Formation)" />
      <node id="Mental retardation, autosomal dominant 13, 614563 (3)" label="Mental retardation, autosomal dominant 13, 614563 (3)" />
      <node id="{Hangover, susceptibility to}, 610251 (3)" label="{Hangover, susceptibility to}, 610251 (3)" />
      <node id="Glomerulopathy with fibronectin deposits 2, 601894 (3)" label="Glomerulopathy with fibronectin deposits 2, 601894 (3)" />
      <node id="Xeroderma pigmentosum, group D, 278730 (3)" label="Xeroderma pigmentosum, group D, 278730 (3)" />
      <node id="Sema4D in semaphorin signaling" label="Sema4D in semaphorin signaling" />
      <node id="Dysfibrinogenemia, beta type (3)" label="Dysfibrinogenemia, beta type (3)" />
      <node id="2-LTR circle formation" label="2-LTR circle formation" />
      <node id="Osteogenesis imperfecta, type III, 259420 (3)" label="Osteogenesis imperfecta, type III, 259420 (3)" />
      <node id="RAF/MAP kinase cascade" label="RAF/MAP kinase cascade" />
      <node id="{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)" label="{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)" />
      <node id="Diamond-Blackfan anemia 9, 613308 (3)" label="Diamond-Blackfan anemia 9, 613308 (3)" />
      <node id="Hemophilia B, 306900 (3)" label="Hemophilia B, 306900 (3)" />
      <node id="Astrocytic Glutamate-Glutamine Uptake And Metabolism" label="Astrocytic Glutamate-Glutamine Uptake And Metabolism" />
      <node id="Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)" label="Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)" />
      <node id="Holoprosencephaly 11, 614226 (3)" label="Holoprosencephaly 11, 614226 (3)" />
      <node id="Thrombocythemia 1, 187950 (3)" label="Thrombocythemia 1, 187950 (3)" />
      <node id="APOBEC3G mediated resistance to HIV-1 infection" label="APOBEC3G mediated resistance to HIV-1 infection" />
      <node id="Colorectal cancer, somatic, 114500 (3)" label="Colorectal cancer, somatic, 114500 (3)" />
      <node id="Response to elevated platelet cytosolic Ca2+" label="Response to elevated platelet cytosolic Ca2+" />
      <node id="Sickle cell anemia, 603903 (3)" label="Sickle cell anemia, 603903 (3)" />
      <node id="Creutzfeldt-Jakob disease, 123400 (3)" label="Creutzfeldt-Jakob disease, 123400 (3)" />
      <node id="Muscular dystrophy, limb-girdle, type 2J, 608807 (3)" label="Muscular dystrophy, limb-girdle, type 2J, 608807 (3)" />
      <node id="Factor XIIIA deficiency, 613225 (3)" label="Factor XIIIA deficiency, 613225 (3)" />
      <node id="{Parkinson disease, susceptibility to}, 168600 (3)" label="{Parkinson disease, susceptibility to}, 168600 (3)" />
      <node id="Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)" label="Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <node id="Aortic valve disease, 109730 (3)" label="Aortic valve disease, 109730 (3)" />
      <node id="Semaphorin interactions" label="Semaphorin interactions" />
      <node id="SCID due to LCK deficiency (1)" label="SCID due to LCK deficiency (1)" />
      <node id="{Malaria, resistance to}, 611162 (3)" label="{Malaria, resistance to}, 611162 (3)" />
      <node id="Angioedema, hereditary, types I and II, 106100 (3)" label="Angioedema, hereditary, types I and II, 106100 (3)" />
      <node id="PI3K/AKT activation" label="PI3K/AKT activation" />
      <node id="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" label="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" />
      <node id="Becker muscular dystrophy, 300376 (3)" label="Becker muscular dystrophy, 300376 (3)" />
      <node id="Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)" label="Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)" />
      <node id="Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)" label="Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)" />
      <node id="Thrombophilia, dysplasminogenemic (1)" label="Thrombophilia, dysplasminogenemic (1)" />
      <node id="Hypoglycemia of infancy, leucine-sensitive, 240800 (3)" label="Hypoglycemia of infancy, leucine-sensitive, 240800 (3)" />
      <node id="PTEN hamartoma tumor syndrome (3)" label="PTEN hamartoma tumor syndrome (3)" />
      <node id="{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)" label="{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)" />
      <node id="Factor XII deficiency, 234000 (3)" label="Factor XII deficiency, 234000 (3)" />
      <node id="Dejerine-Sottas disease, 145900 (3)" label="Dejerine-Sottas disease, 145900 (3)" />
      <node id="Neurotransmitter uptake and Metabolism In Glial Cells" label="Neurotransmitter uptake and Metabolism In Glial Cells" />
      <node id="Nasopharyngeal carcinoma, 607107 (3)" label="Nasopharyngeal carcinoma, 607107 (3)" />
      <node id="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" label="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" />
      <node id="Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)" label="Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)" />
      <node id="M Phase" label="M Phase" />
      <node id="Charcot-Marie-Tooth disease, type 2B2, 605589 (3)" label="Charcot-Marie-Tooth disease, type 2B2, 605589 (3)" />
      <node id="Sema4D induced cell migration and growth-cone collapse" label="Sema4D induced cell migration and growth-cone collapse" />
      <node id="Erythrocytosis, somatic, 133100 (3)" label="Erythrocytosis, somatic, 133100 (3)" />
      <node id="GP1b-IX-V activation signalling" label="GP1b-IX-V activation signalling" />
      <node id="Cornelia de Lange syndrome 3, 610759 (3)" label="Cornelia de Lange syndrome 3, 610759 (3)" />
      <node id="{Rheumatoid arthritis, susceptibility to}, 180300 (3)" label="{Rheumatoid arthritis, susceptibility to}, 180300 (3)" />
      <node id="[Macrothrombocytopenia] (1)" label="[Macrothrombocytopenia] (1)" />
      <node id="[Blood group, OK], 111380 (3)" label="[Blood group, OK], 111380 (3)" />
      <node id="Fetal hemoglobin quantitative trait locus 1, 141749 (3)" label="Fetal hemoglobin quantitative trait locus 1, 141749 (3)" />
      <node id="Prostate cancer, progression and metastasis of, 603688 (3)" label="Prostate cancer, progression and metastasis of, 603688 (3)" />
      <node id="Ehlers-Danlos syndrome, type VIIA, 130060 (3)" label="Ehlers-Danlos syndrome, type VIIA, 130060 (3)" />
      <node id="{Glioma susceptibility 2}, 613028 (3)" label="{Glioma susceptibility 2}, 613028 (3)" />
      <node id="Oculopharyngeal muscular dystrophy, 164300 (3)" label="Oculopharyngeal muscular dystrophy, 164300 (3)" />
      <node id="Lissencephaly, X-linked, 300067 (3)" label="Lissencephaly, X-linked, 300067 (3)" />
      <node id="Processing of Intronless Pre-mRNAs" label="Processing of Intronless Pre-mRNAs" />
      <node id="Krabbe disease, atypical, 611722 (3)" label="Krabbe disease, atypical, 611722 (3)" />
      <node id="Subcortical laminar heterotopia, 607432 (3)" label="Subcortical laminar heterotopia, 607432 (3)" />
      <node id="Cardiomyopathy, familial hypertrophic, 15, 613255 (3)" label="Cardiomyopathy, familial hypertrophic, 15, 613255 (3)" />
      <node id="Nef and signal transduction" label="Nef and signal transduction" />
      <node id="Heinz body anemias, beta-, 140700 (3)" label="Heinz body anemias, beta-, 140700 (3)" />
      <node id="Mosaic variegated aneuploidy syndrome 2, 614114 (3)" label="Mosaic variegated aneuploidy syndrome 2, 614114 (3)" />
      <node id="Aplasia of lacrimal and salivary glands, 180920 (3)" label="Aplasia of lacrimal and salivary glands, 180920 (3)" />
      <node id="Combined hyperlipidemia, familial, 144250 (3)" label="Combined hyperlipidemia, familial, 144250 (3)" />
      <node id="Integrin alphaIIb beta3 signaling" label="Integrin alphaIIb beta3 signaling" />
      <node id="{Diabetes mellitus, noninsulin-dependent}, 125853 (3)" label="{Diabetes mellitus, noninsulin-dependent}, 125853 (3)" />
      <node id="Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)" label="Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)" />
      <node id="Nephronophthisis 15, 614845 (3)" label="Nephronophthisis 15, 614845 (3)" />
      <node id="Hepatocellular carcinoma, 114550 (3)" label="Hepatocellular carcinoma, 114550 (3)" />
      <node id="{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)" label="{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)" />
      <node id="APC-Cdc20 mediated degradation of Nek2A" label="APC-Cdc20 mediated degradation of Nek2A" />
      <node id="DNA Replication" label="DNA Replication" />
      <node id="Tibial muscular dystrophy, tardive, 600334 (3)" label="Tibial muscular dystrophy, tardive, 600334 (3)" />
      <node id="Breast cancer, 114480 (3)" label="Breast cancer, 114480 (3)" />
      <node id="[Kininogen deficiency], 228960 (3)" label="[Kininogen deficiency], 228960 (3)" />
      <node id="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" label="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" />
      <node id="{Nevus sebaceous, somatic}, 162900 (3)" label="{Nevus sebaceous, somatic}, 162900 (3)" />
      <node id="Mitotic M-M/G1 phases" label="Mitotic M-M/G1 phases" />
      <node id="{Esophageal cancer, alcohol-related, susceptibility to} (3)" label="{Esophageal cancer, alcohol-related, susceptibility to} (3)" />
      <node id="Thrombophilia, dysfibrinogenemic (3)" label="Thrombophilia, dysfibrinogenemic (3)" />
      <node id="Formation of Fibrin Clot (Clotting Cascade)" label="Formation of Fibrin Clot (Clotting Cascade)" />
      <node id="Seckel syndrome 6, 614728 (3)" label="Seckel syndrome 6, 614728 (3)" />
      <node id="Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)" label="Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)" />
      <node id="Activation of Na-permeable Kainate Receptors" label="Activation of Na-permeable Kainate Receptors" />
      <node id="Pseudohypoparathyroidism Ib, 603233 (3)" label="Pseudohypoparathyroidism Ib, 603233 (3)" />
      <node id="{Insulin resistance, susceptibility to}, 125853 (3)" label="{Insulin resistance, susceptibility to}, 125853 (3)" />
      <node id="{Myocardial infarction, decreased susceptibility to}, 608446 (3)" label="{Myocardial infarction, decreased susceptibility to}, 608446 (3)" />
      <node id="{Asthma, susceptibility to}, 600807 (3)" label="{Asthma, susceptibility to}, 600807 (3)" />
      <node id="Nasu-Hakola disease, 221770 (3)" label="Nasu-Hakola disease, 221770 (3)" />
      <node id="Colorectal cancer, 114500 (3)" label="Colorectal cancer, 114500 (3)" />
      <node id="GRB2:SOS provides linkage to MAPK signaling for Intergrins" label="GRB2:SOS provides linkage to MAPK signaling for Intergrins" />
      <node id="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" label="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <node id="Cardiomyopathy, dilated, 1AA, 612158 (3)" label="Cardiomyopathy, dilated, 1AA, 612158 (3)" />
      <node id="Thrombophilia, X-linked, due to factor IX defect, 300807 (3)" label="Thrombophilia, X-linked, due to factor IX defect, 300807 (3)" />
      <node id="Gaucher disease, atypical, 610539 (3)" label="Gaucher disease, atypical, 610539 (3)" />
      <node id="ERK2 activation" label="ERK2 activation" />
      <node id="Cataract, pulverulent, autosomal dominant (3)" label="Cataract, pulverulent, autosomal dominant (3)" />
      <node id="Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)" label="Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)" />
      <node id="Vpu mediated degradation of CD4" label="Vpu mediated degradation of CD4" />
      <node id="Gerstmann-Straussler disease, 137440 (3)" label="Gerstmann-Straussler disease, 137440 (3)" />
      <node id="Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)" label="Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)" />
      <node id="Meier-Gorlin syndrome 3, 613803 (3)" label="Meier-Gorlin syndrome 3, 613803 (3)" />
      <node id="Regulation of gene expression in early pancreatic precursor cells" label="Regulation of gene expression in early pancreatic precursor cells" />
      <node id="Joubert syndrome 15, 614464 (3)" label="Joubert syndrome 15, 614464 (3)" />
      <node id="Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)" label="Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)" />
      <node id="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" label="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <node id="Hypoprothrombinemia, 613679 (3)" label="Hypoprothrombinemia, 613679 (3)" />
      <node id="Signal amplification" label="Signal amplification" />
      <node id="Senior-Loken syndrome 6, 610189 (3)" label="Senior-Loken syndrome 6, 610189 (3)" />
      <node id="Myasthenia, limb-girdle, familial, 254300 (3)" label="Myasthenia, limb-girdle, familial, 254300 (3)" />
      <node id="Abortive elongation of HIV-1 transcript in the absence of Tat" label="Abortive elongation of HIV-1 transcript in the absence of Tat" />
      <node id="Activation of G protein gated Potassium channels" label="Activation of G protein gated Potassium channels" />
      <node id="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" label="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" />
      <node id="Post-Elongation Processing of Intronless pre-mRNA" label="Post-Elongation Processing of Intronless pre-mRNA" />
      <node id="Heterotopia, periventricular, 300049 (3)" label="Heterotopia, periventricular, 300049 (3)" />
      <node id="Intestinal pseudoobstruction, neuronal, 300048 (3)" label="Intestinal pseudoobstruction, neuronal, 300048 (3)" />
      <node id="Mental retardation, autosomal recessive 18, 614249 (3)" label="Mental retardation, autosomal recessive 18, 614249 (3)" />
      <node id="Regulation of beta-cell development" label="Regulation of beta-cell development" />
      <node id="Macrocephaly/autism syndrome, 605309 (3)" label="Macrocephaly/autism syndrome, 605309 (3)" />
      <node id="{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)" label="{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)" />
      <node id="SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion" label="SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion" />
      <node id="Neurofascin interactions" label="Neurofascin interactions" />
      <node id="Trichothiodystrophy, 601675 (3)" label="Trichothiodystrophy, 601675 (3)" />
      <node id="Pleuropulmonary blastoma, 601200 (3)" label="Pleuropulmonary blastoma, 601200 (3)" />
      <node id="Prion disease with protracted course, 606688 (3)" label="Prion disease with protracted course, 606688 (3)" />
      <node id="Binding and entry of HIV virion" label="Binding and entry of HIV virion" />
      <node id="Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)" label="Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)" />
      <node id="MASA syndrome, 303350 (3)" label="MASA syndrome, 303350 (3)" />
      <node id="Diamond-Blackfan anemia 5, 612528 (3)" label="Diamond-Blackfan anemia 5, 612528 (3)" />
      <node id="PECAM1 interactions" label="PECAM1 interactions" />
      <node id="Signal transduction by L1" label="Signal transduction by L1" />
      <node id="Diabetes mellitus, insulin-dependent, 2, 125852 (3)" label="Diabetes mellitus, insulin-dependent, 2, 125852 (3)" />
      <node id="Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6, 615156 (3)" label="Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6, 615156 (3)" />
      <node id="{Osteoporosis, postmenopausal}, 166710 (3)" label="{Osteoporosis, postmenopausal}, 166710 (3)" />
      <node id="Other semaphorin interactions" label="Other semaphorin interactions" />
      <node id="LEOPARD syndrome 2, 611554 (3)" label="LEOPARD syndrome 2, 611554 (3)" />
      <node id="Cardiomyopathy, dilated, 3B, 302045 (3)" label="Cardiomyopathy, dilated, 3B, 302045 (3)" />
      <node id="{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)" label="{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)" />
      <node id="[Blood group, Yt system], 112100 (3)" label="[Blood group, Yt system], 112100 (3)" />
      <node id="L1CAM interactions" label="L1CAM interactions" />
      <node id="Thyroid carcinoma, follicular, somatic, 188470 (3)" label="Thyroid carcinoma, follicular, somatic, 188470 (3)" />
      <node id="Factor X deficiency, 227600 (3)" label="Factor X deficiency, 227600 (3)" />
      <node id="Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components" label="Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components" />
      <node id="Malignant melanoma, somatic, 155600 (3)" label="Malignant melanoma, somatic, 155600 (3)" />
      <node id="Bleeding disorder due to P2RX1 defect (3)" label="Bleeding disorder due to P2RX1 defect (3)" />
      <node id="Pancreatic cancer (3)" label="Pancreatic cancer (3)" />
      <node id="Myhre syndrome, 139210 (3)" label="Myhre syndrome, 139210 (3)" />
      <node id="HIV-1 elongation arrest and recovery" label="HIV-1 elongation arrest and recovery" />
      <node id="Hydrocephalus with Hirschsprung disease, 307000 (3)" label="Hydrocephalus with Hirschsprung disease, 307000 (3)" />
      <node id="[Premature chromatid separation trait], 176430 (3)" label="[Premature chromatid separation trait], 176430 (3)" />
      <node id="Adiponectin deficiency, 612556 (3)" label="Adiponectin deficiency, 612556 (3)" />
      <node id="Interaction between L1 and Ankyrins" label="Interaction between L1 and Ankyrins" />
      <node id="Plasminogen Tochigi disease (3)" label="Plasminogen Tochigi disease (3)" />
      <node id="{Nicotine dependence, susceptibility to}, 188890 (3)" label="{Nicotine dependence, susceptibility to}, 188890 (3)" />
      <node id="Cardiomyopathy, dilated, 1O, 608569 (3)" label="Cardiomyopathy, dilated, 1O, 608569 (3)" />
      <node id="Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)" label="Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)" />
      <node id="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" label="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <node id="Heterotopia, periventricular, ED variant, 300537 (3)" label="Heterotopia, periventricular, ED variant, 300537 (3)" />
      <node id="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" label="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" />
      <node id="CREB phosphorylation through the activation of CaMKII" label="CREB phosphorylation through the activation of CaMKII" />
      <node id="Microcephaly 4, primary, autosomal recessive, 604321 (3)" label="Microcephaly 4, primary, autosomal recessive, 604321 (3)" />
      <node id="OI type IV, 166220 (3)" label="OI type IV, 166220 (3)" />
      <node id="cGMP effects" label="cGMP effects" />
      <node id="Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)" label="Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)" />
      <node id="Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)" label="Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)" />
      <node id="Meckel syndrome 10, 614175 (3)" label="Meckel syndrome 10, 614175 (3)" />
      <node id="Elevation of cytosolic Ca2+ levels" label="Elevation of cytosolic Ca2+ levels" />
      <node id="Ionotropic activity of Kainate Receptors" label="Ionotropic activity of Kainate Receptors" />
      <node id="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal" label="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal" />
      <node id="Acid-labile subunit, deficiency of (3)" label="Acid-labile subunit, deficiency of (3)" />
      <node id="Costello syndrome, 218040 (3)" label="Costello syndrome, 218040 (3)" />
      <node id="Microcephaly 8, primary, autosomal recessive, 614673 (3)" label="Microcephaly 8, primary, autosomal recessive, 614673 (3)" />
      <node id="Cardiomyopathy, familial hypertrophic, 9, 613765 (3)" label="Cardiomyopathy, familial hypertrophic, 9, 613765 (3)" />
      <node id="{Kuru, susceptibility to}, 245300 (3)" label="{Kuru, susceptibility to}, 245300 (3)" />
      <node id="Host Interactions of HIV factors" label="Host Interactions of HIV factors" />
      <node id="Advanced sleep-phase syndrome, 604348 (3)" label="Advanced sleep-phase syndrome, 604348 (3)" />
      <node id="Joubert syndrome 5, 610188 (3)" label="Joubert syndrome 5, 610188 (3)" />
      <node id="{Transcription of plasminogen activator inhibitor, modulator of} (3)" label="{Transcription of plasminogen activator inhibitor, modulator of} (3)" />
      <node id="Mental retardation, autosomal dominant 11, 614257 (3)" label="Mental retardation, autosomal dominant 11, 614257 (3)" />
      <node id="Mitotic Prometaphase" label="Mitotic Prometaphase" />
      <node id="GABA-transaminase deficiency, 613163 (3)" label="GABA-transaminase deficiency, 613163 (3)" />
      <node id="RSK activation" label="RSK activation" />
      <node id="Lissencephaly 4 (with microcephaly), 614019 (3)" label="Lissencephaly 4 (with microcephaly), 614019 (3)" />
      <node id="Dystonia-Parkinsonism, X-linked, 314250 (3)" label="Dystonia-Parkinsonism, X-linked, 314250 (3)" />
      <node id="Delta-beta thalassemia, 141749 (3)" label="Delta-beta thalassemia, 141749 (3)" />
      <node id="Meier-Gorlin syndrome 1, 224690 (3)" label="Meier-Gorlin syndrome 1, 224690 (3)" />
      <node id="Joubert syndrome 10, 300804 (3)" label="Joubert syndrome 10, 300804 (3)" />
      <node id="Formation of HIV-1 elongation complex containing HIV-1 Tat" label="Formation of HIV-1 elongation complex containing HIV-1 Tat" />
      <node id="Tat-mediated HIV-1 elongation arrest and recovery" label="Tat-mediated HIV-1 elongation arrest and recovery" />
      <node id="Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)" label="Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)" />
      <node id="Maturity-onset diabetes of the young 6, 606394 (3)" label="Maturity-onset diabetes of the young 6, 606394 (3)" />
      <node id="[Blood group, John-Milton-Hagen system], 614745 (3)" label="[Blood group, John-Milton-Hagen system], 614745 (3)" />
      <node id="Post-Elongation Processing of Intron-Containing pre-mRNA" label="Post-Elongation Processing of Intron-Containing pre-mRNA" />
      <node id="Netrin mediated repulsion signals" label="Netrin mediated repulsion signals" />
      <node id="Cardiomyopathy, dilated, 1I, 604765 (3)" label="Cardiomyopathy, dilated, 1I, 604765 (3)" />
      <node id="Senior-Loken syndrome 7, 613615 (3)" label="Senior-Loken syndrome 7, 613615 (3)" />
      <node id="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" label="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" />
      <node id="Mental retardation, autosomal dominant 17, 615009 (3)" label="Mental retardation, autosomal dominant 17, 615009 (3)" />
      <node id="Platelet activation, signaling and aggregation" label="Platelet activation, signaling and aggregation" />
      <node id="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" label="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <node id="Obesity, morbid, due to leptin deficiency, 614962 (3)" label="Obesity, morbid, due to leptin deficiency, 614962 (3)" />
      <node id="Hemophilia A, 306700 (3)" label="Hemophilia A, 306700 (3)" />
      <node id="Meier-Gorlin syndrome 4, 613804 (3)" label="Meier-Gorlin syndrome 4, 613804 (3)" />
      <node id="{Dementia, vascular, susceptibility to} (3)" label="{Dementia, vascular, susceptibility to} (3)" />
      <node id="LIG4 syndrome, 606593 (3)" label="LIG4 syndrome, 606593 (3)" />
      <node id="Pancreatic cancer, somatic (3)" label="Pancreatic cancer, somatic (3)" />
      <node id="{T-cell acute lymphoblastic leukemia} (3)" label="{T-cell acute lymphoblastic leukemia} (3)" />
      <node id="OI type III, 259420 (3)" label="OI type III, 259420 (3)" />
      <node id="Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)" label="Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)" />
      <node id="Hyperproinsulinemia, familial, with or without diabetes (3)" label="Hyperproinsulinemia, familial, with or without diabetes (3)" />
      <node id="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" label="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" />
      <node id="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" label="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" />
      <node id="AKT-mediated inactivation of FOXO1A" label="AKT-mediated inactivation of FOXO1A" />
      <node id="Golgi Cisternae Pericentriolar Stack Reorganization" label="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <node id="von Willebrand disease, platelet-type, 177820 (3)" label="von Willebrand disease, platelet-type, 177820 (3)" />
      <node id="Diabetes mellitus, type 1, 125852 (3)" label="Diabetes mellitus, type 1, 125852 (3)" />
      <node id="Early Phase of HIV Life Cycle" label="Early Phase of HIV Life Cycle" />
      <node id="Diamond-Blackfan anemia 4, 612527 (3)" label="Diamond-Blackfan anemia 4, 612527 (3)" />
      <node id="?N syndrome, 310465 (1)" label="?N syndrome, 310465 (1)" />
      <node id="Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)" label="Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)" />
      <node id="Terminal osseous dysplasia, 300244 (3)" label="Terminal osseous dysplasia, 300244 (3)" />
      <node id="{Hepatitic C virus, susceptibility to}, 609532 (3)" label="{Hepatitic C virus, susceptibility to}, 609532 (3)" />
      <node id="TWIK-related spinal cord K+ channel (TRESK)" label="TWIK-related spinal cord K+ channel (TRESK)" />
      <node id="mRNA 3'-end processing" label="mRNA 3'-end processing" />
      <node id="Dissolution of Fibrin Clot" label="Dissolution of Fibrin Clot" />
      <node id="Alpha-2-plasmin inhibitor deficiency, 262850 (3)" label="Alpha-2-plasmin inhibitor deficiency, 262850 (3)" />
      <node id="[Bone mineral density variation QTL], 166710 (3)" label="[Bone mineral density variation QTL], 166710 (3)" />
      <node id="Spherocytosis, type 1, 182900 (3)" label="Spherocytosis, type 1, 182900 (3)" />
      <node id="Pseudohypoparathyroidism Ic, 612462 (3)" label="Pseudohypoparathyroidism Ic, 612462 (3)" />
      <node id="Myelofibrosis, somatic, 254450 (3)" label="Myelofibrosis, somatic, 254450 (3)" />
      <node id="Lissencephaly 5, 615191 (3)" label="Lissencephaly 5, 615191 (3)" />
      <node id="Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits" label="Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits" />
      <node id="Lymphoma, somatic (3)" label="Lymphoma, somatic (3)" />
      <node id="Charcot-Marie-Tooth disease, type 1D, 607678 (3)" label="Charcot-Marie-Tooth disease, type 1D, 607678 (3)" />
      <node id="Signaling by NODAL" label="Signaling by NODAL" />
      <node id="Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)" label="Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)" />
      <node id="Hereditary persistence of fetal hemoglobin, 141749 (3)" label="Hereditary persistence of fetal hemoglobin, 141749 (3)" />
      <node id="Lipoprotein lipase deficiency, 238600 (3)" label="Lipoprotein lipase deficiency, 238600 (3)" />
      <node id="Polycythemia vera, 263300 (3)" label="Polycythemia vera, 263300 (3)" />
      <node id="{Schizophrenia, susceptibility to}, 181500 (3)" label="{Schizophrenia, susceptibility to}, 181500 (3)" />
      <node id="Alstrom syndrome, 203800 (3)" label="Alstrom syndrome, 203800 (3)" />
      <node id="Heterotaxy, visceral, 4, autosomal, 613751 (3)" label="Heterotaxy, visceral, 4, autosomal, 613751 (3)" />
      <node id="Rev-mediated nuclear export of HIV-1 RNA" label="Rev-mediated nuclear export of HIV-1 RNA" />
      <node id="Sema3A PAK dependent Axon repulsion" label="Sema3A PAK dependent Axon repulsion" />
      <node id="NCAM1 interactions" label="NCAM1 interactions" />
      <node id="Combined SAP deficiency, 611721 (3)" label="Combined SAP deficiency, 611721 (3)" />
      <node id="Unblocking of NMDA receptor, glutamate binding and activation" label="Unblocking of NMDA receptor, glutamate binding and activation" />
      <node id="Hydrocephalus due to aqueductal stenosis, 307000 (3)" label="Hydrocephalus due to aqueductal stenosis, 307000 (3)" />
      <node id="{Panic disorder, susceptibility to}, 167870 (3)" label="{Panic disorder, susceptibility to}, 167870 (3)" />
      <node id="Ca2+ activated K+ channels" label="Ca2+ activated K+ channels" />
      <node id="Activation of GABAB receptors" label="Activation of GABAB receptors" />
      <node id="Signal attenuation" label="Signal attenuation" />
      <node id="Opitz-Kaveggia syndrome, 305450 (3)" label="Opitz-Kaveggia syndrome, 305450 (3)" />
      <node id="Lipodystrophy, familial partial, type 4, 613877 (3)" label="Lipodystrophy, familial partial, type 4, 613877 (3)" />
      <node id="Amyloidosis, hereditary renal, 105200 (3)" label="Amyloidosis, hereditary renal, 105200 (3)" />
      <node id="OKT4 epitope deficiency, 613949 (3)" label="OKT4 epitope deficiency, 613949 (3)" />
      <node id="Late Phase of HIV Life Cycle" label="Late Phase of HIV Life Cycle" />
      <node id="Factor XI deficiency, autosomal recessive, 612416 (3)" label="Factor XI deficiency, autosomal recessive, 612416 (3)" />
      <node id="Lipodystrophy, congenital generalized, type 3, 612526 (3)" label="Lipodystrophy, congenital generalized, type 3, 612526 (3)" />
      <node id="Spinocerebellar ataxia 17, 607136 (3)" label="Spinocerebellar ataxia 17, 607136 (3)" />
      <node id="Transmission across Chemical Synapses" label="Transmission across Chemical Synapses" />
      <node id="Familial cold autoinflammatory syndrome 3, 614468 (3)" label="Familial cold autoinflammatory syndrome 3, 614468 (3)" />
      <node id="Hepatocellular carcinoma, childhood type, 114550 (3)" label="Hepatocellular carcinoma, childhood type, 114550 (3)" />
      <node id="LADD syndrome, 149730 (3)" label="LADD syndrome, 149730 (3)" />
      <node id="Polyposis, juvenile intestinal, 174900 (3)" label="Polyposis, juvenile intestinal, 174900 (3)" />
      <node id="Nitric oxide stimulates guanylate cyclase" label="Nitric oxide stimulates guanylate cyclase" />
      <node id="Noonan syndrome 4, 610733 (3)" label="Noonan syndrome 4, 610733 (3)" />
      <node id="Recycling pathway of L1" label="Recycling pathway of L1" />
      <node id="Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)" label="Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)" />
      <node id="Insulin receptor recycling" label="Insulin receptor recycling" />
      <node id="{Autism suseptibility 9}, 611015 (3)" label="{Autism suseptibility 9}, 611015 (3)" />
      <node id="Fibromatosis, gingival, 135300 (3)" label="Fibromatosis, gingival, 135300 (3)" />
      <node id="MEK activation" label="MEK activation" />
      <node id="Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)" label="Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)" />
      <node id="Cell surface interactions at the vascular wall" label="Cell surface interactions at the vascular wall" />
      <node id="Muscular dystrophy, limb-girdle, type 2G, 601954 (3)" label="Muscular dystrophy, limb-girdle, type 2G, 601954 (3)" />
      <node id="Activation of NMDA receptor upon glutamate binding and postsynaptic events" label="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <node id="Fletcher factor deficiency, 612423 (3)" label="Fletcher factor deficiency, 612423 (3)" />
      <node id="RNA Pol II CTD phosphorylation and interaction with CE" label="RNA Pol II CTD phosphorylation and interaction with CE" />
      <node id="Dopamine Neurotransmitter Release Cycle" label="Dopamine Neurotransmitter Release Cycle" />
      <node id="Bardet-Biedl syndrome 14, 209900 (3)" label="Bardet-Biedl syndrome 14, 209900 (3)" />
      <node id="{Migraine without aura, susceptibility to}, 157300 (3)" label="{Migraine without aura, susceptibility to}, 157300 (3)" />
      <node id="Lissencephaly 1, 607432 (3)" label="Lissencephaly 1, 607432 (3)" />
      <node id="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" label="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" />
      <node id="Alpha-2-macroglobulin deficiency, 614036 (1)" label="Alpha-2-macroglobulin deficiency, 614036 (1)" />
      <node id="Conjunctivitis, ligneous, 217090 (3)" label="Conjunctivitis, ligneous, 217090 (3)" />
      <node id="Diabetes mellitus, noninsulin-dependent, 125853 (3)" label="Diabetes mellitus, noninsulin-dependent, 125853 (3)" />
      <node id="{Basal cell carcinoma 7}, 614740 (3)" label="{Basal cell carcinoma 7}, 614740 (3)" />
      <node id="GABA synthesis, release, reuptake and degradation" label="GABA synthesis, release, reuptake and degradation" />
      <node id="Thrombophilia due to thrombomodulin defect, 614486 (3)" label="Thrombophilia due to thrombomodulin defect, 614486 (3)" />
      <node id="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" label="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" />
      <node id="Glutamate Neurotransmitter Release Cycle" label="Glutamate Neurotransmitter Release Cycle" />
      <node id="Seckel syndrome 4, 613676 (3)" label="Seckel syndrome 4, 613676 (3)" />
      <node id="Tie2 Signaling" label="Tie2 Signaling" />
      <node id="MicroRNA (miRNA) Biogenesis" label="MicroRNA (miRNA) Biogenesis" />
      <node id="Thalassemia-beta, dominant inclusion-body, 603902 (3)" label="Thalassemia-beta, dominant inclusion-body, 603902 (3)" />
      <node id="Metachondromatosis, 156250 (3)" label="Metachondromatosis, 156250 (3)" />
      <node id="Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)" label="Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)" />
      <node id="ACTH-independent macronodular adrenal hyperplasia, 219080 (3)" label="ACTH-independent macronodular adrenal hyperplasia, 219080 (3)" />
      <node id="Succinic semialdehyde dehydrogenase deficiency, 271980 (3)" label="Succinic semialdehyde dehydrogenase deficiency, 271980 (3)" />
      <node id="Platelet glycoprotein IV deficiency, 608404 (3)" label="Platelet glycoprotein IV deficiency, 608404 (3)" />
      <node id="Thrombophilia due to thrombin defect, 188050 (3)" label="Thrombophilia due to thrombin defect, 188050 (3)" />
      <node id="Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)" label="Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)" />
      <node id="Seckel syndrome 5, 613823 (3)" label="Seckel syndrome 5, 613823 (3)" />
      <node id="{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)" label="{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)" />
      <node id="CREB phosphorylation through the activation of Ras" label="CREB phosphorylation through the activation of Ras" />
      <node id="Vpr-mediated nuclear import of PICs" label="Vpr-mediated nuclear import of PICs" />
      <node id="von Willebrand disease, type 1, 193400 (3)" label="von Willebrand disease, type 1, 193400 (3)" />
      <node id="{Prostate cancer, somatic}, 176807 (3)" label="{Prostate cancer, somatic}, 176807 (3)" />
      <node id="Maturity-onset diabetes of the young, type 10, 613370 (3)" label="Maturity-onset diabetes of the young, type 10, 613370 (3)" />
      <node id="Schwartz-Jampel syndrome, type 1, 255800 (3)" label="Schwartz-Jampel syndrome, type 1, 255800 (3)" />
      <node id="RNA Polymerase II HIV-1 Promoter Escape" label="RNA Polymerase II HIV-1 Promoter Escape" />
      <node id="Brunner syndrome, 300615 (3)" label="Brunner syndrome, 300615 (3)" />
      <node id="Neuronal System" label="Neuronal System" />
      <node id="Microcephaly 3, primary, autosomal recessive, 604804 (3)" label="Microcephaly 3, primary, autosomal recessive, 604804 (3)" />
      <node id="Li-Fraumeni syndrome, 151623 (3)" label="Li-Fraumeni syndrome, 151623 (3)" />
      <node id="Inactivation of APC/C via direct inhibition of the APC/C complex" label="Inactivation of APC/C via direct inhibition of the APC/C complex" />
      <node id="{Colorectal cancer, susceptibiliyt to, 10}, 612591 (3)" label="{Colorectal cancer, susceptibiliyt to, 10}, 612591 (3)" />
      <node id="Endometrial carcinoma, somatic, 608089 (3)" label="Endometrial carcinoma, somatic, 608089 (3)" />
      <node id="Neurotransmitter Clearance In The Synaptic Cleft" label="Neurotransmitter Clearance In The Synaptic Cleft" />
      <node id="G protein gated Potassium channels" label="G protein gated Potassium channels" />
      <node id="Adrenal cortical carcinoma, 202300 (3)" label="Adrenal cortical carcinoma, 202300 (3)" />
      <node id="Nemaline myopathy 2, autosomal recessive, 256030 (3)" label="Nemaline myopathy 2, autosomal recessive, 256030 (3)" />
      <node id="Rubinstein-Taybi syndrome, 180849 (3)" label="Rubinstein-Taybi syndrome, 180849 (3)" />
      <node id="Thyroid carcinoma, papillary, 188550 (3)" label="Thyroid carcinoma, papillary, 188550 (3)" />
      <node id="Prostacyclin signalling through prostacyclin receptor" label="Prostacyclin signalling through prostacyclin receptor" />
      <node id="{Sublingual nitroglycerin, susceptibility to poor response to} (3)" label="{Sublingual nitroglycerin, susceptibility to poor response to} (3)" />
      <node id="Nef Mediated CD4 Down-regulation" label="Nef Mediated CD4 Down-regulation" />
      <node id="Meier-Gorlin syndrome 5, 613805 (3)" label="Meier-Gorlin syndrome 5, 613805 (3)" />
      <node id="Transposition of the great arteries, dextro-looped 1, 608808 (3)" label="Transposition of the great arteries, dextro-looped 1, 608808 (3)" />
      <node id="Congenital myopathy with excess of muscle spindles, 218040 (3)" label="Congenital myopathy with excess of muscle spindles, 218040 (3)" />
      <node id="SOS-mediated signalling" label="SOS-mediated signalling" />
      <node id="Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)" label="Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <node id="{Diabetes mellitus, noninsulin-dependent} (3)" label="{Diabetes mellitus, noninsulin-dependent} (3)" />
      <node id="Post NMDA receptor activation events" label="Post NMDA receptor activation events" />
      <node id="Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)" label="Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)" />
      <node id="Cortical dysplasia, complex, with other brain malformations, 614039 (3)" label="Cortical dysplasia, complex, with other brain malformations, 614039 (3)" />
      <node id="Serotonin Neurotransmitter Release Cycle" label="Serotonin Neurotransmitter Release Cycle" />
      <node id="Dysfibrinogenemia, gamma type (3)" label="Dysfibrinogenemia, gamma type (3)" />
      <node id="Striatonigral degeneration, infantile, 271930 (3)" label="Striatonigral degeneration, infantile, 271930 (3)" />
      <node id="Angioedema, hereditary, type III, 610618 (3)" label="Angioedema, hereditary, type III, 610618 (3)" />
      <node id="Leukocyte adhesion deficiency, 116920 (3)" label="Leukocyte adhesion deficiency, 116920 (3)" />
      <node id="Pausing and recovery of HIV-1 elongation" label="Pausing and recovery of HIV-1 elongation" />
      <node id="Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)" label="Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)" />
      <node id="Factor V deficiency, 227400 (3)" label="Factor V deficiency, 227400 (3)" />
      <node id="HIV-1 Transcription Initiation" label="HIV-1 Transcription Initiation" />
      <node id="Factor XIIIB deficiency, 613235 (3)" label="Factor XIIIB deficiency, 613235 (3)" />
      <node id="Colorectal cancer (3)" label="Colorectal cancer (3)" />
      <node id="Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)" label="Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)" />
      <node id="{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)" label="{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)" />
      <node id="Subcortical laminal heteropia, X-linked, 300067 (3)" label="Subcortical laminal heteropia, X-linked, 300067 (3)" />
      <node id="Regulatory RNA pathways" label="Regulatory RNA pathways" />
      <node id="Atrial fibrillation, familial, 12, 614050 (3)" label="Atrial fibrillation, familial, 12, 614050 (3)" />
      <node id="p130Cas linkage to MAPK signaling for integrins" label="p130Cas linkage to MAPK signaling for integrins" />
      <node id="Thrombophilia due to antithrombin III deficiency, 613118 (3)" label="Thrombophilia due to antithrombin III deficiency, 613118 (3)" />
      <node id="Neuropathy, congenital hypomyelinating, 1, 605253 (3)" label="Neuropathy, congenital hypomyelinating, 1, 605253 (3)" />
      <node id="Activation of Kainate Receptors upon glutamate binding" label="Activation of Kainate Receptors upon glutamate binding" />
      <node id="Platelet homeostasis" label="Platelet homeostasis" />
      <node id="Mental retardation, autosomal recessive, 6, 611092 (3)" label="Mental retardation, autosomal recessive, 6, 611092 (3)" />
      <node id="{Deep venous thrombosis, protection against}, 300807 (3)" label="{Deep venous thrombosis, protection against}, 300807 (3)" />
      <node id="{Myocardial infarction, protection against}, 608446 (3)" label="{Myocardial infarction, protection against}, 608446 (3)" />
      <node id="GABA B receptor activation" label="GABA B receptor activation" />
      <node id="Thrombophilia due to HRG deficiency, 613116 (3)" label="Thrombophilia due to HRG deficiency, 613116 (3)" />
      <node id="Thrombocytopenia, neonatal alloimmune (3)" label="Thrombocytopenia, neonatal alloimmune (3)" />
      <node id="Thrombophilia due to elevated HRG, 613116 (1)" label="Thrombophilia due to elevated HRG, 613116 (1)" />
      <node id="Thalassemia due to Hb Lepore (3)" label="Thalassemia due to Hb Lepore (3)" />
      <node id="Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)" label="Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)" />
      <node id="Glanzmann thrombasthenia, 273800 (3)" label="Glanzmann thrombasthenia, 273800 (3)" />
    </nodes>
    <edges>
      <edge id="0" source="Pancreatic cancer, 260350 (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="1" source="Pancreatic cancer, 260350 (3)" target="Hemostasis" />
      <edge id="2" source="Platelet Adhesion to exposed collagen" target="Ehlers-Danlos syndrome, type VIIA, 130060 (3)" />
      <edge id="3" source="Platelet Adhesion to exposed collagen" target="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" />
      <edge id="4" source="Platelet Adhesion to exposed collagen" target="Osteogenesis imperfecta, type III, 259420 (3)" />
      <edge id="5" source="Platelet Adhesion to exposed collagen" target="Osteogenesis imperfecta, type IV, 166220 (3)" />
      <edge id="6" source="Platelet Adhesion to exposed collagen" target="Ehlers-Danlos syndrome, type I, 130000 (3)" />
      <edge id="7" source="Platelet Adhesion to exposed collagen" target="von Willebrand disease, platelet-type, 177820 (3)" />
      <edge id="8" source="Platelet Adhesion to exposed collagen" target="Caffey disease, 114000 (3)" />
      <edge id="9" source="Platelet Adhesion to exposed collagen" target="?Glycoprotein Ia deficiency, 614200 (1)" />
      <edge id="10" source="Platelet Adhesion to exposed collagen" target="Bernard-Soulier syndrome, type B, 231200 (3)" />
      <edge id="11" source="Platelet Adhesion to exposed collagen" target="von Willibrand disease, type 3, 277480 (3)" />
      <edge id="12" source="Platelet Adhesion to exposed collagen" target="{Osteoporosis, postmenopausal}, 166710 (3)" />
      <edge id="13" source="Platelet Adhesion to exposed collagen" target="[Macrothrombocytopenia] (1)" />
      <edge id="14" source="Platelet Adhesion to exposed collagen" target="Platelet glycoprotein IV deficiency, 608404 (3)" />
      <edge id="15" source="Platelet Adhesion to exposed collagen" target="Giant platelet disorder, isolated, 231200 (3)" />
      <edge id="16" source="Platelet Adhesion to exposed collagen" target="[Bone mineral density variation QTL], 166710 (3)" />
      <edge id="17" source="Platelet Adhesion to exposed collagen" target="Osteogenesis imperfecta, type II, 166210 (3)" />
      <edge id="18" source="Platelet Adhesion to exposed collagen" target="{Malaria, cerebral, susceptibility to}, 611162 (3)" />
      <edge id="19" source="Platelet Adhesion to exposed collagen" target="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" />
      <edge id="20" source="Platelet Adhesion to exposed collagen" target="{Coronary heart disease, susceptibility to, 7}, 610938 (3)" />
      <edge id="21" source="Platelet Adhesion to exposed collagen" target="Bleeding disorder, platelet-type, 11, 614201 (3)" />
      <edge id="22" source="Platelet Adhesion to exposed collagen" target="von Willebrand disease, type 1, 193400 (3)" />
      <edge id="23" source="Platelet Adhesion to exposed collagen" target="Ehlers-Danlos syndrome, type VIIB, 130060 (3)" />
      <edge id="24" source="Platelet Adhesion to exposed collagen" target="{Osteoporosis}, 166710 (3)" />
      <edge id="25" source="Platelet Adhesion to exposed collagen" target="OI type II, 166210 (3)" />
      <edge id="26" source="Platelet Adhesion to exposed collagen" target="OI type IV, 166220 (3)" />
      <edge id="27" source="Platelet Adhesion to exposed collagen" target="Osteogenesis imperfecta, type I, 166200 (3)" />
      <edge id="28" source="Platelet Adhesion to exposed collagen" target="{Malaria, cerebral, reduced risk of}, 611162 (3)" />
      <edge id="29" source="Platelet Adhesion to exposed collagen" target="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" />
      <edge id="30" source="Platelet Adhesion to exposed collagen" target="OI type III, 259420 (3)" />
      <edge id="31" source="Platelet Adhesion to exposed collagen" target="Bernard-Soulier syndrome, type C, 231200 (3)" />
      <edge id="32" source="Platelet Adhesion to exposed collagen" target="Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)" />
      <edge id="33" source="Platelet Adhesion to exposed collagen" target="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" />
      <edge id="34" source="Glutamine deficiency, congenital, 610015 (3)" target="Neurotransmitter uptake and Metabolism In Glial Cells" />
      <edge id="35" source="Glutamine deficiency, congenital, 610015 (3)" target="Astrocytic Glutamate-Glutamine Uptake And Metabolism" />
      <edge id="36" source="Glutamine deficiency, congenital, 610015 (3)" target="Neuronal System" />
      <edge id="37" source="Glutamine deficiency, congenital, 610015 (3)" target="Transmission across Chemical Synapses" />
      <edge id="38" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="CREB phosphorylation through the activation of Adenylate Cyclase" />
      <edge id="39" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Developmental Biology" />
      <edge id="40" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="PI3K/AKT activation" />
      <edge id="41" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="42" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Neuronal System" />
      <edge id="43" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Post NMDA receptor activation events" />
      <edge id="44" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="AKT-mediated inactivation of FOXO1A" />
      <edge id="45" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="46" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="CREB phosphorylation through the activation of CaMKII" />
      <edge id="47" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Regulation of beta-cell development" />
      <edge id="48" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Activation of CaMK IV" />
      <edge id="49" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="50" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" />
      <edge id="51" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="CREB phosphorylation through the activation of CaMKK" />
      <edge id="52" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Nuclear Events (kinase and transcription factor activation)" />
      <edge id="53" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Transmission across Chemical Synapses" />
      <edge id="54" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="Axon guidance" />
      <edge id="55" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="PLC-gamma1 signalling" />
      <edge id="56" source="Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)" target="NCAM signaling for neurite out-growth" />
      <edge id="57" source="{?Amyloidosis, secondary, susceptibility to} (1)" target="Amyloids" />
      <edge id="58" source="{Cystic fibrosis lung disease, modifier of}, 219700 (3)" target="Transcriptional Regulation of White Adipocyte Differentiation" />
      <edge id="59" source="{Cystic fibrosis lung disease, modifier of}, 219700 (3)" target="Developmental Biology" />
      <edge id="60" source="Transcriptional Regulation of White Adipocyte Differentiation" target="[High density lipoprotein cholesterol level QTL 11] (3)" />
      <edge id="61" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Malaria, cerebral, susceptibility to}, 611162 (3)" />
      <edge id="62" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Rubinstein-Taybi syndrome, 180849 (3)" />
      <edge id="63" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Asthma, susceptibility to}, 600807 (3)" />
      <edge id="64" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Mental retardation, autosomal recessive 18, 614249 (3)" />
      <edge id="65" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Transposition of the great arteries, dextro-looped 1, 608808 (3)" />
      <edge id="66" source="Transcriptional Regulation of White Adipocyte Differentiation" target="?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)" />
      <edge id="67" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Melanoma, cutaneous malignant, 3}, 609048 (3)" />
      <edge id="68" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Migraine without aura, susceptibility to}, 157300 (3)" />
      <edge id="69" source="Transcriptional Regulation of White Adipocyte Differentiation" target="[Macrothrombocytopenia] (1)" />
      <edge id="70" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Lipodystrophy, familial partial, type 4, 613877 (3)" />
      <edge id="71" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Colorectal cancer, somatic, 114500 (3)" />
      <edge id="72" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Charcot-Marie-Tooth disease, type 2B2, 605589 (3)" />
      <edge id="73" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Septic shock, susceptibility to} (3)" />
      <edge id="74" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Camurati-Engelmann disease, 131300 (3)" />
      <edge id="75" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Platelet glycoprotein IV deficiency, 608404 (3)" />
      <edge id="76" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Lujan-Fryns syndrome, 309520 (3)" />
      <edge id="77" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)" />
      <edge id="78" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Leukemia, acute myeloid, 601626 (3)" />
      <edge id="79" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Adiponectin deficiency, 612556 (3)" />
      <edge id="80" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Combined hyperlipidemia, familial, 144250 (3)" />
      <edge id="81" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Dejerine-Sottas disease, 145900 (3)" />
      <edge id="82" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Diabetes mellitus, noninsulin-dependent}, 125853 (3)" />
      <edge id="83" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Neuropathy, congenital hypomyelinating, 1, 605253 (3)" />
      <edge id="84" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Reduced triglycerides, susceptibility to} (3)" />
      <edge id="85" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Charcot-Marie-Tooth disease, type 1D, 607678 (3)" />
      <edge id="86" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Obesity, morbid, due to leptin deficiency, 614962 (3)" />
      <edge id="87" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Dementia, vascular, susceptibility to} (3)" />
      <edge id="88" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Opitz-Kaveggia syndrome, 305450 (3)" />
      <edge id="89" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Malaria, cerebral, reduced risk of}, 611162 (3)" />
      <edge id="90" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Rubinstein-Taybi syndrome 2, 613684 (3)" />
      <edge id="91" source="Transcriptional Regulation of White Adipocyte Differentiation" target="Lipoprotein lipase deficiency, 238600 (3)" />
      <edge id="92" source="Transcriptional Regulation of White Adipocyte Differentiation" target="{Coronary heart disease, susceptibility to, 7}, 610938 (3)" />
      <edge id="93" source="HIV Infection" target="Xeroderma pigmentosum, group D, 278730 (3)" />
      <edge id="94" source="HIV Infection" target="{Myocardial infarcation, susceptibility to}, 608446 (3)" />
      <edge id="95" source="HIV Infection" target="Trichothiodystrophy, 601675 (3)" />
      <edge id="96" source="HIV Infection" target="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" />
      <edge id="97" source="HIV Infection" target="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <edge id="98" source="HIV Infection" target="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" />
      <edge id="99" source="HIV Infection" target="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" />
      <edge id="100" source="HIV Infection" target="Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)" />
      <edge id="101" source="HIV Infection" target="Leukemia, T-cell acute lymphoblastic (3)" />
      <edge id="102" source="HIV Infection" target="Dystonia-Parkinsonism, X-linked, 314250 (3)" />
      <edge id="103" source="HIV Infection" target="DNA ligase I deficiency (3)" />
      <edge id="104" source="HIV Infection" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="105" source="HIV Infection" target="Spinocerebellar ataxia 17, 607136 (3)" />
      <edge id="106" source="HIV Infection" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="107" source="HIV Infection" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="108" source="HIV Infection" target="Nestor-Guillermo progeria syndrome, 614008 (3)" />
      <edge id="109" source="HIV Infection" target="Leukemia, acute myeloid, 601626 (3)" />
      <edge id="110" source="HIV Infection" target="SCID due to LCK deficiency (1)" />
      <edge id="111" source="HIV Infection" target="{Parkinson disease, susceptibility to}, 168600 (3)" />
      <edge id="112" source="HIV Infection" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="113" source="HIV Infection" target="Hypoproteinemia, hypercatabolic, 241600 (3)" />
      <edge id="114" source="HIV Infection" target="Mental retardation, autosomal dominant 17, 615009 (3)" />
      <edge id="115" source="HIV Infection" target="{Multiple myeloma, resistance to}, 254500 (3)" />
      <edge id="116" source="HIV Infection" target="LIG4 syndrome, 606593 (3)" />
      <edge id="117" source="HIV Infection" target="Xeroderma pigmentosum, group B, 610651 (3)" />
      <edge id="118" source="HIV Infection" target="{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)" />
      <edge id="119" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="120" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="121" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="122" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Hemostasis" />
      <edge id="123" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Common Pathway" />
      <edge id="124" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Thrombin signalling through proteinase activated receptors (PARs)" />
      <edge id="125" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Intrinsic Pathway" />
      <edge id="126" source="{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="127" source="MODY, type II, 125851 (3)" target="Regulation of beta-cell development" />
      <edge id="128" source="MODY, type II, 125851 (3)" target="Developmental Biology" />
      <edge id="129" source="MODY, type II, 125851 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="130" source="Frontometaphyseal dysplasia, 305620 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="131" source="Frontometaphyseal dysplasia, 305620 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="132" source="Frontometaphyseal dysplasia, 305620 (3)" target="Hemostasis" />
      <edge id="133" source="Ovarian cancer, somatic, (3)" target="Sema4D induced cell migration and growth-cone collapse" />
      <edge id="134" source="Ovarian cancer, somatic, (3)" target="Sema4D in semaphorin signaling" />
      <edge id="135" source="Ovarian cancer, somatic, (3)" target="Developmental Biology" />
      <edge id="136" source="Ovarian cancer, somatic, (3)" target="Axon guidance" />
      <edge id="137" source="Ovarian cancer, somatic, (3)" target="Semaphorin interactions" />
      <edge id="138" source="Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)" target="ATP sensitive Potassium channels" />
      <edge id="139" source="Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)" target="Potassium Channels" />
      <edge id="140" source="Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)" target="Neuronal System" />
      <edge id="141" source="Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)" target="Inwardly rectifying K+ channels" />
      <edge id="142" source="Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="143" source="Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="144" source="Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)" target="Hemostasis" />
      <edge id="145" source="Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="146" source="Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)" target="Hemostasis" />
      <edge id="147" source="Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)" target="Common Pathway" />
      <edge id="148" source="Regulation of Signaling by NODAL" target="Heterotaxy, visceral, 5, 270100 (3)" />
      <edge id="149" source="CREB phosphorylation through the activation of CaMKK" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="150" source="Pseudopseudohypoparathyroidism, 612463 (3)" target="Platelet homeostasis" />
      <edge id="151" source="Pseudopseudohypoparathyroidism, 612463 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="152" source="Pseudopseudohypoparathyroidism, 612463 (3)" target="Hemostasis" />
      <edge id="153" source="Meckel syndrome 4, 611134 (3)" target="DNA Replication" />
      <edge id="154" source="Meckel syndrome 4, 611134 (3)" target="Mitotic Prophase" />
      <edge id="155" source="Meckel syndrome 4, 611134 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="156" source="Meckel syndrome 4, 611134 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="157" source="Meckel syndrome 4, 611134 (3)" target="M Phase" />
      <edge id="158" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" />
      <edge id="159" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" />
      <edge id="160" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="161" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" />
      <edge id="162" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="Costello syndrome, 218040 (3)" />
      <edge id="163" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="{Bladder cancer, somatic}, 109800 (3)" />
      <edge id="164" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="{Nevus sebaceous, somatic}, 162900 (3)" />
      <edge id="165" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" />
      <edge id="166" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="Cardiomyopathy, dilated, 1AA, 612158 (3)" />
      <edge id="167" source="Ras activation uopn Ca2+ infux through NMDA receptor" target="Congenital myopathy with excess of muscle spindles, 218040 (3)" />
      <edge id="168" source="COPD, rate of decline of lung function in, 606963 (3)" target="Basigin interactions" />
      <edge id="169" source="COPD, rate of decline of lung function in, 606963 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="170" source="COPD, rate of decline of lung function in, 606963 (3)" target="Hemostasis" />
      <edge id="171" source="Giant platelet disorder, isolated, 231200 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="172" source="Giant platelet disorder, isolated, 231200 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="173" source="Giant platelet disorder, isolated, 231200 (3)" target="Hemostasis" />
      <edge id="174" source="Giant platelet disorder, isolated, 231200 (3)" target="Intrinsic Pathway" />
      <edge id="175" source="Giant platelet disorder, isolated, 231200 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="176" source="Giant platelet disorder, isolated, 231200 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="177" source="Adenocarcinoma of lung, somatic, 211980 (3)" target="Sema4D induced cell migration and growth-cone collapse" />
      <edge id="178" source="Adenocarcinoma of lung, somatic, 211980 (3)" target="Sema4D in semaphorin signaling" />
      <edge id="179" source="Adenocarcinoma of lung, somatic, 211980 (3)" target="Developmental Biology" />
      <edge id="180" source="Adenocarcinoma of lung, somatic, 211980 (3)" target="Axon guidance" />
      <edge id="181" source="Adenocarcinoma of lung, somatic, 211980 (3)" target="Semaphorin interactions" />
      <edge id="182" source="Lhermitte-Duclos syndrome, 158350 (3)" target="PI3K/AKT activation" />
      <edge id="183" source="Hypobetalipoproteinemia, normotriglyceridemic (3)" target="Platelet sensitization by LDL" />
      <edge id="184" source="Hypobetalipoproteinemia, normotriglyceridemic (3)" target="Platelet homeostasis" />
      <edge id="185" source="Hypobetalipoproteinemia, normotriglyceridemic (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="186" source="Hypobetalipoproteinemia, normotriglyceridemic (3)" target="Hemostasis" />
      <edge id="187" source="VATER association with macrocephaly and ventriculomegaly, 276950 (3)" target="PI3K/AKT activation" />
      <edge id="188" source="Bleeding disorder, platelet-type, 8, 609821 (3)" target="ADP signalling through P2Y purinoceptor 12" />
      <edge id="189" source="Bleeding disorder, platelet-type, 8, 609821 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="190" source="Bleeding disorder, platelet-type, 8, 609821 (3)" target="Signal amplification" />
      <edge id="191" source="Bleeding disorder, platelet-type, 8, 609821 (3)" target="Hemostasis" />
      <edge id="192" source="Fanconi-Bickel syndrome, 227810 (3)" target="Regulation of beta-cell development" />
      <edge id="193" source="Fanconi-Bickel syndrome, 227810 (3)" target="Developmental Biology" />
      <edge id="194" source="Fanconi-Bickel syndrome, 227810 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="195" source="Mental retardation, X-linked, syndromic 14, 300676 (3)" target="Post-Elongation Processing of Intron-Containing pre-mRNA" />
      <edge id="196" source="Mental retardation, X-linked, syndromic 14, 300676 (3)" target="Post-Elongation Processing of the Transcript" />
      <edge id="197" source="Mental retardation, X-linked, syndromic 14, 300676 (3)" target="mRNA 3'-end processing" />
      <edge id="198" source="ATP sensitive Potassium channels" target="Diabetes mellitus, permanent neonatal, 606176 (3)" />
      <edge id="199" source="ATP sensitive Potassium channels" target="Diabetes mellitus, noninsulin-dependent, 125853 (3)" />
      <edge id="200" source="ATP sensitive Potassium channels" target="Atrial fibrillation, familial, 12, 614050 (3)" />
      <edge id="201" source="ATP sensitive Potassium channels" target="Hypertrichotic osteochondrodysplasia, 239850 (3)" />
      <edge id="202" source="ATP sensitive Potassium channels" target="Hypoglycemia of infancy, leucine-sensitive, 240800 (3)" />
      <edge id="203" source="ATP sensitive Potassium channels" target="Cardiomyopathy, dilated, 1O, 608569 (3)" />
      <edge id="204" source="ATP sensitive Potassium channels" target="Diabetes mellitus, transient neonatal 2, 610374 (3)" />
      <edge id="205" source="Fanconi anemia, complementation group 0, 613390 (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="206" source="Fanconi anemia, complementation group 0, 613390 (3)" target="Hemostasis" />
      <edge id="207" source="Thalassemias, beta-, 613985 (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="208" source="Thalassemias, beta-, 613985 (3)" target="Hemostasis" />
      <edge id="209" source="Noonan syndrome 5, 611553 (3)" target="SOS-mediated signalling" />
      <edge id="210" source="Noonan syndrome 5, 611553 (3)" target="MEK activation" />
      <edge id="211" source="Noonan syndrome 5, 611553 (3)" target="RAF/MAP kinase cascade" />
      <edge id="212" source="Noonan syndrome 5, 611553 (3)" target="Developmental Biology" />
      <edge id="213" source="Noonan syndrome 5, 611553 (3)" target="Hemostasis" />
      <edge id="214" source="Noonan syndrome 5, 611553 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="215" source="Noonan syndrome 5, 611553 (3)" target="Neuronal System" />
      <edge id="216" source="Noonan syndrome 5, 611553 (3)" target="Post NMDA receptor activation events" />
      <edge id="217" source="Noonan syndrome 5, 611553 (3)" target="Axon guidance" />
      <edge id="218" source="Noonan syndrome 5, 611553 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="219" source="Noonan syndrome 5, 611553 (3)" target="RAF activation" />
      <edge id="220" source="Noonan syndrome 5, 611553 (3)" target="NCAM signaling for neurite out-growth" />
      <edge id="221" source="Noonan syndrome 5, 611553 (3)" target="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" />
      <edge id="222" source="Noonan syndrome 5, 611553 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="223" source="Noonan syndrome 5, 611553 (3)" target="Transmission across Chemical Synapses" />
      <edge id="224" source="Noonan syndrome 5, 611553 (3)" target="RAF phosphorylates MEK" />
      <edge id="225" source="Noonan syndrome 5, 611553 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="226" source="Prolonged bleeding time, brachydactyly and mental retardation (3)" target="Platelet homeostasis" />
      <edge id="227" source="Prolonged bleeding time, brachydactyly and mental retardation (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="228" source="Prolonged bleeding time, brachydactyly and mental retardation (3)" target="Hemostasis" />
      <edge id="229" source="Microcephaly 9, primary, autosomal recessive, 614852 (3)" target="DNA Replication" />
      <edge id="230" source="Microcephaly 9, primary, autosomal recessive, 614852 (3)" target="Mitotic Prophase" />
      <edge id="231" source="Microcephaly 9, primary, autosomal recessive, 614852 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="232" source="Microcephaly 9, primary, autosomal recessive, 614852 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="233" source="Microcephaly 9, primary, autosomal recessive, 614852 (3)" target="M Phase" />
      <edge id="234" source="OI type II, 166210 (3)" target="Hemostasis" />
      <edge id="235" source="Cardiomyopathy, dilated, 1N, 607487 (3)" target="Striated Muscle Contraction" />
      <edge id="236" source="Cardiomyopathy, dilated, 1N, 607487 (3)" target="Muscle contraction" />
      <edge id="237" source="{Myocardial infarcation, susceptibility to}, 608446 (3)" target="DNA Replication" />
      <edge id="238" source="{Myocardial infarcation, susceptibility to}, 608446 (3)" target="Vif-mediated degradation of APOBEC3G" />
      <edge id="239" source="{Myocardial infarcation, susceptibility to}, 608446 (3)" target="Host Interactions of HIV factors" />
      <edge id="240" source="{Myocardial infarcation, susceptibility to}, 608446 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="241" source="{Myocardial infarcation, susceptibility to}, 608446 (3)" target="Vpu mediated degradation of CD4" />
      <edge id="242" source="Hypofibrinogenemia, gamma type (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="243" source="Hypofibrinogenemia, gamma type (3)" target="Hemostasis" />
      <edge id="244" source="Hypofibrinogenemia, gamma type (3)" target="Common Pathway" />
      <edge id="245" source="Retinitis pigmentosa 38, 613862 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="246" source="Retinitis pigmentosa 38, 613862 (3)" target="Hemostasis" />
      <edge id="247" source="{Malaria, cerebral, susceptibility to}, 611162 (3)" target="Developmental Biology" />
      <edge id="248" source="{Malaria, cerebral, susceptibility to}, 611162 (3)" target="Hemostasis" />
      <edge id="249" source="Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells" target="Aortic valve disease, 109730 (3)" />
      <edge id="250" source="Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells" target="Leukemia, T-cell acute lymphoblastic (2)" />
      <edge id="251" source="Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells" target="Diarrhea 4, malabsorptive, congenital, 610370 (3)" />
      <edge id="252" source="Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)" target="Neurotransmitter Release Cycle" />
      <edge id="253" source="Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)" target="Neuronal System" />
      <edge id="254" source="Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)" target="GABA synthesis, release, reuptake and degradation" />
      <edge id="255" source="Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)" target="Transmission across Chemical Synapses" />
      <edge id="256" source="Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="257" source="Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="258" source="Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)" target="Hemostasis" />
      <edge id="259" source="Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)" target="Common Pathway" />
      <edge id="260" source="Retinitis pigmentosa 35, 610282 (3)" target="Developmental Biology" />
      <edge id="261" source="Retinitis pigmentosa 35, 610282 (3)" target="Semaphorin interactions" />
      <edge id="262" source="Retinitis pigmentosa 35, 610282 (3)" target="Axon guidance" />
      <edge id="263" source="Retinitis pigmentosa 35, 610282 (3)" target="Other semaphorin interactions" />
      <edge id="264" source="Serotonin clearance from the synaptic cleft" target="Brunner syndrome, 300615 (3)" />
      <edge id="265" source="Serotonin clearance from the synaptic cleft" target="{Esophageal cancer, alcohol-related, susceptibility to} (3)" />
      <edge id="266" source="Serotonin clearance from the synaptic cleft" target="{Hangover, susceptibility to}, 610251 (3)" />
      <edge id="267" source="Serotonin clearance from the synaptic cleft" target="{Sublingual nitroglycerin, susceptibility to poor response to} (3)" />
      <edge id="268" source="Serotonin clearance from the synaptic cleft" target="Alcohol sensitivity, acute, 610251 (3)" />
      <edge id="269" source="Post-Elongation Processing of the Transcript" target="Thrombocytopenia-absent radius syndrome, 274000 (3)" />
      <edge id="270" source="Post-Elongation Processing of the Transcript" target="Oculopharyngeal muscular dystrophy, 164300 (3)" />
      <edge id="271" source="Nef Mediated CD8 Down-regulation" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="272" source="{Meningioma}, 607174 (3)" target="PI3K/AKT activation" />
      <edge id="273" source="Thrombocythemia 2, 601977 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="274" source="Thrombocythemia 2, 601977 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="275" source="Thrombocythemia 2, 601977 (3)" target="Hemostasis" />
      <edge id="276" source="Leukemia, T-cell acute lymphoblastic (3)" target="HIV Life Cycle" />
      <edge id="277" source="Leukemia, T-cell acute lymphoblastic (3)" target="Nuclear import of Rev protein" />
      <edge id="278" source="Leukemia, T-cell acute lymphoblastic (3)" target="Rev-mediated nuclear export of HIV-1 RNA" />
      <edge id="279" source="Leukemia, T-cell acute lymphoblastic (3)" target="Interactions of Vpr with host cellular proteins" />
      <edge id="280" source="Leukemia, T-cell acute lymphoblastic (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="281" source="Leukemia, T-cell acute lymphoblastic (3)" target="Host Interactions of HIV factors" />
      <edge id="282" source="Leukemia, T-cell acute lymphoblastic (3)" target="Vpr-mediated nuclear import of PICs" />
      <edge id="283" source="Leukemia, T-cell acute lymphoblastic (3)" target="Interactions of Rev with host cellular proteins" />
      <edge id="284" source="Hemostasis" target="Nasopharyngeal carcinoma, 607107 (3)" />
      <edge id="285" source="Hemostasis" target="Cardiac valvular dysplasia, X-linked, 314400 (3)" />
      <edge id="286" source="Hemostasis" target="Ehlers-Danlos syndrome, type VIIA, 130060 (3)" />
      <edge id="287" source="Hemostasis" target="Factor XI deficiency, autosomal dominant, 612416 (3)" />
      <edge id="288" source="Hemostasis" target="Ehlers-Danlos syndrome, type I, 130000 (3)" />
      <edge id="289" source="Hemostasis" target="von Willebrand disease, platelet-type, 177820 (3)" />
      <edge id="290" source="Hemostasis" target="Erythrocytosis, somatic, 133100 (3)" />
      <edge id="291" source="Hemostasis" target="Gaucher disease, atypical, 610539 (3)" />
      <edge id="292" source="Hemostasis" target="Afibrinogenemia, congenital, 202400 (3)" />
      <edge id="293" source="Hemostasis" target="?Glycoprotein Ia deficiency, 614200 (1)" />
      <edge id="294" source="Hemostasis" target="Complement component 4, partial deficiency of, 120790 (3)" />
      <edge id="295" source="Hemostasis" target="[Macrothrombocytopenia] (1)" />
      <edge id="296" source="Hemostasis" target="Alpha-2-macroglobulin deficiency, 614036 (1)" />
      <edge id="297" source="Hemostasis" target="[Blood group, OK], 111380 (3)" />
      <edge id="298" source="Hemostasis" target="Fetal hemoglobin quantitative trait locus 1, 141749 (3)" />
      <edge id="299" source="Hemostasis" target="Purpura, posttransfusion (3)" />
      <edge id="300" source="Hemostasis" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="301" source="Hemostasis" target="Factor X deficiency, 227600 (3)" />
      <edge id="302" source="Hemostasis" target="Prolonged bleeding time, brachydactyly, and mental retardation (3)" />
      <edge id="303" source="Hemostasis" target="Heterotopia, periventricular, ED variant, 300537 (3)" />
      <edge id="304" source="Hemostasis" target="[Bone mineral density variation QTL], 166710 (3)" />
      <edge id="305" source="Hemostasis" target="{Budd-Chiari syndrome}, 600880 (3)" />
      <edge id="306" source="Hemostasis" target="Heinz body anemias, beta-, 140700 (3)" />
      <edge id="307" source="Hemostasis" target="Agammaglobulinemia 7, autosomal recessive, 615214 (3)" />
      <edge id="308" source="Hemostasis" target="Myelofibrosis, somatic, 254450 (3)" />
      <edge id="309" source="Hemostasis" target="Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)" />
      <edge id="310" source="Hemostasis" target="Plasminogen activator inhibitor-1 deficiency, 613329 (3)" />
      <edge id="311" source="Hemostasis" target="Hepatocellular carcinoma, 114550 (3)" />
      <edge id="312" source="Hemostasis" target="Otopalatodigital syndrome, type I, 311300 (3)" />
      <edge id="313" source="Hemostasis" target="Leukocyte adhesion deficiency, 116920 (3)" />
      <edge id="314" source="Hemostasis" target="{Myocardial infarction, susceptibility to}, 608446 (3)" />
      <edge id="315" source="Hemostasis" target="Thrombocytopenia, congenital amegakaryocytic, 604498 (3)" />
      <edge id="316" source="Hemostasis" target="Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)" />
      <edge id="317" source="Hemostasis" target="Breast cancer, 114480 (3)" />
      <edge id="318" source="Hemostasis" target="[Kininogen deficiency], 228960 (3)" />
      <edge id="319" source="Hemostasis" target="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" />
      <edge id="320" source="Hemostasis" target="Hereditary persistence of fetal hemoglobin, 141749 (3)" />
      <edge id="321" source="Hemostasis" target="Bernard-Soulier syndrome, type C, 231200 (3)" />
      <edge id="322" source="Hemostasis" target="Thrombophilia, dysfibrinogenemic (3)" />
      <edge id="323" source="Hemostasis" target="Pseudohypoparathyroidism Ib, 603233 (3)" />
      <edge id="324" source="Hemostasis" target="{Insulin resistance, susceptibility to}, 125853 (3)" />
      <edge id="325" source="Hemostasis" target="{Myocardial infarction, decreased susceptibility to}, 608446 (3)" />
      <edge id="326" source="Hemostasis" target="Combined SAP deficiency, 611721 (3)" />
      <edge id="327" source="Hemostasis" target="{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)" />
      <edge id="328" source="Hemostasis" target="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" />
      <edge id="329" source="Hemostasis" target="Phospholipase A2, group IV A, deficiency of (3)" />
      <edge id="330" source="Hemostasis" target="{Rheumatoid arthritis, susceptibility to}, 180300 (3)" />
      <edge id="331" source="Hemostasis" target="Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)" />
      <edge id="332" source="Hemostasis" target="Factor V deficiency, 227400 (3)" />
      <edge id="333" source="Hemostasis" target="Colorectal cancer, 114500 (3)" />
      <edge id="334" source="Hemostasis" target="Plasminogen Tochigi disease (3)" />
      <edge id="335" source="Hemostasis" target="Venous malformations, multiple cutaneous and mucosal, 600195 (3)" />
      <edge id="336" source="Hemostasis" target="von Willibrand disease, type 3, 277480 (3)" />
      <edge id="337" source="Hemostasis" target="Osteogenesis imperfecta, type II, 166210 (3)" />
      <edge id="338" source="Hemostasis" target="Thrombophilia, X-linked, due to factor IX defect, 300807 (3)" />
      <edge id="339" source="Hemostasis" target="Myelodysplastic syndrome, preleukemic (3)" />
      <edge id="340" source="Hemostasis" target="Amyloidosis, hereditary renal, 105200 (3)" />
      <edge id="341" source="Hemostasis" target="Factor XI deficiency, autosomal recessive, 612416 (3)" />
      <edge id="342" source="Hemostasis" target="Myelogenous leukemia, acute (3)" />
      <edge id="343" source="Hemostasis" target="Lipodystrophy, congenital generalized, type 3, 612526 (3)" />
      <edge id="344" source="Hemostasis" target="Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)" />
      <edge id="345" source="Hemostasis" target="Otopalatodigital syndrome, type II, 304120 (3)" />
      <edge id="346" source="Hemostasis" target="Familial cold autoinflammatory syndrome 3, 614468 (3)" />
      <edge id="347" source="Hemostasis" target="Nonsmall cell lung cancer, somatic, 211980 (3)" />
      <edge id="348" source="Hemostasis" target="Hypoprothrombinemia, 613679 (3)" />
      <edge id="349" source="Hemostasis" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="350" source="Hemostasis" target="McCune-Albright syndrome, 174800 (3)" />
      <edge id="351" source="Hemostasis" target="Bernard-Soulier syndrome, type B, 231200 (3)" />
      <edge id="352" source="Hemostasis" target="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" />
      <edge id="353" source="Hemostasis" target="Quebec platelet disorder, 601709 (3)" />
      <edge id="354" source="Hemostasis" target="OI type IV, 166220 (3)" />
      <edge id="355" source="Hemostasis" target="Intestinal pseudoobstruction, neuronal, 300048 (3)" />
      <edge id="356" source="Hemostasis" target="Fletcher factor deficiency, 612423 (3)" />
      <edge id="357" source="Hemostasis" target="Hypobetalipoproteinemia (3)" />
      <edge id="358" source="Hemostasis" target="Osteogenesis imperfecta, type I, 166200 (3)" />
      <edge id="359" source="Hemostasis" target="{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)" />
      <edge id="360" source="Hemostasis" target="{Osteoporosis, postmenopausal}, 166710 (3)" />
      <edge id="361" source="Hemostasis" target="Erythremias, beta- (3)" />
      <edge id="362" source="Hemostasis" target="{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)" />
      <edge id="363" source="Hemostasis" target="Thalassemia, delta- (3)" />
      <edge id="364" source="Hemostasis" target="LEOPARD syndrome 1, 151100 (3)" />
      <edge id="365" source="Hemostasis" target="Noonan syndrome 1, 163950 (3)" />
      <edge id="366" source="Hemostasis" target="Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)" />
      <edge id="367" source="Hemostasis" target="Polycythemia vera, 263300 (3)" />
      <edge id="368" source="Hemostasis" target="Conjunctivitis, ligneous, 217090 (3)" />
      <edge id="369" source="Hemostasis" target="{Basal cell carcinoma 7}, 614740 (3)" />
      <edge id="370" source="Hemostasis" target="Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)" />
      <edge id="371" source="Hemostasis" target="{Osteoporosis}, 166710 (3)" />
      <edge id="372" source="Hemostasis" target="Terminal osseous dysplasia, 300244 (3)" />
      <edge id="373" source="Hemostasis" target="Thrombophilia due to thrombomodulin defect, 614486 (3)" />
      <edge id="374" source="Hemostasis" target="Osteosarcoma, 259500 (3)" />
      <edge id="375" source="Hemostasis" target="{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)" />
      <edge id="376" source="Hemostasis" target="Thalassemia-beta, dominant inclusion-body, 603902 (3)" />
      <edge id="377" source="Hemostasis" target="Factor VII deficiency, 227500 (3)" />
      <edge id="378" source="Hemostasis" target="Thrombocythemia 3, 614521 (3)" />
      <edge id="379" source="Hemostasis" target="Metachondromatosis, 156250 (3)" />
      <edge id="380" source="Hemostasis" target="Plasma fibronectin deficiency, 614101 (1)" />
      <edge id="381" source="Hemostasis" target="Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)" />
      <edge id="382" source="Hemostasis" target="Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)" />
      <edge id="383" source="Hemostasis" target="ACTH-independent macronodular adrenal hyperplasia, 219080 (3)" />
      <edge id="384" source="Hemostasis" target="Platelet glycoprotein IV deficiency, 608404 (3)" />
      <edge id="385" source="Hemostasis" target="{Warfarin sensitivity}, 122700 (3)" />
      <edge id="386" source="Hemostasis" target="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" />
      <edge id="387" source="Hemostasis" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="388" source="Hemostasis" target="Myopathy, tubular aggregate, 160565 (3)" />
      <edge id="389" source="Hemostasis" target="Thrombophilia due to activated protein C resistance, 188055 (3)" />
      <edge id="390" source="Hemostasis" target="Bleeding disorder due to P2RX1 defect (3)" />
      <edge id="391" source="Hemostasis" target="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" />
      <edge id="392" source="Hemostasis" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="393" source="Hemostasis" target="Melnick-Needles syndrome, 309350 (3)" />
      <edge id="394" source="Hemostasis" target="{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)" />
      <edge id="395" source="Hemostasis" target="{Coronary heart disease, susceptibility to, 7}, 610938 (3)" />
      <edge id="396" source="Hemostasis" target="von Willebrand disease, type 1, 193400 (3)" />
      <edge id="397" source="Hemostasis" target="Ehlers-Danlos syndrome, type VIIB, 130060 (3)" />
      <edge id="398" source="Hemostasis" target="Alpha-2-plasmin inhibitor deficiency, 262850 (3)" />
      <edge id="399" source="Hemostasis" target="Krabbe disease, atypical, 611722 (3)" />
      <edge id="400" source="Hemostasis" target="{Glioma susceptibility 1}, 137800 (3)" />
      <edge id="401" source="Hemostasis" target="{Stroke, ischemic, susceptibility to}, 601367 (3)" />
      <edge id="402" source="Hemostasis" target="Heterotopia, periventricular, 300049 (3)" />
      <edge id="403" source="Hemostasis" target="[High molecular weight kininogen deficiency], 228960 (3)" />
      <edge id="404" source="Hemostasis" target="Choroid plexus papilloma, 260500 (3)" />
      <edge id="405" source="Hemostasis" target="{Deep venous thrombosis, protection against}, 300807 (3)" />
      <edge id="406" source="Hemostasis" target="{Malaria, cerebral, reduced risk of}, 611162 (3)" />
      <edge id="407" source="Hemostasis" target="{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)" />
      <edge id="408" source="Hemostasis" target="Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)" />
      <edge id="409" source="Hemostasis" target="Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)" />
      <edge id="410" source="Hemostasis" target="Adrenal cortical carcinoma, 202300 (3)" />
      <edge id="411" source="Hemostasis" target="Methemoglobinemias, beta- (3)" />
      <edge id="412" source="Hemostasis" target="Glomerulopathy with fibronectin deposits 2, 601894 (3)" />
      <edge id="413" source="Hemostasis" target="Dysfibrinogenemia, beta type (3)" />
      <edge id="414" source="Hemostasis" target="Acid-labile subunit, deficiency of (3)" />
      <edge id="415" source="Hemostasis" target="Osteogenesis imperfecta, type III, 259420 (3)" />
      <edge id="416" source="Hemostasis" target="Osteogenesis imperfecta, type IV, 166220 (3)" />
      <edge id="417" source="Hemostasis" target="Leukemia, juvenile myelomonocytic, 607785 (3)" />
      <edge id="418" source="Hemostasis" target="FG syndrome 2, 300321 (3)" />
      <edge id="419" source="Hemostasis" target="{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)" />
      <edge id="420" source="Hemostasis" target="Hemophilia B, 306900 (3)" />
      <edge id="421" source="Hemostasis" target="Pseudohypoparathyroidism Ic, 612462 (3)" />
      <edge id="422" source="Hemostasis" target="{Transcription of plasminogen activator inhibitor, modulator of} (3)" />
      <edge id="423" source="Hemostasis" target="Leukemia, acute myelogenous, 601626 (3)" />
      <edge id="424" source="Hemostasis" target="Thrombocythemia 1, 187950 (3)" />
      <edge id="425" source="Hemostasis" target="Plasminogen deficiency, types I and II (1)" />
      <edge id="426" source="Hemostasis" target="Sickle cell anemia, 603903 (3)" />
      <edge id="427" source="Hemostasis" target="Dysfibrinogenemia, gamma type (3)" />
      <edge id="428" source="Hemostasis" target="Delta-beta thalassemia, 141749 (3)" />
      <edge id="429" source="Hemostasis" target="Thrombophilia, dysplasminogenemic (1)" />
      <edge id="430" source="Hemostasis" target="Angioedema, hereditary, type III, 610618 (3)" />
      <edge id="431" source="Hemostasis" target="Osseous heteroplasia, progressive, 166350 (3)" />
      <edge id="432" source="Hemostasis" target="Factor XIIIA deficiency, 613225 (3)" />
      <edge id="433" source="Hemostasis" target="Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)" />
      <edge id="434" source="Hemostasis" target="Caffey disease, 114000 (3)" />
      <edge id="435" source="Hemostasis" target="Factor XIIIB deficiency, 613235 (3)" />
      <edge id="436" source="Hemostasis" target="Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)" />
      <edge id="437" source="Hemostasis" target="Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)" />
      <edge id="438" source="Hemostasis" target="{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)" />
      <edge id="439" source="Hemostasis" target="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" />
      <edge id="440" source="Hemostasis" target="{Venous thrombosis, protection against}, 188050 (3)" />
      <edge id="441" source="Hemostasis" target="Bleeding disorder, platelet-type, 11, 614201 (3)" />
      <edge id="442" source="Hemostasis" target="Acromegaly, 102200 (3)" />
      <edge id="443" source="Hemostasis" target="Thrombophilia due to antithrombin III deficiency, 613118 (3)" />
      <edge id="444" source="Hemostasis" target="Pseudohypoparathyroidism Ia, 103580 (3)" />
      <edge id="445" source="Hemostasis" target="{Malaria, resistance to}, 611162 (3)" />
      <edge id="446" source="Hemostasis" target="Angioedema, hereditary, types I and II, 106100 (3)" />
      <edge id="447" source="Hemostasis" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="448" source="Hemostasis" target="Li-Fraumeni syndrome, 151623 (3)" />
      <edge id="449" source="Hemostasis" target="{Myocardial infarction, protection against}, 608446 (3)" />
      <edge id="450" source="Hemostasis" target="Dysprothrombinemia, 613679 (3)" />
      <edge id="451" source="Hemostasis" target="Thrombophilia due to HRG deficiency, 613116 (3)" />
      <edge id="452" source="Hemostasis" target="Hemophilia A, 306700 (3)" />
      <edge id="453" source="Hemostasis" target="Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)" />
      <edge id="454" source="Hemostasis" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="455" source="Hemostasis" target="Gastric cancer, somatic, 613659 (3)" />
      <edge id="456" source="Hemostasis" target="{T-cell acute lymphoblastic leukemia} (3)" />
      <edge id="457" source="Hemostasis" target="OI type III, 259420 (3)" />
      <edge id="458" source="Hemostasis" target="{Alzheimer disease, susceptibility to}, 104300 (3)" />
      <edge id="459" source="Hemostasis" target="Thalassemia due to Hb Lepore (3)" />
      <edge id="460" source="Hemostasis" target="Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)" />
      <edge id="461" source="Hemostasis" target="Factor XII deficiency, 234000 (3)" />
      <edge id="462" source="Hemostasis" target="Thrombophilia due to elevated HRG, 613116 (1)" />
      <edge id="463" source="Myelodysplastic syndrome, preleukemic (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="464" source="Xeroderma pigmentosum, group B, 610651 (3)" target="HIV-1 Transcription Initiation" />
      <edge id="465" source="Xeroderma pigmentosum, group B, 610651 (3)" target="RNA Polymerase II HIV-1 Promoter Escape" />
      <edge id="466" source="Xeroderma pigmentosum, group B, 610651 (3)" target="Transcription of the HIV genome" />
      <edge id="467" source="Xeroderma pigmentosum, group B, 610651 (3)" target="RNA Pol II CTD phosphorylation and interaction with CE" />
      <edge id="468" source="Xeroderma pigmentosum, group B, 610651 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="469" source="Xeroderma pigmentosum, group B, 610651 (3)" target="HIV-1 Transcription Elongation" />
      <edge id="470" source="Xeroderma pigmentosum, group B, 610651 (3)" target="Formation of the HIV-1 Early Elongation Complex" />
      <edge id="471" source="Xeroderma pigmentosum, group B, 610651 (3)" target="Tat-mediated elongation of the HIV-1 transcript" />
      <edge id="472" source="Xeroderma pigmentosum, group B, 610651 (3)" target="Formation of HIV-1 elongation complex containing HIV-1 Tat" />
      <edge id="473" source="Xeroderma pigmentosum, group B, 610651 (3)" target="Formation of HIV-1 elongation complex in the absence of HIV-1 Tat" />
      <edge id="474" source="Xeroderma pigmentosum, group B, 610651 (3)" target="HIV Life Cycle" />
      <edge id="475" source="Myelogenous leukemia, acute (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="476" source="Diamond-Blackfan anemia 1, 105650 (3)" target="Regulation of beta-cell development" />
      <edge id="477" source="Diamond-Blackfan anemia 1, 105650 (3)" target="Developmental Biology" />
      <edge id="478" source="Diamond-Blackfan anemia 1, 105650 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="479" source="Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)" target="DNA Replication" />
      <edge id="480" source="Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)" target="Mitotic Prophase" />
      <edge id="481" source="Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="482" source="Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="483" source="Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)" target="M Phase" />
      <edge id="484" source="Muscle contraction" target="Nemaline myopathy 2, autosomal recessive, 256030 (3)" />
      <edge id="485" source="Muscle contraction" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="486" source="Muscle contraction" target="Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)" />
      <edge id="487" source="Muscle contraction" target="Muscular dystrophy, limb-girdle, type 2G, 601954 (3)" />
      <edge id="488" source="Muscle contraction" target="Tibial muscular dystrophy, tardive, 600334 (3)" />
      <edge id="489" source="Muscle contraction" target="Aortic aneurysm, familial thoracic 7, 613780 (3)" />
      <edge id="490" source="Muscle contraction" target="Duchenne muscular dystrophy, 310200 (3)" />
      <edge id="491" source="Muscle contraction" target="Cardiomyopathy, dilated, 3B, 302045 (3)" />
      <edge id="492" source="Muscle contraction" target="Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)" />
      <edge id="493" source="Muscle contraction" target="Cardiomyopathy, dilated, 1G, 604145 (3)" />
      <edge id="494" source="Muscle contraction" target="Cardiomyopathy, familial hypertrophic, 9, 613765 (3)" />
      <edge id="495" source="Muscle contraction" target="Muscular dystrophy, limb-girdle, type 2J, 608807 (3)" />
      <edge id="496" source="Muscle contraction" target="Cataract, pulverulent, autosomal dominant (3)" />
      <edge id="497" source="Muscle contraction" target="Myopathy, myofibrillar, 1, 601419 (3)" />
      <edge id="498" source="Muscle contraction" target="Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)" />
      <edge id="499" source="Muscle contraction" target="Becker muscular dystrophy, 300376 (3)" />
      <edge id="500" source="Muscle contraction" target="Cardiomyopathy, dilated, 1W, 611407 (3)" />
      <edge id="501" source="Muscle contraction" target="Cardiomyopathy, familial hypertrophic, 15, 613255 (3)" />
      <edge id="502" source="Muscle contraction" target="Cardiomyopathy, dilated, 1I, 604765 (3)" />
      <edge id="503" source="ERK1 activation" target="Cardiofaciocutaneous syndrome, 115150 (3)" />
      <edge id="504" source="Smooth Muscle Contraction" target="Cardiomyopathy, dilated, 1W, 611407 (3)" />
      <edge id="505" source="Smooth Muscle Contraction" target="Cardiomyopathy, familial hypertrophic, 15, 613255 (3)" />
      <edge id="506" source="Smooth Muscle Contraction" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="507" source="Smooth Muscle Contraction" target="Aortic aneurysm, familial thoracic 7, 613780 (3)" />
      <edge id="508" source="{Accelerated tumor formation, susceptibility to}, 614401 (3)" target="Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity" />
      <edge id="509" source="{Accelerated tumor formation, susceptibility to}, 614401 (3)" target="PI3K/AKT activation" />
      <edge id="510" source="{Accelerated tumor formation, susceptibility to}, 614401 (3)" target="Neuronal System" />
      <edge id="511" source="{Accelerated tumor formation, susceptibility to}, 614401 (3)" target="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" />
      <edge id="512" source="{Accelerated tumor formation, susceptibility to}, 614401 (3)" target="Transmission across Chemical Synapses" />
      <edge id="513" source="{Accelerated tumor formation, susceptibility to}, 614401 (3)" target="Trafficking of AMPA receptors" />
      <edge id="514" source="NCAM signaling for neurite out-growth" target="Huntington disease-like 1, 603218 (3)" />
      <edge id="515" source="NCAM signaling for neurite out-growth" target="{Kuru, susceptibility to}, 245300 (3)" />
      <edge id="516" source="NCAM signaling for neurite out-growth" target="Leukemia, juvenile myelomonocytic, 607785 (3)" />
      <edge id="517" source="NCAM signaling for neurite out-growth" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="518" source="NCAM signaling for neurite out-growth" target="Insomnia, fatal familial, 600072 (3)" />
      <edge id="519" source="NCAM signaling for neurite out-growth" target="Metachondromatosis, 156250 (3)" />
      <edge id="520" source="NCAM signaling for neurite out-growth" target="Purpura, posttransfusion (3)" />
      <edge id="521" source="NCAM signaling for neurite out-growth" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="522" source="NCAM signaling for neurite out-growth" target="Creutzfeldt-Jakob disease, 123400 (3)" />
      <edge id="523" source="NCAM signaling for neurite out-growth" target="Gerstmann-Straussler disease, 137440 (3)" />
      <edge id="524" source="NCAM signaling for neurite out-growth" target="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" />
      <edge id="525" source="NCAM signaling for neurite out-growth" target="Myasthenia, limb-girdle, familial, 254300 (3)" />
      <edge id="526" source="NCAM signaling for neurite out-growth" target="Cardiofaciocutaneous syndrome, 115150 (3)" />
      <edge id="527" source="NCAM signaling for neurite out-growth" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="528" source="NCAM signaling for neurite out-growth" target="{Myocardial infarction, susceptibility to}, 608446 (3)" />
      <edge id="529" source="NCAM signaling for neurite out-growth" target="Prion disease with protracted course, 606688 (3)" />
      <edge id="530" source="NCAM signaling for neurite out-growth" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="531" source="NCAM signaling for neurite out-growth" target="LEOPARD syndrome 1, 151100 (3)" />
      <edge id="532" source="NCAM signaling for neurite out-growth" target="Noonan syndrome 1, 163950 (3)" />
      <edge id="533" source="NCAM signaling for neurite out-growth" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="534" source="Trafficking of AMPA receptors" target="Mental retardation, autosomal dominant 11, 614257 (3)" />
      <edge id="535" source="Corpus callosum, partial agenesis of, 304100 (3)" target="Neurofascin interactions" />
      <edge id="536" source="Corpus callosum, partial agenesis of, 304100 (3)" target="Signal transduction by L1" />
      <edge id="537" source="Corpus callosum, partial agenesis of, 304100 (3)" target="Developmental Biology" />
      <edge id="538" source="Corpus callosum, partial agenesis of, 304100 (3)" target="Axon guidance" />
      <edge id="539" source="Corpus callosum, partial agenesis of, 304100 (3)" target="Interaction between L1 and Ankyrins" />
      <edge id="540" source="Corpus callosum, partial agenesis of, 304100 (3)" target="L1CAM interactions" />
      <edge id="541" source="Corpus callosum, partial agenesis of, 304100 (3)" target="Recycling pathway of L1" />
      <edge id="542" source="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" target="Ca2+ activated K+ channels" />
      <edge id="543" source="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" target="Potassium Channels" />
      <edge id="544" source="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" target="Neuronal System" />
      <edge id="545" source="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" target="Nitric oxide stimulates guanylate cyclase" />
      <edge id="546" source="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" target="cGMP effects" />
      <edge id="547" source="Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)" target="Platelet homeostasis" />
      <edge id="548" source="Extrinsic Pathway" target="{Warfarin sensitivity}, 122700 (3)" />
      <edge id="549" source="Extrinsic Pathway" target="{Deep venous thrombosis, protection against}, 300807 (3)" />
      <edge id="550" source="Extrinsic Pathway" target="Factor VII deficiency, 227500 (3)" />
      <edge id="551" source="Extrinsic Pathway" target="Thrombophilia, X-linked, due to factor IX defect, 300807 (3)" />
      <edge id="552" source="Extrinsic Pathway" target="Factor X deficiency, 227600 (3)" />
      <edge id="553" source="Extrinsic Pathway" target="{Myocardial infarction, decreased susceptibility to}, 608446 (3)" />
      <edge id="554" source="Extrinsic Pathway" target="Hemophilia B, 306900 (3)" />
      <edge id="555" source="Hypobetalipoproteinemia (3)" target="Platelet sensitization by LDL" />
      <edge id="556" source="Hypobetalipoproteinemia (3)" target="Platelet homeostasis" />
      <edge id="557" source="Hypobetalipoproteinemia (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="558" source="Lissencephaly 3, 611603 (3)" target="DNA Replication" />
      <edge id="559" source="Lissencephaly 3, 611603 (3)" target="Mitotic Prophase" />
      <edge id="560" source="Lissencephaly 3, 611603 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="561" source="Lissencephaly 3, 611603 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="562" source="Lissencephaly 3, 611603 (3)" target="M Phase" />
      <edge id="563" source="Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)" target="Striated Muscle Contraction" />
      <edge id="564" source="Thalassemia, delta- (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="565" source="Mitotic Prophase" target="Myeloproliferative disorder (2)" />
      <edge id="566" source="Mitotic Prophase" target="Alstrom syndrome, 203800 (3)" />
      <edge id="567" source="Mitotic Prophase" target="Thyroid carcinoma, papillary, 188550 (3)" />
      <edge id="568" source="Mitotic Prophase" target="Microcephaly 8, primary, autosomal recessive, 614673 (3)" />
      <edge id="569" source="Mitotic Prophase" target="Lissencephaly 4 (with microcephaly), 614019 (3)" />
      <edge id="570" source="Mitotic Prophase" target="Long QT syndrome-11, 611820 (3)" />
      <edge id="571" source="Mitotic Prophase" target="Advanced sleep-phase syndrome, 604348 (3)" />
      <edge id="572" source="Mitotic Prophase" target="Seckel syndrome 4, 613676 (3)" />
      <edge id="573" source="Mitotic Prophase" target="Joubert syndrome 5, 610188 (3)" />
      <edge id="574" source="Mitotic Prophase" target="Senior-Loken syndrome 6, 610189 (3)" />
      <edge id="575" source="Mitotic Prophase" target="Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)" />
      <edge id="576" source="Mitotic Prophase" target="Cortical dysplasia, complex, with other brain malformations, 614039 (3)" />
      <edge id="577" source="Mitotic Prophase" target="Leber congenital amaurosis 10, 611755 (3)" />
      <edge id="578" source="Mitotic Prophase" target="Seckel syndrome 5, 613823 (3)" />
      <edge id="579" source="Mitotic Prophase" target="Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)" />
      <edge id="580" source="Mitotic Prophase" target="Subcortical laminar heterotopia, 607432 (3)" />
      <edge id="581" source="Mitotic Prophase" target="Joubert syndrome 10, 300804 (3)" />
      <edge id="582" source="Mitotic Prophase" target="Mosaic variegated aneuploidy syndrome 2, 614114 (3)" />
      <edge id="583" source="Mitotic Prophase" target="Joubert syndrome 15, 614464 (3)" />
      <edge id="584" source="Mitotic Prophase" target="Microcephaly 6, primary, autosomal recessive, 608393 (3)" />
      <edge id="585" source="Mitotic Prophase" target="Seckel syndrome 6, 614728 (3)" />
      <edge id="586" source="Mitotic Prophase" target="Microcephaly 3, primary, autosomal recessive, 604804 (3)" />
      <edge id="587" source="Mitotic Prophase" target="Nephronophthisis 15, 614845 (3)" />
      <edge id="588" source="Mitotic Prophase" target="Senior-Loken syndrome 7, 613615 (3)" />
      <edge id="589" source="Mitotic Prophase" target="Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)" />
      <edge id="590" source="Mitotic Prophase" target="Oral-facial-digital syndrome 1, 311200 (3)" />
      <edge id="591" source="Mitotic Prophase" target="Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)" />
      <edge id="592" source="Mitotic Prophase" target="Bardet-Biedl syndrome 14, 209900 (3)" />
      <edge id="593" source="Mitotic Prophase" target="Lissencephaly 1, 607432 (3)" />
      <edge id="594" source="Mitotic Prophase" target="Mental retardation, autosomal dominant 13, 614563 (3)" />
      <edge id="595" source="Netrin-1 signaling" target="Mirror movements, congenital, 157600 (3)" />
      <edge id="596" source="Netrin-1 signaling" target="{Myocardial infarction, susceptibility to}, 608446 (3)" />
      <edge id="597" source="Netrin-1 signaling" target="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" />
      <edge id="598" source="Netrin-1 signaling" target="Metachondromatosis, 156250 (3)" />
      <edge id="599" source="Netrin-1 signaling" target="Purpura, posttransfusion (3)" />
      <edge id="600" source="Netrin-1 signaling" target="Leukemia, juvenile myelomonocytic, 607785 (3)" />
      <edge id="601" source="Netrin-1 signaling" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="602" source="Netrin-1 signaling" target="Colorectal cancer (3)" />
      <edge id="603" source="Netrin-1 signaling" target="LEOPARD syndrome 1, 151100 (3)" />
      <edge id="604" source="Netrin-1 signaling" target="Noonan syndrome 1, 163950 (3)" />
      <edge id="605" source="Netrin-1 signaling" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="606" source="Mirror movements, congenital, 157600 (3)" target="Developmental Biology" />
      <edge id="607" source="Mirror movements, congenital, 157600 (3)" target="DCC mediated attractive signaling" />
      <edge id="608" source="Mirror movements, congenital, 157600 (3)" target="Axon guidance" />
      <edge id="609" source="Mirror movements, congenital, 157600 (3)" target="Role of second messengers in netrin-1 signaling" />
      <edge id="610" source="Mirror movements, congenital, 157600 (3)" target="Netrin mediated repulsion signals" />
      <edge id="611" source="Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)" target="MicroRNA (miRNA) Biogenesis" />
      <edge id="612" source="Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)" target="Regulatory RNA pathways" />
      <edge id="613" source="Degradation of GABA" target="Succinic semialdehyde dehydrogenase deficiency, 271980 (3)" />
      <edge id="614" source="Degradation of GABA" target="GABA-transaminase deficiency, 613163 (3)" />
      <edge id="615" source="Dopamine clearance from the synaptic cleft" target="Brunner syndrome, 300615 (3)" />
      <edge id="616" source="Dopamine clearance from the synaptic cleft" target="Parkinsonism-dystonia, infantile, 613135 (3)" />
      <edge id="617" source="Dopamine clearance from the synaptic cleft" target="{Nicotine dependence, protection against}, 188890 (3)" />
      <edge id="618" source="Dopamine clearance from the synaptic cleft" target="{Schizophrenia, susceptibility to}, 181500 (3)" />
      <edge id="619" source="Dopamine clearance from the synaptic cleft" target="{Panic disorder, susceptibility to}, 167870 (3)" />
      <edge id="620" source="{Melanoma, cutaneous malignant, 3}, 609048 (3)" target="Developmental Biology" />
      <edge id="621" source="Transcription of the HIV genome" target="Xeroderma pigmentosum, group D, 278730 (3)" />
      <edge id="622" source="Transcription of the HIV genome" target="Trichothiodystrophy, 601675 (3)" />
      <edge id="623" source="Transcription of the HIV genome" target="{Parkinson disease, susceptibility to}, 168600 (3)" />
      <edge id="624" source="Transcription of the HIV genome" target="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <edge id="625" source="Transcription of the HIV genome" target="Dystonia-Parkinsonism, X-linked, 314250 (3)" />
      <edge id="626" source="Transcription of the HIV genome" target="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" />
      <edge id="627" source="Transcription of the HIV genome" target="Spinocerebellar ataxia 17, 607136 (3)" />
      <edge id="628" source="Plasma fibronectin deficiency, 614101 (1)" target="Cell surface interactions at the vascular wall" />
      <edge id="629" source="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)" target="Signaling by NODAL" />
      <edge id="630" source="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)" target="Developmental Biology" />
      <edge id="631" source="Myogenesis" target="Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)" />
      <edge id="632" source="Myogenesis" target="Holoprosencephaly 11, 614226 (3)" />
      <edge id="633" source="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="634" source="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="635" source="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" target="Intrinsic Pathway" />
      <edge id="636" source="von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="637" source="Lethal congenital contractural syndrome 3, 611369 (3)" target="Semaphorin interactions" />
      <edge id="638" source="Lethal congenital contractural syndrome 3, 611369 (3)" target="Axon guidance" />
      <edge id="639" source="Lethal congenital contractural syndrome 3, 611369 (3)" target="Developmental Biology" />
      <edge id="640" source="Lethal congenital contractural syndrome 3, 611369 (3)" target="SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion" />
      <edge id="641" source="Meier-Gorlin syndrome 2, 613800 (3)" target="DNA Replication" />
      <edge id="642" source="Meier-Gorlin syndrome 2, 613800 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="643" source="Prolonged bleeding time, brachydactyly, and mental retardation (3)" target="Platelet homeostasis" />
      <edge id="644" source="Prolonged bleeding time, brachydactyly, and mental retardation (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="645" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="GRB2:SOS provides linkage to MAPK signaling for Intergrins" />
      <edge id="646" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="Developmental Biology" />
      <edge id="647" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="Axon guidance" />
      <edge id="648" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="Integrin alphaIIb beta3 signaling" />
      <edge id="649" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="L1CAM interactions" />
      <edge id="650" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="Netrin mediated repulsion signals" />
      <edge id="651" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="p130Cas linkage to MAPK signaling for integrins" />
      <edge id="652" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="653" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="654" source="Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)" target="Recycling pathway of L1" />
      <edge id="655" source="Microcephaly 6, primary, autosomal recessive, 608393 (3)" target="DNA Replication" />
      <edge id="656" source="Microcephaly 6, primary, autosomal recessive, 608393 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="657" source="Microcephaly 6, primary, autosomal recessive, 608393 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="658" source="Microcephaly 6, primary, autosomal recessive, 608393 (3)" target="M Phase" />
      <edge id="659" source="Thrombin signalling through proteinase activated receptors (PARs)" target="{Stroke, ischemic, susceptibility to}, 601367 (3)" />
      <edge id="660" source="Thrombin signalling through proteinase activated receptors (PARs)" target="Dysprothrombinemia, 613679 (3)" />
      <edge id="661" source="Thrombin signalling through proteinase activated receptors (PARs)" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="662" source="Thrombin signalling through proteinase activated receptors (PARs)" target="Hypoprothrombinemia, 613679 (3)" />
      <edge id="663" source="Thrombin signalling through proteinase activated receptors (PARs)" target="Acid-labile subunit, deficiency of (3)" />
      <edge id="664" source="Hypertrichotic osteochondrodysplasia, 239850 (3)" target="Neuronal System" />
      <edge id="665" source="Hypertrichotic osteochondrodysplasia, 239850 (3)" target="Potassium Channels" />
      <edge id="666" source="Hypertrichotic osteochondrodysplasia, 239850 (3)" target="Inwardly rectifying K+ channels" />
      <edge id="667" source="CRASH syndrome, 303350 (3)" target="Neurofascin interactions" />
      <edge id="668" source="CRASH syndrome, 303350 (3)" target="Signal transduction by L1" />
      <edge id="669" source="CRASH syndrome, 303350 (3)" target="Developmental Biology" />
      <edge id="670" source="CRASH syndrome, 303350 (3)" target="Axon guidance" />
      <edge id="671" source="CRASH syndrome, 303350 (3)" target="Interaction between L1 and Ankyrins" />
      <edge id="672" source="CRASH syndrome, 303350 (3)" target="L1CAM interactions" />
      <edge id="673" source="CRASH syndrome, 303350 (3)" target="Recycling pathway of L1" />
      <edge id="674" source="Myopathy, myofibrillar, 1, 601419 (3)" target="Striated Muscle Contraction" />
      <edge id="675" source="Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)" target="DNA Replication" />
      <edge id="676" source="Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="677" source="Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="678" source="Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)" target="M Phase" />
      <edge id="679" source="{Stroke, ischemic, susceptibility to}, 601367 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="680" source="{Stroke, ischemic, susceptibility to}, 601367 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="681" source="{Stroke, ischemic, susceptibility to}, 601367 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="682" source="{Stroke, ischemic, susceptibility to}, 601367 (3)" target="Common Pathway" />
      <edge id="683" source="{Stroke, ischemic, susceptibility to}, 601367 (3)" target="Intrinsic Pathway" />
      <edge id="684" source="{Stroke, ischemic, susceptibility to}, 601367 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="685" source="[High molecular weight kininogen deficiency], 228960 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="686" source="[High molecular weight kininogen deficiency], 228960 (3)" target="Intrinsic Pathway" />
      <edge id="687" source="Interactions of Vpr with host cellular proteins" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="688" source="Interactions of Vpr with host cellular proteins" target="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" />
      <edge id="689" source="Interactions of Vpr with host cellular proteins" target="Nestor-Guillermo progeria syndrome, 614008 (3)" />
      <edge id="690" source="Interactions of Vpr with host cellular proteins" target="Leukemia, acute myeloid, 601626 (3)" />
      <edge id="691" source="Interactions of Vpr with host cellular proteins" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="692" source="Retrograde neurotrophin signalling" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="693" source="{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)" target="Thromboxane signalling through TP receptor" />
      <edge id="694" source="{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="695" source="{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)" target="Signal amplification" />
      <edge id="696" source="DCC mediated attractive signaling" target="Colorectal cancer (3)" />
      <edge id="697" source="Formation of the HIV-1 Early Elongation Complex" target="Xeroderma pigmentosum, group D, 278730 (3)" />
      <edge id="698" source="Formation of the HIV-1 Early Elongation Complex" target="Trichothiodystrophy, 601675 (3)" />
      <edge id="699" source="Formation of the HIV-1 Early Elongation Complex" target="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" />
      <edge id="700" source="Formation of the HIV-1 Early Elongation Complex" target="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <edge id="701" source="Platelet degranulation" target="Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)" />
      <edge id="702" source="Platelet degranulation" target="Krabbe disease, atypical, 611722 (3)" />
      <edge id="703" source="Platelet degranulation" target="Gaucher disease, atypical, 610539 (3)" />
      <edge id="704" source="Platelet degranulation" target="Combined SAP deficiency, 611721 (3)" />
      <edge id="705" source="Pausing and recovery of Tat-mediated HIV-1 elongation" target="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" />
      <edge id="706" source="Formation of HIV-1 elongation complex in the absence of HIV-1 Tat" target="Xeroderma pigmentosum, group D, 278730 (3)" />
      <edge id="707" source="Formation of HIV-1 elongation complex in the absence of HIV-1 Tat" target="Trichothiodystrophy, 601675 (3)" />
      <edge id="708" source="Formation of HIV-1 elongation complex in the absence of HIV-1 Tat" target="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" />
      <edge id="709" source="Formation of HIV-1 elongation complex in the absence of HIV-1 Tat" target="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <edge id="710" source="Methemoglobinemias, beta- (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="711" source="Myeloproliferative disorder (2)" target="DNA Replication" />
      <edge id="712" source="Myeloproliferative disorder (2)" target="Mitotic M-M/G1 phases" />
      <edge id="713" source="Myeloproliferative disorder (2)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="714" source="Myeloproliferative disorder (2)" target="M Phase" />
      <edge id="715" source="Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)" target="Striated Muscle Contraction" />
      <edge id="716" source="Axon guidance" target="{Autism suseptibility 9}, 611015 (3)" />
      <edge id="717" source="Axon guidance" target="Huntington disease-like 1, 603218 (3)" />
      <edge id="718" source="Axon guidance" target="MASA syndrome, 303350 (3)" />
      <edge id="719" source="Axon guidance" target="Cone-rod dystrophy 10, 610283 (3)" />
      <edge id="720" source="Axon guidance" target="{Kuru, susceptibility to}, 245300 (3)" />
      <edge id="721" source="Axon guidance" target="Prion disease with protracted course, 606688 (3)" />
      <edge id="722" source="Axon guidance" target="Leukemia, juvenile myelomonocytic, 607785 (3)" />
      <edge id="723" source="Axon guidance" target="{Hepatitic C virus, susceptibility to}, 609532 (3)" />
      <edge id="724" source="Axon guidance" target="Phospholipase A2, group IV A, deficiency of (3)" />
      <edge id="725" source="Axon guidance" target="Hydrocephalus due to aqueductal stenosis, 307000 (3)" />
      <edge id="726" source="Axon guidance" target="Nasu-Hakola disease, 221770 (3)" />
      <edge id="727" source="Axon guidance" target="Prostate cancer, progression and metastasis of, 603688 (3)" />
      <edge id="728" source="Axon guidance" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="729" source="Axon guidance" target="CHARGE syndrome, 214800 (3)" />
      <edge id="730" source="Axon guidance" target="Purpura, posttransfusion (3)" />
      <edge id="731" source="Axon guidance" target="Insomnia, fatal familial, 600072 (3)" />
      <edge id="732" source="Axon guidance" target="Metachondromatosis, 156250 (3)" />
      <edge id="733" source="Axon guidance" target="Cardiofaciocutaneous syndrome, 115150 (3)" />
      <edge id="734" source="Axon guidance" target="Renal cell carcinoma, papillary, familial and somatic, 605074 (3)" />
      <edge id="735" source="Axon guidance" target="{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)" />
      <edge id="736" source="Axon guidance" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="737" source="Axon guidance" target="Creutzfeldt-Jakob disease, 123400 (3)" />
      <edge id="738" source="Axon guidance" target="Lissencephaly, X-linked, 300067 (3)" />
      <edge id="739" source="Axon guidance" target="Myopathy, congenital, Compton-North, 612540 (3)" />
      <edge id="740" source="Axon guidance" target="Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <edge id="741" source="Axon guidance" target="Gerstmann-Straussler disease, 137440 (3)" />
      <edge id="742" source="Axon guidance" target="Hepatocellular carcinoma, childhood type, 114550 (3)" />
      <edge id="743" source="Axon guidance" target="Colorectal cancer (3)" />
      <edge id="744" source="Axon guidance" target="Hydrocephalus with Hirschsprung disease, 307000 (3)" />
      <edge id="745" source="Axon guidance" target="[Blood group, John-Milton-Hagen system], 614745 (3)" />
      <edge id="746" source="Axon guidance" target="Lissencephaly 5, 615191 (3)" />
      <edge id="747" source="Axon guidance" target="Subcortical laminal heteropia, X-linked, 300067 (3)" />
      <edge id="748" source="Axon guidance" target="Myasthenia, limb-girdle, familial, 254300 (3)" />
      <edge id="749" source="Axon guidance" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="750" source="Axon guidance" target="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" />
      <edge id="751" source="Axon guidance" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="752" source="Axon guidance" target="LEOPARD syndrome 1, 151100 (3)" />
      <edge id="753" source="Axon guidance" target="{Myocardial infarction, susceptibility to}, 608446 (3)" />
      <edge id="754" source="Axon guidance" target="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" />
      <edge id="755" source="Axon guidance" target="Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)" />
      <edge id="756" source="Axon guidance" target="Glioblastoma, somatic, 137800 (3)" />
      <edge id="757" source="Axon guidance" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="758" source="Axon guidance" target="Gastric cancer, somatic, 613659 (3)" />
      <edge id="759" source="Axon guidance" target="Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <edge id="760" source="Axon guidance" target="Spherocytosis, type 1, 182900 (3)" />
      <edge id="761" source="Axon guidance" target="Noonan syndrome 1, 163950 (3)" />
      <edge id="762" source="Axon guidance" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="763" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="Elongation arrest and recovery" />
      <edge id="764" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="HIV Life Cycle" />
      <edge id="765" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="Tat-mediated HIV-1 elongation arrest and recovery" />
      <edge id="766" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="HIV-1 elongation arrest and recovery" />
      <edge id="767" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="768" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="Formation of HIV-1 elongation complex containing HIV-1 Tat" />
      <edge id="769" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="HIV-1 Transcription Elongation" />
      <edge id="770" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="Tat-mediated elongation of the HIV-1 transcript" />
      <edge id="771" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="Abortive elongation of HIV-1 transcript in the absence of Tat" />
      <edge id="772" source="Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)" target="Pausing and recovery of HIV-1 elongation" />
      <edge id="773" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="SOS-mediated signalling" />
      <edge id="774" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="ERK activation" />
      <edge id="775" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="RAF/MAP kinase cascade" />
      <edge id="776" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="Developmental Biology" />
      <edge id="777" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="778" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="Netrin mediated repulsion signals" />
      <edge id="779" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="Platelet sensitization by LDL" />
      <edge id="780" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="Platelet homeostasis" />
      <edge id="781" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="PECAM1 interactions" />
      <edge id="782" source="Leukemia, juvenile myelomonocytic, 607785 (3)" target="Tie2 Signaling" />
      <edge id="783" source="GABA receptor activation" target="{Nicotine dependence, susceptibility to}, 188890 (3)" />
      <edge id="784" source="GABA receptor activation" target="{Nicotine dependence, protection against}, 188890 (3)" />
      <edge id="785" source="FG syndrome 2, 300321 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="786" source="FG syndrome 2, 300321 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="787" source="{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)" target="Basigin interactions" />
      <edge id="788" source="{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="789" source="Developmental Biology" target="Huntington disease-like 1, 603218 (3)" />
      <edge id="790" source="Developmental Biology" target="Cone-rod dystrophy 10, 610283 (3)" />
      <edge id="791" source="Developmental Biology" target="Diabetes mellitus, type 1, 125852 (3)" />
      <edge id="792" source="Developmental Biology" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="793" source="Developmental Biology" target="Diamond-Blackfan anemia 4, 612527 (3)" />
      <edge id="794" source="Developmental Biology" target="Insomnia, fatal familial, 600072 (3)" />
      <edge id="795" source="Developmental Biology" target="[Macrothrombocytopenia] (1)" />
      <edge id="796" source="Developmental Biology" target="{Septic shock, susceptibility to} (3)" />
      <edge id="797" source="Developmental Biology" target="Prostate cancer, progression and metastasis of, 603688 (3)" />
      <edge id="798" source="Developmental Biology" target="Purpura, posttransfusion (3)" />
      <edge id="799" source="Developmental Biology" target="Lacticacidemia due to PDX1 deficiency, 245349 (3)" />
      <edge id="800" source="Developmental Biology" target="Lissencephaly, X-linked, 300067 (3)" />
      <edge id="801" source="Developmental Biology" target="Spherocytosis, type 1, 182900 (3)" />
      <edge id="802" source="Developmental Biology" target="Aplasia of lacrimal and salivary glands, 180920 (3)" />
      <edge id="803" source="Developmental Biology" target="Combined hyperlipidemia, familial, 144250 (3)" />
      <edge id="804" source="Developmental Biology" target="Lissencephaly 5, 615191 (3)" />
      <edge id="805" source="Developmental Biology" target="{Diabetes mellitus, noninsulin-dependent}, 125853 (3)" />
      <edge id="806" source="Developmental Biology" target="{Reduced triglycerides, susceptibility to} (3)" />
      <edge id="807" source="Developmental Biology" target="Charcot-Marie-Tooth disease, type 1D, 607678 (3)" />
      <edge id="808" source="Developmental Biology" target="{Myocardial infarction, susceptibility to}, 608446 (3)" />
      <edge id="809" source="Developmental Biology" target="Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)" />
      <edge id="810" source="Developmental Biology" target="Glioblastoma, somatic, 137800 (3)" />
      <edge id="811" source="Developmental Biology" target="Lipoprotein lipase deficiency, 238600 (3)" />
      <edge id="812" source="Developmental Biology" target="Heterotaxy, visceral, 4, autosomal, 613751 (3)" />
      <edge id="813" source="Developmental Biology" target="{Asthma, susceptibility to}, 600807 (3)" />
      <edge id="814" source="Developmental Biology" target="Phospholipase A2, group IV A, deficiency of (3)" />
      <edge id="815" source="Developmental Biology" target="Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <edge id="816" source="Developmental Biology" target="Hydrocephalus due to aqueductal stenosis, 307000 (3)" />
      <edge id="817" source="Developmental Biology" target="Nasu-Hakola disease, 221770 (3)" />
      <edge id="818" source="Developmental Biology" target="Opitz-Kaveggia syndrome, 305450 (3)" />
      <edge id="819" source="Developmental Biology" target="Lipodystrophy, familial partial, type 4, 613877 (3)" />
      <edge id="820" source="Developmental Biology" target="Charcot-Marie-Tooth disease, type 2B2, 605589 (3)" />
      <edge id="821" source="Developmental Biology" target="Camurati-Engelmann disease, 131300 (3)" />
      <edge id="822" source="Developmental Biology" target="Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)" />
      <edge id="823" source="Developmental Biology" target="Diarrhea 4, malabsorptive, congenital, 610370 (3)" />
      <edge id="824" source="Developmental Biology" target="Gerstmann-Straussler disease, 137440 (3)" />
      <edge id="825" source="Developmental Biology" target="Hepatocellular carcinoma, childhood type, 114550 (3)" />
      <edge id="826" source="Developmental Biology" target="Heterotaxy, visceral, 5, 270100 (3)" />
      <edge id="827" source="Developmental Biology" target="LADD syndrome, 149730 (3)" />
      <edge id="828" source="Developmental Biology" target="Polyposis, juvenile intestinal, 174900 (3)" />
      <edge id="829" source="Developmental Biology" target="{Autism, susceptibility to, X-linked 5}, 300847 (3)" />
      <edge id="830" source="Developmental Biology" target="Myasthenia, limb-girdle, familial, 254300 (3)" />
      <edge id="831" source="Developmental Biology" target="Cardiofaciocutaneous syndrome, 115150 (3)" />
      <edge id="832" source="Developmental Biology" target="Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)" />
      <edge id="833" source="Developmental Biology" target="{Autism suseptibility 9}, 611015 (3)" />
      <edge id="834" source="Developmental Biology" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="835" source="Developmental Biology" target="Leukemia, T-cell acute lymphoblastic (2)" />
      <edge id="836" source="Developmental Biology" target="Mental retardation, autosomal recessive 18, 614249 (3)" />
      <edge id="837" source="Developmental Biology" target="Lujan-Fryns syndrome, 309520 (3)" />
      <edge id="838" source="Developmental Biology" target="Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)" />
      <edge id="839" source="Developmental Biology" target="{Migraine without aura, susceptibility to}, 157300 (3)" />
      <edge id="840" source="Developmental Biology" target="LEOPARD syndrome 1, 151100 (3)" />
      <edge id="841" source="Developmental Biology" target="Noonan syndrome 1, 163950 (3)" />
      <edge id="842" source="Developmental Biology" target="Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)" />
      <edge id="843" source="Developmental Biology" target="Prion disease with protracted course, 606688 (3)" />
      <edge id="844" source="Developmental Biology" target="MASA syndrome, 303350 (3)" />
      <edge id="845" source="Developmental Biology" target="{Hepatitic C virus, susceptibility to}, 609532 (3)" />
      <edge id="846" source="Developmental Biology" target="Diamond-Blackfan anemia 5, 612528 (3)" />
      <edge id="847" source="Developmental Biology" target="?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)" />
      <edge id="848" source="Developmental Biology" target="CHARGE syndrome, 214800 (3)" />
      <edge id="849" source="Developmental Biology" target="Metachondromatosis, 156250 (3)" />
      <edge id="850" source="Developmental Biology" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="851" source="Developmental Biology" target="Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)" />
      <edge id="852" source="Developmental Biology" target="Platelet glycoprotein IV deficiency, 608404 (3)" />
      <edge id="853" source="Developmental Biology" target="Diamond-Blackfan anemia 9, 613308 (3)" />
      <edge id="854" source="Developmental Biology" target="Pancreatic cancer (3)" />
      <edge id="855" source="Developmental Biology" target="Myhre syndrome, 139210 (3)" />
      <edge id="856" source="Developmental Biology" target="Leukemia, acute myeloid, 601626 (3)" />
      <edge id="857" source="Developmental Biology" target="Hydrocephalus with Hirschsprung disease, 307000 (3)" />
      <edge id="858" source="Developmental Biology" target="Adiponectin deficiency, 612556 (3)" />
      <edge id="859" source="Developmental Biology" target="{Coronary heart disease, susceptibility to, 7}, 610938 (3)" />
      <edge id="860" source="Developmental Biology" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="861" source="Developmental Biology" target="Maturity-onset diabetes of the young, type 10, 613370 (3)" />
      <edge id="862" source="Developmental Biology" target="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" />
      <edge id="863" source="Developmental Biology" target="{Malaria, cerebral, reduced risk of}, 611162 (3)" />
      <edge id="864" source="Developmental Biology" target="Myopathy, congenital, Compton-North, 612540 (3)" />
      <edge id="865" source="Developmental Biology" target="Rubinstein-Taybi syndrome 2, 613684 (3)" />
      <edge id="866" source="Developmental Biology" target="Rubinstein-Taybi syndrome, 180849 (3)" />
      <edge id="867" source="Developmental Biology" target="Diabetes mellitus, insulin-dependent, 2, 125852 (3)" />
      <edge id="868" source="Developmental Biology" target="{Kuru, susceptibility to}, 245300 (3)" />
      <edge id="869" source="Developmental Biology" target="Transposition of the great arteries, dextro-looped 1, 608808 (3)" />
      <edge id="870" source="Developmental Biology" target="Holoprosencephaly 11, 614226 (3)" />
      <edge id="871" source="Developmental Biology" target="Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <edge id="872" source="Developmental Biology" target="Colorectal cancer, somatic, 114500 (3)" />
      <edge id="873" source="Developmental Biology" target="{Diabetes mellitus, noninsulin-dependent} (3)" />
      <edge id="874" source="Developmental Biology" target="Diabetes mellitus, permanent neonatal, 606176 (3)" />
      <edge id="875" source="Developmental Biology" target="Diabetes mellitus, gestational, 125851 (3)" />
      <edge id="876" source="Developmental Biology" target="Renal cell carcinoma, papillary, familial and somatic, 605074 (3)" />
      <edge id="877" source="Developmental Biology" target="Creutzfeldt-Jakob disease, 123400 (3)" />
      <edge id="878" source="Developmental Biology" target="[High density lipoprotein cholesterol level QTL 11] (3)" />
      <edge id="879" source="Developmental Biology" target="Diamond-Blackfan anemia 6, 612561 (3)" />
      <edge id="880" source="Developmental Biology" target="Colorectal cancer (3)" />
      <edge id="881" source="Developmental Biology" target="Maturity-onset diabetes of the young 6, 606394 (3)" />
      <edge id="882" source="Developmental Biology" target="[Blood group, John-Milton-Hagen system], 614745 (3)" />
      <edge id="883" source="Developmental Biology" target="Subcortical laminal heteropia, X-linked, 300067 (3)" />
      <edge id="884" source="Developmental Biology" target="Neuropathy, congenital hypomyelinating, 1, 605253 (3)" />
      <edge id="885" source="Developmental Biology" target="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" />
      <edge id="886" source="Developmental Biology" target="Obesity, morbid, due to leptin deficiency, 614962 (3)" />
      <edge id="887" source="Developmental Biology" target="{Dementia, vascular, susceptibility to} (3)" />
      <edge id="888" source="Developmental Biology" target="Pancreatic cancer, somatic (3)" />
      <edge id="889" source="Developmental Biology" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="890" source="Developmental Biology" target="Gastric cancer, somatic, 613659 (3)" />
      <edge id="891" source="Developmental Biology" target="Aortic valve disease, 109730 (3)" />
      <edge id="892" source="Developmental Biology" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="893" source="Developmental Biology" target="{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)" />
      <edge id="894" source="Developmental Biology" target="Hyperproinsulinemia, familial, with or without diabetes (3)" />
      <edge id="895" source="Developmental Biology" target="Dejerine-Sottas disease, 145900 (3)" />
      <edge id="896" source="Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)" target="Integration of provirus" />
      <edge id="897" source="Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)" target="Early Phase of HIV Life Cycle" />
      <edge id="898" source="Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)" target="HIV Life Cycle" />
      <edge id="899" source="Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)" target="2-LTR circle formation" />
      <edge id="900" source="Platelet calcium homeostasis" target="Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)" />
      <edge id="901" source="Platelet calcium homeostasis" target="Bleeding disorder due to P2RX1 defect (3)" />
      <edge id="902" source="Platelet calcium homeostasis" target="Myopathy, tubular aggregate, 160565 (3)" />
      <edge id="903" source="Platelet calcium homeostasis" target="Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)" />
      <edge id="904" source="Osseous heteroplasia, progressive, 166350 (3)" target="Platelet homeostasis" />
      <edge id="905" source="Osseous heteroplasia, progressive, 166350 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="906" source="Leukemia, acute myelogenous, 601626 (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="907" source="Mitotic Metaphase/Anaphase Transition" target="Cornelia de Lange syndrome 4, 614701 (3)" />
      <edge id="908" source="Mitotic Metaphase/Anaphase Transition" target="Cornelia de Lange syndrome 3, 610759 (3)" />
      <edge id="909" source="Thrombocytopenia-absent radius syndrome, 274000 (3)" target="Post-Elongation Processing of Intron-Containing pre-mRNA" />
      <edge id="910" source="Thrombocytopenia-absent radius syndrome, 274000 (3)" target="mRNA 3'-end processing" />
      <edge id="911" source="Plasminogen deficiency, types I and II (1)" target="Dissolution of Fibrin Clot" />
      <edge id="912" source="Diabetes mellitus, permanent neonatal, 606176 (3)" target="Potassium Channels" />
      <edge id="913" source="Diabetes mellitus, permanent neonatal, 606176 (3)" target="Signal attenuation" />
      <edge id="914" source="Diabetes mellitus, permanent neonatal, 606176 (3)" target="Neuronal System" />
      <edge id="915" source="Diabetes mellitus, permanent neonatal, 606176 (3)" target="Regulation of beta-cell development" />
      <edge id="916" source="Diabetes mellitus, permanent neonatal, 606176 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="917" source="Diabetes mellitus, permanent neonatal, 606176 (3)" target="Insulin receptor recycling" />
      <edge id="918" source="Diabetes mellitus, permanent neonatal, 606176 (3)" target="Inwardly rectifying K+ channels" />
      <edge id="919" source="Renal cell carcinoma, papillary, familial and somatic, 605074 (3)" target="Semaphorin interactions" />
      <edge id="920" source="Renal cell carcinoma, papillary, familial and somatic, 605074 (3)" target="Sema4D in semaphorin signaling" />
      <edge id="921" source="Renal cell carcinoma, papillary, familial and somatic, 605074 (3)" target="Sema4D mediated inhibition of cell attachment and migration" />
      <edge id="922" source="Cowden syndrome 1, 158350 (3)" target="PI3K/AKT activation" />
      <edge id="923" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Mental retardation, autosomal dominant 11, 614257 (3)" />
      <edge id="924" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" />
      <edge id="925" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" />
      <edge id="926" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="927" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="{Bladder cancer, somatic}, 109800 (3)" />
      <edge id="928" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" />
      <edge id="929" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Costello syndrome, 218040 (3)" />
      <edge id="930" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Mental retardation, autosomal recessive, 6, 611092 (3)" />
      <edge id="931" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="932" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="{Nicotine dependence, protection against}, 188890 (3)" />
      <edge id="933" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="{Nicotine dependence, susceptibility to}, 188890 (3)" />
      <edge id="934" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="{Nevus sebaceous, somatic}, 162900 (3)" />
      <edge id="935" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Phospholipase A2, group IV A, deficiency of (3)" />
      <edge id="936" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" />
      <edge id="937" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Cardiomyopathy, dilated, 1AA, 612158 (3)" />
      <edge id="938" source="Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell" target="Congenital myopathy with excess of muscle spindles, 218040 (3)" />
      <edge id="939" source="Integration of provirus" target="LIG4 syndrome, 606593 (3)" />
      <edge id="940" source="Integration of provirus" target="{Multiple myeloma, resistance to}, 254500 (3)" />
      <edge id="941" source="Integration of provirus" target="Nestor-Guillermo progeria syndrome, 614008 (3)" />
      <edge id="942" source="The role of Nef in HIV-1 replication and disease pathogenesis" target="Mental retardation, autosomal dominant 17, 615009 (3)" />
      <edge id="943" source="The role of Nef in HIV-1 replication and disease pathogenesis" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="944" source="The role of Nef in HIV-1 replication and disease pathogenesis" target="SCID due to LCK deficiency (1)" />
      <edge id="945" source="The role of Nef in HIV-1 replication and disease pathogenesis" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="946" source="The role of Nef in HIV-1 replication and disease pathogenesis" target="Hypoproteinemia, hypercatabolic, 241600 (3)" />
      <edge id="947" source="The role of Nef in HIV-1 replication and disease pathogenesis" target="{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)" />
      <edge id="948" source="Basigin interactions" target="[Blood group, OK], 111380 (3)" />
      <edge id="949" source="Basigin interactions" target="Lipodystrophy, congenital generalized, type 3, 612526 (3)" />
      <edge id="950" source="Duchenne muscular dystrophy, 310200 (3)" target="Striated Muscle Contraction" />
      <edge id="951" source="Erythremias, beta- (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="952" source="Bleeding disorder, platelet-type, 11, 614201 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="953" source="Bleeding disorder, platelet-type, 11, 614201 (3)" target="GPVI-mediated activation cascade" />
      <edge id="954" source="Bleeding disorder, platelet-type, 11, 614201 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="955" source="Acromegaly, 102200 (3)" target="Platelet homeostasis" />
      <edge id="956" source="Acromegaly, 102200 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="957" source="Agammaglobulinemia 7, autosomal recessive, 615214 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="958" source="Agammaglobulinemia 7, autosomal recessive, 615214 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="959" source="Pseudohypoparathyroidism Ia, 103580 (3)" target="Platelet homeostasis" />
      <edge id="960" source="Pseudohypoparathyroidism Ia, 103580 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="961" source="Sema4D mediated inhibition of cell attachment and migration" target="Hepatocellular carcinoma, childhood type, 114550 (3)" />
      <edge id="962" source="Sema4D mediated inhibition of cell attachment and migration" target="{Autism suseptibility 9}, 611015 (3)" />
      <edge id="963" source="Quebec platelet disorder, 601709 (3)" target="Dissolution of Fibrin Clot" />
      <edge id="964" source="Dysprothrombinemia, 613679 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="965" source="Dysprothrombinemia, 613679 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="966" source="Dysprothrombinemia, 613679 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="967" source="Dysprothrombinemia, 613679 (3)" target="Common Pathway" />
      <edge id="968" source="Dysprothrombinemia, 613679 (3)" target="Intrinsic Pathway" />
      <edge id="969" source="Dysprothrombinemia, 613679 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="970" source="Otopalatodigital syndrome, type II, 304120 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="971" source="Otopalatodigital syndrome, type II, 304120 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="972" source="{Multiple myeloma, resistance to}, 254500 (3)" target="Early Phase of HIV Life Cycle" />
      <edge id="973" source="{Multiple myeloma, resistance to}, 254500 (3)" target="HIV Life Cycle" />
      <edge id="974" source="{Multiple myeloma, resistance to}, 254500 (3)" target="2-LTR circle formation" />
      <edge id="975" source="Gastric cancer, somatic, 613659 (3)" target="Sema4D in semaphorin signaling" />
      <edge id="976" source="Gastric cancer, somatic, 613659 (3)" target="Semaphorin interactions" />
      <edge id="977" source="Gastric cancer, somatic, 613659 (3)" target="Sema4D induced cell migration and growth-cone collapse" />
      <edge id="978" source="Gastric cancer, somatic, 613659 (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="979" source="Noonan syndrome 1, 163950 (3)" target="SOS-mediated signalling" />
      <edge id="980" source="Noonan syndrome 1, 163950 (3)" target="ERK activation" />
      <edge id="981" source="Noonan syndrome 1, 163950 (3)" target="RAF/MAP kinase cascade" />
      <edge id="982" source="Noonan syndrome 1, 163950 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="983" source="Noonan syndrome 1, 163950 (3)" target="Netrin mediated repulsion signals" />
      <edge id="984" source="Noonan syndrome 1, 163950 (3)" target="Platelet sensitization by LDL" />
      <edge id="985" source="Noonan syndrome 1, 163950 (3)" target="Platelet homeostasis" />
      <edge id="986" source="Noonan syndrome 1, 163950 (3)" target="PECAM1 interactions" />
      <edge id="987" source="Noonan syndrome 1, 163950 (3)" target="Tie2 Signaling" />
      <edge id="988" source="Leprechaunism, 246200 (3)" target="Insulin receptor recycling" />
      <edge id="989" source="Leprechaunism, 246200 (3)" target="Signal attenuation" />
      <edge id="990" source="Autointegration results in viral DNA circles" target="Nestor-Guillermo progeria syndrome, 614008 (3)" />
      <edge id="991" source="{Alzheimer disease, susceptibility to}, 104300 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="992" source="{Alzheimer disease, susceptibility to}, 104300 (3)" target="Intrinsic Pathway" />
      <edge id="993" source="Colorectal cancer with chromosomal instability (3)" target="DNA Replication" />
      <edge id="994" source="Colorectal cancer with chromosomal instability (3)" target="Mitotic M-M/G1 phases" />
      <edge id="995" source="Colorectal cancer with chromosomal instability (3)" target="Mitotic Prometaphase" />
      <edge id="996" source="Colorectal cancer with chromosomal instability (3)" target="M Phase" />
      <edge id="997" source="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="998" source="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="999" source="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" target="Intrinsic Pathway" />
      <edge id="1000" source="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="1001" source="{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1002" source="Huntington disease-like 1, 603218 (3)" target="NCAM1 interactions" />
      <edge id="1003" source="Parkinsonism-dystonia, infantile, 613135 (3)" target="Neuronal System" />
      <edge id="1004" source="Parkinsonism-dystonia, infantile, 613135 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1005" source="Parkinsonism-dystonia, infantile, 613135 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1006" source="Factor XI deficiency, autosomal dominant, 612416 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1007" source="Factor XI deficiency, autosomal dominant, 612416 (3)" target="Intrinsic Pathway" />
      <edge id="1008" source="Cone-rod dystrophy 10, 610283 (3)" target="Semaphorin interactions" />
      <edge id="1009" source="Cone-rod dystrophy 10, 610283 (3)" target="Other semaphorin interactions" />
      <edge id="1010" source="GPVI-mediated activation cascade" target="Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)" />
      <edge id="1011" source="GPVI-mediated activation cascade" target="Familial cold autoinflammatory syndrome 3, 614468 (3)" />
      <edge id="1012" source="Lactase persistance/nonpersistance, 223100 (3)" target="DNA Replication" />
      <edge id="1013" source="Lactase persistance/nonpersistance, 223100 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1014" source="Alcohol sensitivity, acute, 610251 (3)" target="Metabolism of serotonin" />
      <edge id="1015" source="Alcohol sensitivity, acute, 610251 (3)" target="Neuronal System" />
      <edge id="1016" source="Alcohol sensitivity, acute, 610251 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1017" source="Alcohol sensitivity, acute, 610251 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1018" source="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" target="Mitotic Prometaphase" />
      <edge id="1019" source="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" target="APC-Cdc20 mediated degradation of Nek2A" />
      <edge id="1020" source="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" target="DNA Replication" />
      <edge id="1021" source="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" target="M Phase" />
      <edge id="1022" source="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" target="Inactivation of APC/C via direct inhibition of the APC/C complex" />
      <edge id="1023" source="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1024" source="Mosaic variegated aneuploidy syndrome 1, 257300 (3)" target="Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components" />
      <edge id="1025" source="ADP signalling through P2Y purinoceptor 1" target="Phospholipase A2, group IV A, deficiency of (3)" />
      <edge id="1026" source="Otopalatodigital syndrome, type I, 311300 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1027" source="Otopalatodigital syndrome, type I, 311300 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1028" source="Diarrhea 4, malabsorptive, congenital, 610370 (3)" target="Regulation of beta-cell development" />
      <edge id="1029" source="Diarrhea 4, malabsorptive, congenital, 610370 (3)" target="Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells" />
      <edge id="1030" source="Metabolism of serotonin" target="Brunner syndrome, 300615 (3)" />
      <edge id="1031" source="Metabolism of serotonin" target="{Esophageal cancer, alcohol-related, susceptibility to} (3)" />
      <edge id="1032" source="Metabolism of serotonin" target="{Hangover, susceptibility to}, 610251 (3)" />
      <edge id="1033" source="Metabolism of serotonin" target="{Sublingual nitroglycerin, susceptibility to poor response to} (3)" />
      <edge id="1034" source="Afibrinogenemia, congenital, 202400 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1035" source="Afibrinogenemia, congenital, 202400 (3)" target="Common Pathway" />
      <edge id="1036" source="Squamous cell carcinoma, head and neck, somatic, 275355 (3)" target="PI3K/AKT activation" />
      <edge id="1037" source="Complement component 4, partial deficiency of, 120790 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1038" source="Complement component 4, partial deficiency of, 120790 (3)" target="Intrinsic Pathway" />
      <edge id="1039" source="Insomnia, fatal familial, 600072 (3)" target="NCAM1 interactions" />
      <edge id="1040" source="Purpura, posttransfusion (3)" target="GRB2:SOS provides linkage to MAPK signaling for Intergrins" />
      <edge id="1041" source="Purpura, posttransfusion (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1042" source="Purpura, posttransfusion (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1043" source="Purpura, posttransfusion (3)" target="Integrin alphaIIb beta3 signaling" />
      <edge id="1044" source="Purpura, posttransfusion (3)" target="L1CAM interactions" />
      <edge id="1045" source="Purpura, posttransfusion (3)" target="Netrin mediated repulsion signals" />
      <edge id="1046" source="Purpura, posttransfusion (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="1047" source="Purpura, posttransfusion (3)" target="p130Cas linkage to MAPK signaling for integrins" />
      <edge id="1048" source="Purpura, posttransfusion (3)" target="Recycling pathway of L1" />
      <edge id="1049" source="Purpura, posttransfusion (3)" target="PECAM1 interactions" />
      <edge id="1050" source="Lacticacidemia due to PDX1 deficiency, 245349 (3)" target="Regulation of beta-cell development" />
      <edge id="1051" source="Lacticacidemia due to PDX1 deficiency, 245349 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="1052" source="Lacticacidemia due to PDX1 deficiency, 245349 (3)" target="Regulation of gene expression in early pancreatic precursor cells" />
      <edge id="1053" source="Processing of Capped Intronless Pre-mRNA" target="Oculopharyngeal muscular dystrophy, 164300 (3)" />
      <edge id="1054" source="HIV-1 Transcription Elongation" target="Xeroderma pigmentosum, group D, 278730 (3)" />
      <edge id="1055" source="HIV-1 Transcription Elongation" target="Trichothiodystrophy, 601675 (3)" />
      <edge id="1056" source="HIV-1 Transcription Elongation" target="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <edge id="1057" source="PLC-gamma1 signalling" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="1058" source="{Budd-Chiari syndrome}, 600880 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1059" source="{Budd-Chiari syndrome}, 600880 (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="1060" source="{Budd-Chiari syndrome}, 600880 (3)" target="Common Pathway" />
      <edge id="1061" source="ERK activation" target="Cardiofaciocutaneous syndrome, 115150 (3)" />
      <edge id="1062" source="ERK activation" target="Metachondromatosis, 156250 (3)" />
      <edge id="1063" source="ERK activation" target="LEOPARD syndrome 1, 151100 (3)" />
      <edge id="1064" source="Common Pathway" target="Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)" />
      <edge id="1065" source="Common Pathway" target="Thrombophilia, dysfibrinogenemic (3)" />
      <edge id="1066" source="Common Pathway" target="Dysfibrinogenemia, beta type (3)" />
      <edge id="1067" source="Common Pathway" target="Acid-labile subunit, deficiency of (3)" />
      <edge id="1068" source="Common Pathway" target="Thrombophilia due to thrombomodulin defect, 614486 (3)" />
      <edge id="1069" source="Common Pathway" target="{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)" />
      <edge id="1070" source="Common Pathway" target="Factor V deficiency, 227400 (3)" />
      <edge id="1071" source="Common Pathway" target="{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)" />
      <edge id="1072" source="Common Pathway" target="Amyloidosis, hereditary renal, 105200 (3)" />
      <edge id="1073" source="Common Pathway" target="Factor X deficiency, 227600 (3)" />
      <edge id="1074" source="Common Pathway" target="Dysfibrinogenemia, gamma type (3)" />
      <edge id="1075" source="Common Pathway" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="1076" source="Common Pathway" target="Factor XIIIA deficiency, 613225 (3)" />
      <edge id="1077" source="Common Pathway" target="Factor XIIIB deficiency, 613235 (3)" />
      <edge id="1078" source="Common Pathway" target="Hypoprothrombinemia, 613679 (3)" />
      <edge id="1079" source="Common Pathway" target="Thrombophilia due to activated protein C resistance, 188055 (3)" />
      <edge id="1080" source="Common Pathway" target="Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)" />
      <edge id="1081" source="Common Pathway" target="Thrombophilia due to antithrombin III deficiency, 613118 (3)" />
      <edge id="1082" source="Common Pathway" target="{Venous thrombosis, protection against}, 188050 (3)" />
      <edge id="1083" source="Common Pathway" target="{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)" />
      <edge id="1084" source="Common Pathway" target="Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)" />
      <edge id="1085" source="Common Pathway" target="{Myocardial infarction, protection against}, 608446 (3)" />
      <edge id="1086" source="Common Pathway" target="Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)" />
      <edge id="1087" source="Neurotransmitter Release Cycle" target="Cone-rod dystrophy 7, 603649 (3)" />
      <edge id="1088" source="Neurotransmitter Release Cycle" target="GABA-transaminase deficiency, 613163 (3)" />
      <edge id="1089" source="Neurotransmitter Release Cycle" target="Brunner syndrome, 300615 (3)" />
      <edge id="1090" source="Neurotransmitter Release Cycle" target="Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)" />
      <edge id="1091" source="Neurotransmitter Release Cycle" target="Succinic semialdehyde dehydrogenase deficiency, 271980 (3)" />
      <edge id="1092" source="Neurotransmitter Release Cycle" target="Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)" />
      <edge id="1093" source="Rabson-Mendenhall syndrome, 262190 (3)" target="Insulin receptor recycling" />
      <edge id="1094" source="Rabson-Mendenhall syndrome, 262190 (3)" target="Signal attenuation" />
      <edge id="1095" source="Amyloids" target="Schwartz-Jampel syndrome, type 1, 255800 (3)" />
      <edge id="1096" source="Amyloids" target="Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)" />
      <edge id="1097" source="Tandem pore domain potassium channels" target="{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)" />
      <edge id="1098" source="Plasminogen activator inhibitor-1 deficiency, 613329 (3)" target="Dissolution of Fibrin Clot" />
      <edge id="1099" source="Hypoproteinemia, hypercatabolic, 241600 (3)" target="Nef mediated downregulation of MHC class I complex cell surface expression" />
      <edge id="1100" source="Hypoproteinemia, hypercatabolic, 241600 (3)" target="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" />
      <edge id="1101" source="Hypoproteinemia, hypercatabolic, 241600 (3)" target="Host Interactions of HIV factors" />
      <edge id="1102" source="CDO in myogenesis" target="Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)" />
      <edge id="1103" source="CDO in myogenesis" target="Holoprosencephaly 11, 614226 (3)" />
      <edge id="1104" source="Cone-rod dystrophy 7, 603649 (3)" target="Acetylcholine Neurotransmitter Release Cycle" />
      <edge id="1105" source="Cone-rod dystrophy 7, 603649 (3)" target="Norepinephrine Neurotransmitter Release Cycle" />
      <edge id="1106" source="Cone-rod dystrophy 7, 603649 (3)" target="Neuronal System" />
      <edge id="1107" source="Cone-rod dystrophy 7, 603649 (3)" target="Serotonin Neurotransmitter Release Cycle" />
      <edge id="1108" source="Cone-rod dystrophy 7, 603649 (3)" target="Dopamine Neurotransmitter Release Cycle" />
      <edge id="1109" source="Cone-rod dystrophy 7, 603649 (3)" target="GABA synthesis, release, reuptake and degradation" />
      <edge id="1110" source="Cone-rod dystrophy 7, 603649 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1111" source="Cone-rod dystrophy 7, 603649 (3)" target="Glutamate Neurotransmitter Release Cycle" />
      <edge id="1112" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="GRB2:SOS provides linkage to MAPK signaling for Intergrins" />
      <edge id="1113" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1114" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1115" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Integrin alphaIIb beta3 signaling" />
      <edge id="1116" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="L1CAM interactions" />
      <edge id="1117" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Netrin mediated repulsion signals" />
      <edge id="1118" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="p130Cas linkage to MAPK signaling for integrins" />
      <edge id="1119" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="1120" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Platelet sensitization by LDL" />
      <edge id="1121" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Platelet homeostasis" />
      <edge id="1122" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="Recycling pathway of L1" />
      <edge id="1123" source="{Myocardial infarction, susceptibility to}, 608446 (3)" target="PECAM1 interactions" />
      <edge id="1124" source="Thrombocytopenia, congenital amegakaryocytic, 604498 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="1125" source="Thrombocytopenia, congenital amegakaryocytic, 604498 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1126" source="Oral-facial-digital syndrome 1, 311200 (3)" target="DNA Replication" />
      <edge id="1127" source="Oral-facial-digital syndrome 1, 311200 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1128" source="Oral-facial-digital syndrome 1, 311200 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1129" source="Oral-facial-digital syndrome 1, 311200 (3)" target="M Phase" />
      <edge id="1130" source="Vif-mediated degradation of APOBEC3G" target="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" />
      <edge id="1131" source="Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)" target="Regulation of beta-cell development" />
      <edge id="1132" source="Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="1133" source="{Bladder cancer, somatic}, 109800 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1134" source="{Bladder cancer, somatic}, 109800 (3)" target="Neuronal System" />
      <edge id="1135" source="{Bladder cancer, somatic}, 109800 (3)" target="Post NMDA receptor activation events" />
      <edge id="1136" source="{Bladder cancer, somatic}, 109800 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1137" source="{Bladder cancer, somatic}, 109800 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1138" source="Glioblastoma, somatic, 137800 (3)" target="Sema4D induced cell migration and growth-cone collapse" />
      <edge id="1139" source="Glioblastoma, somatic, 137800 (3)" target="Sema4D in semaphorin signaling" />
      <edge id="1140" source="Glioblastoma, somatic, 137800 (3)" target="Semaphorin interactions" />
      <edge id="1141" source="Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1142" source="Nef mediated downregulation of MHC class I complex cell surface expression" target="Mental retardation, autosomal dominant 17, 615009 (3)" />
      <edge id="1143" source="Nef mediated downregulation of MHC class I complex cell surface expression" target="{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)" />
      <edge id="1144" source="Bernard-Soulier syndrome, type C, 231200 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1145" source="Bernard-Soulier syndrome, type C, 231200 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1146" source="Bernard-Soulier syndrome, type C, 231200 (3)" target="Intrinsic Pathway" />
      <edge id="1147" source="Bernard-Soulier syndrome, type C, 231200 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="1148" source="Bernard-Soulier syndrome, type C, 231200 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1149" source="Norepinephrine Neurotransmitter Release Cycle" target="Brunner syndrome, 300615 (3)" />
      <edge id="1150" source="Cardiac valvular dysplasia, X-linked, 314400 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1151" source="Cardiac valvular dysplasia, X-linked, 314400 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1152" source="Long QT syndrome-11, 611820 (3)" target="DNA Replication" />
      <edge id="1153" source="Long QT syndrome-11, 611820 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1154" source="Long QT syndrome-11, 611820 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1155" source="Long QT syndrome-11, 611820 (3)" target="M Phase" />
      <edge id="1156" source="Role of second messengers in netrin-1 signaling" target="Colorectal cancer (3)" />
      <edge id="1157" source="Phospholipase A2, group IV A, deficiency of (3)" target="Signal transduction by L1" />
      <edge id="1158" source="Phospholipase A2, group IV A, deficiency of (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1159" source="Phospholipase A2, group IV A, deficiency of (3)" target="Neuronal System" />
      <edge id="1160" source="Phospholipase A2, group IV A, deficiency of (3)" target="Post NMDA receptor activation events" />
      <edge id="1161" source="Phospholipase A2, group IV A, deficiency of (3)" target="Platelet homeostasis" />
      <edge id="1162" source="Phospholipase A2, group IV A, deficiency of (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1163" source="Phospholipase A2, group IV A, deficiency of (3)" target="Signal amplification" />
      <edge id="1164" source="Phospholipase A2, group IV A, deficiency of (3)" target="L1CAM interactions" />
      <edge id="1165" source="Phospholipase A2, group IV A, deficiency of (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1166" source="Phospholipase A2, group IV A, deficiency of (3)" target="Platelet sensitization by LDL" />
      <edge id="1167" source="Phospholipase A2, group IV A, deficiency of (3)" target="Transmission across Chemical Synapses" />
      <edge id="1168" source="Phospholipase A2, group IV A, deficiency of (3)" target="Recycling pathway of L1" />
      <edge id="1169" source="Phospholipase A2, group IV A, deficiency of (3)" target="RSK activation" />
      <edge id="1170" source="Diabetes mellitus, gestational, 125851 (3)" target="Regulation of beta-cell development" />
      <edge id="1171" source="Diabetes mellitus, gestational, 125851 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="1172" source="Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)" target="Platelet homeostasis" />
      <edge id="1173" source="Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)" target="Elevation of cytosolic Ca2+ levels" />
      <edge id="1174" source="Inwardly rectifying K+ channels" target="Atrial fibrillation, familial, 12, 614050 (3)" />
      <edge id="1175" source="Inwardly rectifying K+ channels" target="Diabetes mellitus, noninsulin-dependent, 125853 (3)" />
      <edge id="1176" source="Inwardly rectifying K+ channels" target="Hypoglycemia of infancy, leucine-sensitive, 240800 (3)" />
      <edge id="1177" source="Inwardly rectifying K+ channels" target="{Nicotine dependence, protection against}, 188890 (3)" />
      <edge id="1178" source="Inwardly rectifying K+ channels" target="{Nicotine dependence, susceptibility to}, 188890 (3)" />
      <edge id="1179" source="Inwardly rectifying K+ channels" target="Cardiomyopathy, dilated, 1O, 608569 (3)" />
      <edge id="1180" source="Inwardly rectifying K+ channels" target="Diabetes mellitus, transient neonatal 2, 610374 (3)" />
      <edge id="1181" source="Diamond-Blackfan anemia 6, 612561 (3)" target="Regulation of beta-cell development" />
      <edge id="1182" source="Diamond-Blackfan anemia 6, 612561 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="1183" source="Venous malformations, multiple cutaneous and mucosal, 600195 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1184" source="Venous malformations, multiple cutaneous and mucosal, 600195 (3)" target="Tie2 Signaling" />
      <edge id="1185" source="von Willibrand disease, type 3, 277480 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1186" source="von Willibrand disease, type 3, 277480 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1187" source="von Willibrand disease, type 3, 277480 (3)" target="Intrinsic Pathway" />
      <edge id="1188" source="von Willibrand disease, type 3, 277480 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1189" source="Cocoon syndrome, 613630 (3)" target="PI3K/AKT activation" />
      <edge id="1190" source="{Venous thrombosis, protection against}, 188050 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1191" source="Cardiomyopathy, dilated, 1G, 604145 (3)" target="Striated Muscle Contraction" />
      <edge id="1192" source="Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="1193" source="Diabetes mellitus, transient neonatal 2, 610374 (3)" target="Potassium Channels" />
      <edge id="1194" source="Diabetes mellitus, transient neonatal 2, 610374 (3)" target="Neuronal System" />
      <edge id="1195" source="Interactions of Rev with host cellular proteins" target="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" />
      <edge id="1196" source="Interactions of Rev with host cellular proteins" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="1197" source="Interactions of Rev with host cellular proteins" target="Leukemia, acute myeloid, 601626 (3)" />
      <edge id="1198" source="Interactions of Rev with host cellular proteins" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="1199" source="Heterotaxy, visceral, 5, 270100 (3)" target="Signaling by NODAL" />
      <edge id="1200" source="Nonsmall cell lung cancer, somatic, 211980 (3)" target="Factors involved in megakaryocyte development and platelet production" />
      <edge id="1201" source="Nestor-Guillermo progeria syndrome, 614008 (3)" target="Early Phase of HIV Life Cycle" />
      <edge id="1202" source="Nestor-Guillermo progeria syndrome, 614008 (3)" target="HIV Life Cycle" />
      <edge id="1203" source="Nestor-Guillermo progeria syndrome, 614008 (3)" target="2-LTR circle formation" />
      <edge id="1204" source="Nestor-Guillermo progeria syndrome, 614008 (3)" target="APOBEC3G mediated resistance to HIV-1 infection" />
      <edge id="1205" source="Nestor-Guillermo progeria syndrome, 614008 (3)" target="Host Interactions of HIV factors" />
      <edge id="1206" source="Nestor-Guillermo progeria syndrome, 614008 (3)" target="Vpr-mediated nuclear import of PICs" />
      <edge id="1207" source="RAF activation" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="1208" source="{Autism, susceptibility to, X-linked 5}, 300847 (3)" target="Regulation of beta-cell development" />
      <edge id="1209" source="{Autism, susceptibility to, X-linked 5}, 300847 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="1210" source="{Nicotine dependence, protection against}, 188890 (3)" target="Activation of GABAB receptors" />
      <edge id="1211" source="{Nicotine dependence, protection against}, 188890 (3)" target="Activation of G protein gated Potassium channels" />
      <edge id="1212" source="{Nicotine dependence, protection against}, 188890 (3)" target="Neuronal System" />
      <edge id="1213" source="{Nicotine dependence, protection against}, 188890 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1214" source="{Nicotine dependence, protection against}, 188890 (3)" target="Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits" />
      <edge id="1215" source="{Nicotine dependence, protection against}, 188890 (3)" target="GABA B receptor activation" />
      <edge id="1216" source="{Nicotine dependence, protection against}, 188890 (3)" target="G protein gated Potassium channels" />
      <edge id="1217" source="{Nicotine dependence, protection against}, 188890 (3)" target="Potassium Channels" />
      <edge id="1218" source="{Nicotine dependence, protection against}, 188890 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1219" source="Cardiofaciocutaneous syndrome, 115150 (3)" target="SOS-mediated signalling" />
      <edge id="1220" source="Cardiofaciocutaneous syndrome, 115150 (3)" target="Signal transduction by L1" />
      <edge id="1221" source="Cardiofaciocutaneous syndrome, 115150 (3)" target="MEK activation" />
      <edge id="1222" source="Cardiofaciocutaneous syndrome, 115150 (3)" target="RAF/MAP kinase cascade" />
      <edge id="1223" source="Cardiofaciocutaneous syndrome, 115150 (3)" target="L1CAM interactions" />
      <edge id="1224" source="Cardiofaciocutaneous syndrome, 115150 (3)" target="ERK2 activation" />
      <edge id="1225" source="Cardiofaciocutaneous syndrome, 115150 (3)" target="RAF phosphorylates MEK" />
      <edge id="1226" source="Platelet sensitization by LDL" target="Metachondromatosis, 156250 (3)" />
      <edge id="1227" source="Platelet sensitization by LDL" target="Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)" />
      <edge id="1228" source="Platelet sensitization by LDL" target="LEOPARD syndrome 1, 151100 (3)" />
      <edge id="1229" source="Enzymatic degradation of Dopamine by monoamine oxidase" target="Brunner syndrome, 300615 (3)" />
      <edge id="1230" source="Enzymatic degradation of Dopamine by monoamine oxidase" target="{Panic disorder, susceptibility to}, 167870 (3)" />
      <edge id="1231" source="Enzymatic degradation of Dopamine by monoamine oxidase" target="{Schizophrenia, susceptibility to}, 181500 (3)" />
      <edge id="1232" source="Bernard-Soulier syndrome, type B, 231200 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1233" source="Bernard-Soulier syndrome, type B, 231200 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1234" source="Bernard-Soulier syndrome, type B, 231200 (3)" target="Intrinsic Pathway" />
      <edge id="1235" source="Bernard-Soulier syndrome, type B, 231200 (3)" target="Platelet Aggregation (Plug Formation)" />
      <edge id="1236" source="Bernard-Soulier syndrome, type B, 231200 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1237" source="HIV Life Cycle" target="Xeroderma pigmentosum, group D, 278730 (3)" />
      <edge id="1238" source="HIV Life Cycle" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="1239" source="HIV Life Cycle" target="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" />
      <edge id="1240" source="HIV Life Cycle" target="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <edge id="1241" source="HIV Life Cycle" target="Leukemia, acute myeloid, 601626 (3)" />
      <edge id="1242" source="HIV Life Cycle" target="DNA ligase I deficiency (3)" />
      <edge id="1243" source="HIV Life Cycle" target="LIG4 syndrome, 606593 (3)" />
      <edge id="1244" source="HIV Life Cycle" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="1245" source="HIV Life Cycle" target="Dystonia-Parkinsonism, X-linked, 314250 (3)" />
      <edge id="1246" source="HIV Life Cycle" target="{Parkinson disease, susceptibility to}, 168600 (3)" />
      <edge id="1247" source="HIV Life Cycle" target="Spinocerebellar ataxia 17, 607136 (3)" />
      <edge id="1248" source="HIV Life Cycle" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="1249" source="HIV Life Cycle" target="Trichothiodystrophy, 601675 (3)" />
      <edge id="1250" source="Leukemia, T-cell acute lymphoblastic (2)" target="Regulation of beta-cell development" />
      <edge id="1251" source="Nuclear import of Rev protein" target="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" />
      <edge id="1252" source="Nuclear import of Rev protein" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="1253" source="Nuclear import of Rev protein" target="Leukemia, acute myeloid, 601626 (3)" />
      <edge id="1254" source="Nuclear import of Rev protein" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="1255" source="Striated Muscle Contraction" target="Nemaline myopathy 2, autosomal recessive, 256030 (3)" />
      <edge id="1256" source="Striated Muscle Contraction" target="Muscular dystrophy, limb-girdle, type 2G, 601954 (3)" />
      <edge id="1257" source="Striated Muscle Contraction" target="Tibial muscular dystrophy, tardive, 600334 (3)" />
      <edge id="1258" source="Striated Muscle Contraction" target="Cardiomyopathy, familial hypertrophic, 9, 613765 (3)" />
      <edge id="1259" source="Striated Muscle Contraction" target="Cardiomyopathy, dilated, 3B, 302045 (3)" />
      <edge id="1260" source="Striated Muscle Contraction" target="Cardiomyopathy, dilated, 1I, 604765 (3)" />
      <edge id="1261" source="Striated Muscle Contraction" target="Muscular dystrophy, limb-girdle, type 2J, 608807 (3)" />
      <edge id="1262" source="Striated Muscle Contraction" target="Cataract, pulverulent, autosomal dominant (3)" />
      <edge id="1263" source="Striated Muscle Contraction" target="Becker muscular dystrophy, 300376 (3)" />
      <edge id="1264" source="Striated Muscle Contraction" target="Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)" />
      <edge id="1265" source="Cornelia de Lange syndrome 4, 614701 (3)" target="Mitotic Prometaphase" />
      <edge id="1266" source="Cornelia de Lange syndrome 4, 614701 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1267" source="Cornelia de Lange syndrome 4, 614701 (3)" target="DNA Replication" />
      <edge id="1268" source="Cornelia de Lange syndrome 4, 614701 (3)" target="M Phase" />
      <edge id="1269" source="{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1270" source="LEOPARD syndrome 1, 151100 (3)" target="SOS-mediated signalling" />
      <edge id="1271" source="LEOPARD syndrome 1, 151100 (3)" target="RAF/MAP kinase cascade" />
      <edge id="1272" source="LEOPARD syndrome 1, 151100 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1273" source="LEOPARD syndrome 1, 151100 (3)" target="Netrin mediated repulsion signals" />
      <edge id="1274" source="LEOPARD syndrome 1, 151100 (3)" target="Platelet homeostasis" />
      <edge id="1275" source="LEOPARD syndrome 1, 151100 (3)" target="PECAM1 interactions" />
      <edge id="1276" source="LEOPARD syndrome 1, 151100 (3)" target="Tie2 Signaling" />
      <edge id="1277" source="Factors involved in megakaryocyte development and platelet production" target="Polycythemia vera, 263300 (3)" />
      <edge id="1278" source="Factors involved in megakaryocyte development and platelet production" target="Nasopharyngeal carcinoma, 607107 (3)" />
      <edge id="1279" source="Factors involved in megakaryocyte development and platelet production" target="Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)" />
      <edge id="1280" source="Factors involved in megakaryocyte development and platelet production" target="Choroid plexus papilloma, 260500 (3)" />
      <edge id="1281" source="Factors involved in megakaryocyte development and platelet production" target="Erythrocytosis, somatic, 133100 (3)" />
      <edge id="1282" source="Factors involved in megakaryocyte development and platelet production" target="{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)" />
      <edge id="1283" source="Factors involved in megakaryocyte development and platelet production" target="Osteosarcoma, 259500 (3)" />
      <edge id="1284" source="Factors involved in megakaryocyte development and platelet production" target="Thalassemia-beta, dominant inclusion-body, 603902 (3)" />
      <edge id="1285" source="Factors involved in megakaryocyte development and platelet production" target="Thrombocythemia 3, 614521 (3)" />
      <edge id="1286" source="Factors involved in megakaryocyte development and platelet production" target="Fetal hemoglobin quantitative trait locus 1, 141749 (3)" />
      <edge id="1287" source="Factors involved in megakaryocyte development and platelet production" target="Sickle cell anemia, 603903 (3)" />
      <edge id="1288" source="Factors involved in megakaryocyte development and platelet production" target="Delta-beta thalassemia, 141749 (3)" />
      <edge id="1289" source="Factors involved in megakaryocyte development and platelet production" target="Heinz body anemias, beta-, 140700 (3)" />
      <edge id="1290" source="Factors involved in megakaryocyte development and platelet production" target="{T-cell acute lymphoblastic leukemia} (3)" />
      <edge id="1291" source="Factors involved in megakaryocyte development and platelet production" target="Colorectal cancer, 114500 (3)" />
      <edge id="1292" source="Factors involved in megakaryocyte development and platelet production" target="Myelofibrosis, somatic, 254450 (3)" />
      <edge id="1293" source="Factors involved in megakaryocyte development and platelet production" target="{Basal cell carcinoma 7}, 614740 (3)" />
      <edge id="1294" source="Factors involved in megakaryocyte development and platelet production" target="{Malaria, resistance to}, 611162 (3)" />
      <edge id="1295" source="Factors involved in megakaryocyte development and platelet production" target="Hepatocellular carcinoma, 114550 (3)" />
      <edge id="1296" source="Factors involved in megakaryocyte development and platelet production" target="{Glioma susceptibility 1}, 137800 (3)" />
      <edge id="1297" source="Factors involved in megakaryocyte development and platelet production" target="Li-Fraumeni syndrome, 151623 (3)" />
      <edge id="1298" source="Factors involved in megakaryocyte development and platelet production" target="Adrenal cortical carcinoma, 202300 (3)" />
      <edge id="1299" source="Factors involved in megakaryocyte development and platelet production" target="Breast cancer, 114480 (3)" />
      <edge id="1300" source="Factors involved in megakaryocyte development and platelet production" target="Hereditary persistence of fetal hemoglobin, 141749 (3)" />
      <edge id="1301" source="Factors involved in megakaryocyte development and platelet production" target="Thalassemia due to Hb Lepore (3)" />
      <edge id="1302" source="Acetylcholine Neurotransmitter Release Cycle" target="Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)" />
      <edge id="1303" source="Acetylcholine Neurotransmitter Release Cycle" target="Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)" />
      <edge id="1304" source="Potassium Channels" target="{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)" />
      <edge id="1305" source="Potassium Channels" target="Atrial fibrillation, familial, 12, 614050 (3)" />
      <edge id="1306" source="Potassium Channels" target="Diabetes mellitus, noninsulin-dependent, 125853 (3)" />
      <edge id="1307" source="Potassium Channels" target="Hypoglycemia of infancy, leucine-sensitive, 240800 (3)" />
      <edge id="1308" source="Potassium Channels" target="{Nicotine dependence, susceptibility to}, 188890 (3)" />
      <edge id="1309" source="Potassium Channels" target="Cardiomyopathy, dilated, 1O, 608569 (3)" />
      <edge id="1310" source="Kinesins" target="Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)" />
      <edge id="1311" source="Prostate cancer, somatic, 176807 (3)" target="Mitotic Prometaphase" />
      <edge id="1312" source="Prostate cancer, somatic, 176807 (3)" target="M Phase" />
      <edge id="1313" source="Prostate cancer, somatic, 176807 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1314" source="Prostate cancer, somatic, 176807 (3)" target="DNA Replication" />
      <edge id="1315" source="Prostate cancer, somatic, 176807 (3)" target="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal" />
      <edge id="1316" source="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1317" source="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" target="Neuronal System" />
      <edge id="1318" source="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" target="Post NMDA receptor activation events" />
      <edge id="1319" source="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" target="CREB phosphorylation through the activation of CaMKII" />
      <edge id="1320" source="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1321" source="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" target="Unblocking of NMDA receptor, glutamate binding and activation" />
      <edge id="1322" source="Charcot-Marie-Tooth disease, type 2E, 607684 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1323" source="Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)" target="Regulation of beta-cell development" />
      <edge id="1324" source="Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)" target="Regulation of gene expression in beta cells" />
      <edge id="1325" source="Activation of CaMK IV" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="1326" source="Intrinsic Pathway" target="Alpha-2-macroglobulin deficiency, 614036 (1)" />
      <edge id="1327" source="Intrinsic Pathway" target="Hemophilia B, 306900 (3)" />
      <edge id="1328" source="Intrinsic Pathway" target="von Willebrand disease, platelet-type, 177820 (3)" />
      <edge id="1329" source="Intrinsic Pathway" target="Factor X deficiency, 227600 (3)" />
      <edge id="1330" source="Intrinsic Pathway" target="Acid-labile subunit, deficiency of (3)" />
      <edge id="1331" source="Intrinsic Pathway" target="Factor XI deficiency, autosomal recessive, 612416 (3)" />
      <edge id="1332" source="Intrinsic Pathway" target="Angioedema, hereditary, type III, 610618 (3)" />
      <edge id="1333" source="Intrinsic Pathway" target="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" />
      <edge id="1334" source="Intrinsic Pathway" target="{Warfarin sensitivity}, 122700 (3)" />
      <edge id="1335" source="Intrinsic Pathway" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="1336" source="Intrinsic Pathway" target="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" />
      <edge id="1337" source="Intrinsic Pathway" target="Hypoprothrombinemia, 613679 (3)" />
      <edge id="1338" source="Intrinsic Pathway" target="von Willebrand disease, type 1, 193400 (3)" />
      <edge id="1339" source="Intrinsic Pathway" target="Angioedema, hereditary, types I and II, 106100 (3)" />
      <edge id="1340" source="Intrinsic Pathway" target="{Deep venous thrombosis, protection against}, 300807 (3)" />
      <edge id="1341" source="Intrinsic Pathway" target="Fletcher factor deficiency, 612423 (3)" />
      <edge id="1342" source="Intrinsic Pathway" target="Hemophilia A, 306700 (3)" />
      <edge id="1343" source="Intrinsic Pathway" target="[Kininogen deficiency], 228960 (3)" />
      <edge id="1344" source="Intrinsic Pathway" target="Thrombophilia, X-linked, due to factor IX defect, 300807 (3)" />
      <edge id="1345" source="Intrinsic Pathway" target="Factor XII deficiency, 234000 (3)" />
      <edge id="1346" source="CHARGE syndrome, 214800 (3)" target="Other semaphorin interactions" />
      <edge id="1347" source="CHARGE syndrome, 214800 (3)" target="Semaphorin interactions" />
      <edge id="1348" source="Factor VII deficiency, 227500 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1349" source="McCune-Albright syndrome, 174800 (3)" target="Platelet homeostasis" />
      <edge id="1350" source="McCune-Albright syndrome, 174800 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="1351" source="DNA ligase I deficiency (3)" target="DNA Replication" />
      <edge id="1352" source="DNA ligase I deficiency (3)" target="Early Phase of HIV Life Cycle" />
      <edge id="1353" source="Leber congenital amaurosis 10, 611755 (3)" target="DNA Replication" />
      <edge id="1354" source="Leber congenital amaurosis 10, 611755 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1355" source="Leber congenital amaurosis 10, 611755 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1356" source="Leber congenital amaurosis 10, 611755 (3)" target="M Phase" />
      <edge id="1357" source="CRMPs in Sema3A signaling" target="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" />
      <edge id="1358" source="Thrombophilia due to activated protein C resistance, 188055 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1359" source="RAF phosphorylates MEK" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="1360" source="Myopathy, tubular aggregate, 160565 (3)" target="Platelet homeostasis" />
      <edge id="1361" source="Myopathy, tubular aggregate, 160565 (3)" target="Elevation of cytosolic Ca2+ levels" />
      <edge id="1362" source="Regulation of gene expression in beta cells" target="{Diabetes mellitus, noninsulin-dependent}, 125853 (3)" />
      <edge id="1363" source="Regulation of gene expression in beta cells" target="Maturity-onset diabetes of the young, type 10, 613370 (3)" />
      <edge id="1364" source="Regulation of gene expression in beta cells" target="Hyperproinsulinemia, familial, with or without diabetes (3)" />
      <edge id="1365" source="Regulation of gene expression in beta cells" target="Diabetes mellitus, insulin-dependent, 2, 125852 (3)" />
      <edge id="1366" source="Regulation of gene expression in beta cells" target="{Diabetes mellitus, noninsulin-dependent} (3)" />
      <edge id="1367" source="Regulation of gene expression in beta cells" target="Diamond-Blackfan anemia 4, 612527 (3)" />
      <edge id="1368" source="Regulation of gene expression in beta cells" target="Maturity-onset diabetes of the young 6, 606394 (3)" />
      <edge id="1369" source="Regulation of gene expression in beta cells" target="Diamond-Blackfan anemia 5, 612528 (3)" />
      <edge id="1370" source="Regulation of gene expression in beta cells" target="Diamond-Blackfan anemia 9, 613308 (3)" />
      <edge id="1371" source="Regulation of gene expression in beta cells" target="Diabetes mellitus, type 1, 125852 (3)" />
      <edge id="1372" source="Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity" target="Mental retardation, autosomal dominant 11, 614257 (3)" />
      <edge id="1373" source="{Warfarin sensitivity}, 122700 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1374" source="Leukemia, acute myeloid, 601626 (3)" target="Rev-mediated nuclear export of HIV-1 RNA" />
      <edge id="1375" source="Leukemia, acute myeloid, 601626 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1376" source="Leukemia, acute myeloid, 601626 (3)" target="Host Interactions of HIV factors" />
      <edge id="1377" source="Leukemia, acute myeloid, 601626 (3)" target="Vpr-mediated nuclear import of PICs" />
      <edge id="1378" source="Melnick-Needles syndrome, 309350 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1379" source="Melnick-Needles syndrome, 309350 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1380" source="Tat-mediated elongation of the HIV-1 transcript" target="Xeroderma pigmentosum, group D, 278730 (3)" />
      <edge id="1381" source="Tat-mediated elongation of the HIV-1 transcript" target="Trichothiodystrophy, 601675 (3)" />
      <edge id="1382" source="Tat-mediated elongation of the HIV-1 transcript" target="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" />
      <edge id="1383" source="NrCAM interactions" target="Spherocytosis, type 1, 182900 (3)" />
      <edge id="1384" source="Enzymatic degradation of dopamine by COMT" target="Brunner syndrome, 300615 (3)" />
      <edge id="1385" source="Enzymatic degradation of dopamine by COMT" target="{Panic disorder, susceptibility to}, 167870 (3)" />
      <edge id="1386" source="Enzymatic degradation of dopamine by COMT" target="{Schizophrenia, susceptibility to}, 181500 (3)" />
      <edge id="1387" source="Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)" target="DNA Replication" />
      <edge id="1388" source="Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1389" source="Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1390" source="Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)" target="M Phase" />
      <edge id="1391" source="CHL1 interactions" target="Spherocytosis, type 1, 182900 (3)" />
      <edge id="1392" source="Myopathy, congenital, Compton-North, 612540 (3)" target="Neurofascin interactions" />
      <edge id="1393" source="Myopathy, congenital, Compton-North, 612540 (3)" target="L1CAM interactions" />
      <edge id="1394" source="Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells" target="{Diabetes mellitus, noninsulin-dependent}, 125853 (3)" />
      <edge id="1395" source="Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells" target="Maturity-onset diabetes of the young 6, 606394 (3)" />
      <edge id="1396" source="Platelet Aggregation (Plug Formation)" target="{Insulin resistance, susceptibility to}, 125853 (3)" />
      <edge id="1397" source="Platelet Aggregation (Plug Formation)" target="von Willebrand disease, platelet-type, 177820 (3)" />
      <edge id="1398" source="Platelet Aggregation (Plug Formation)" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="1399" source="Platelet Aggregation (Plug Formation)" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="1400" source="Platelet Aggregation (Plug Formation)" target="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" />
      <edge id="1401" source="Platelet Aggregation (Plug Formation)" target="Hypoprothrombinemia, 613679 (3)" />
      <edge id="1402" source="Platelet Aggregation (Plug Formation)" target="Thrombocythemia 1, 187950 (3)" />
      <edge id="1403" source="Platelet Aggregation (Plug Formation)" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="1404" source="Platelet Aggregation (Plug Formation)" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1405" source="Platelet Aggregation (Plug Formation)" target="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" />
      <edge id="1406" source="Platelet Aggregation (Plug Formation)" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1407" source="Mental retardation, autosomal dominant 13, 614563 (3)" target="DNA Replication" />
      <edge id="1408" source="Mental retardation, autosomal dominant 13, 614563 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1409" source="Mental retardation, autosomal dominant 13, 614563 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1410" source="Mental retardation, autosomal dominant 13, 614563 (3)" target="M Phase" />
      <edge id="1411" source="{Hangover, susceptibility to}, 610251 (3)" target="Neuronal System" />
      <edge id="1412" source="{Hangover, susceptibility to}, 610251 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1413" source="{Hangover, susceptibility to}, 610251 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1414" source="Glomerulopathy with fibronectin deposits 2, 601894 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1415" source="Xeroderma pigmentosum, group D, 278730 (3)" target="RNA Polymerase II HIV-1 Promoter Escape" />
      <edge id="1416" source="Xeroderma pigmentosum, group D, 278730 (3)" target="RNA Pol II CTD phosphorylation and interaction with CE" />
      <edge id="1417" source="Xeroderma pigmentosum, group D, 278730 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1418" source="Xeroderma pigmentosum, group D, 278730 (3)" target="HIV-1 Transcription Initiation" />
      <edge id="1419" source="Xeroderma pigmentosum, group D, 278730 (3)" target="Formation of HIV-1 elongation complex containing HIV-1 Tat" />
      <edge id="1420" source="Sema4D in semaphorin signaling" target="Hepatocellular carcinoma, childhood type, 114550 (3)" />
      <edge id="1421" source="Sema4D in semaphorin signaling" target="{Hepatitic C virus, susceptibility to}, 609532 (3)" />
      <edge id="1422" source="Sema4D in semaphorin signaling" target="Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)" />
      <edge id="1423" source="Sema4D in semaphorin signaling" target="{Autism suseptibility 9}, 611015 (3)" />
      <edge id="1424" source="Dysfibrinogenemia, beta type (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1425" source="2-LTR circle formation" target="LIG4 syndrome, 606593 (3)" />
      <edge id="1426" source="RAF/MAP kinase cascade" target="Metachondromatosis, 156250 (3)" />
      <edge id="1427" source="RAF/MAP kinase cascade" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="1428" source="{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1429" source="{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1430" source="Diamond-Blackfan anemia 9, 613308 (3)" target="Regulation of beta-cell development" />
      <edge id="1431" source="Hemophilia B, 306900 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1432" source="Thrombocythemia 1, 187950 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1433" source="Colorectal cancer, somatic, 114500 (3)" target="Mitotic Prometaphase" />
      <edge id="1434" source="Colorectal cancer, somatic, 114500 (3)" target="APC-Cdc20 mediated degradation of Nek2A" />
      <edge id="1435" source="Colorectal cancer, somatic, 114500 (3)" target="DNA Replication" />
      <edge id="1436" source="Colorectal cancer, somatic, 114500 (3)" target="M Phase" />
      <edge id="1437" source="Colorectal cancer, somatic, 114500 (3)" target="Inactivation of APC/C via direct inhibition of the APC/C complex" />
      <edge id="1438" source="Colorectal cancer, somatic, 114500 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1439" source="Colorectal cancer, somatic, 114500 (3)" target="Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components" />
      <edge id="1440" source="Response to elevated platelet cytosolic Ca2+" target="Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)" />
      <edge id="1441" source="Response to elevated platelet cytosolic Ca2+" target="Krabbe disease, atypical, 611722 (3)" />
      <edge id="1442" source="Response to elevated platelet cytosolic Ca2+" target="Gaucher disease, atypical, 610539 (3)" />
      <edge id="1443" source="Response to elevated platelet cytosolic Ca2+" target="Combined SAP deficiency, 611721 (3)" />
      <edge id="1444" source="Creutzfeldt-Jakob disease, 123400 (3)" target="NCAM1 interactions" />
      <edge id="1445" source="Factor XIIIA deficiency, 613225 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1446" source="{Parkinson disease, susceptibility to}, 168600 (3)" target="HIV-1 Transcription Initiation" />
      <edge id="1447" source="{Parkinson disease, susceptibility to}, 168600 (3)" target="RNA Polymerase II HIV-1 Promoter Escape" />
      <edge id="1448" source="{Parkinson disease, susceptibility to}, 168600 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1449" source="Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)" target="Signal transduction by L1" />
      <edge id="1450" source="Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)" target="L1CAM interactions" />
      <edge id="1451" source="Aortic valve disease, 109730 (3)" target="Regulation of beta-cell development" />
      <edge id="1452" source="Semaphorin interactions" target="Hepatocellular carcinoma, childhood type, 114550 (3)" />
      <edge id="1453" source="Semaphorin interactions" target="{Hepatitic C virus, susceptibility to}, 609532 (3)" />
      <edge id="1454" source="Semaphorin interactions" target="{Autism suseptibility 9}, 611015 (3)" />
      <edge id="1455" source="Semaphorin interactions" target="[Blood group, John-Milton-Hagen system], 614745 (3)" />
      <edge id="1456" source="Semaphorin interactions" target="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" />
      <edge id="1457" source="Semaphorin interactions" target="Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)" />
      <edge id="1458" source="Semaphorin interactions" target="Nasu-Hakola disease, 221770 (3)" />
      <edge id="1459" source="SCID due to LCK deficiency (1)" target="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" />
      <edge id="1460" source="SCID due to LCK deficiency (1)" target="Host Interactions of HIV factors" />
      <edge id="1461" source="SCID due to LCK deficiency (1)" target="Nef Mediated CD4 Down-regulation" />
      <edge id="1462" source="SCID due to LCK deficiency (1)" target="Nef and signal transduction" />
      <edge id="1463" source="Angioedema, hereditary, types I and II, 106100 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1464" source="PI3K/AKT activation" target="Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)" />
      <edge id="1465" source="PI3K/AKT activation" target="{Glioma susceptibility 2}, 613028 (3)" />
      <edge id="1466" source="PI3K/AKT activation" target="Macrocephaly/autism syndrome, 605309 (3)" />
      <edge id="1467" source="PI3K/AKT activation" target="Endometrial carcinoma, somatic, 608089 (3)" />
      <edge id="1468" source="PI3K/AKT activation" target="Thyroid carcinoma, follicular, somatic, 188470 (3)" />
      <edge id="1469" source="PI3K/AKT activation" target="PTEN hamartoma tumor syndrome (3)" />
      <edge id="1470" source="PI3K/AKT activation" target="Malignant melanoma, somatic, 155600 (3)" />
      <edge id="1471" source="PI3K/AKT activation" target="{Prostate cancer, somatic}, 176807 (3)" />
      <edge id="1472" source="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1473" source="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" target="Neuronal System" />
      <edge id="1474" source="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" target="Post NMDA receptor activation events" />
      <edge id="1475" source="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1476" source="Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1477" source="Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)" target="Platelet homeostasis" />
      <edge id="1478" source="Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)" target="Elevation of cytosolic Ca2+ levels" />
      <edge id="1479" source="Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)" target="DNA Replication" />
      <edge id="1480" source="Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1481" source="Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1482" source="Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)" target="M Phase" />
      <edge id="1483" source="Thrombophilia, dysplasminogenemic (1)" target="Dissolution of Fibrin Clot" />
      <edge id="1484" source="Hypoglycemia of infancy, leucine-sensitive, 240800 (3)" target="Neuronal System" />
      <edge id="1485" source="{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)" target="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" />
      <edge id="1486" source="{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)" target="Host Interactions of HIV factors" />
      <edge id="1487" source="Factor XII deficiency, 234000 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1488" source="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1489" source="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1490" source="Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)" target="GP1b-IX-V activation signalling" />
      <edge id="1491" source="Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)" target="Dissolution of Fibrin Clot" />
      <edge id="1492" source="M Phase" target="Lissencephaly 4 (with microcephaly), 614019 (3)" />
      <edge id="1493" source="M Phase" target="Alstrom syndrome, 203800 (3)" />
      <edge id="1494" source="M Phase" target="Thyroid carcinoma, papillary, 188550 (3)" />
      <edge id="1495" source="M Phase" target="Microcephaly 8, primary, autosomal recessive, 614673 (3)" />
      <edge id="1496" source="M Phase" target="Advanced sleep-phase syndrome, 604348 (3)" />
      <edge id="1497" source="M Phase" target="Seckel syndrome 4, 613676 (3)" />
      <edge id="1498" source="M Phase" target="Joubert syndrome 5, 610188 (3)" />
      <edge id="1499" source="M Phase" target="Cornelia de Lange syndrome 3, 610759 (3)" />
      <edge id="1500" source="M Phase" target="Senior-Loken syndrome 6, 610189 (3)" />
      <edge id="1501" source="M Phase" target="Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)" />
      <edge id="1502" source="M Phase" target="Cortical dysplasia, complex, with other brain malformations, 614039 (3)" />
      <edge id="1503" source="M Phase" target="Seckel syndrome 5, 613823 (3)" />
      <edge id="1504" source="M Phase" target="Subcortical laminar heterotopia, 607432 (3)" />
      <edge id="1505" source="M Phase" target="Joubert syndrome 10, 300804 (3)" />
      <edge id="1506" source="M Phase" target="Seckel syndrome 6, 614728 (3)" />
      <edge id="1507" source="M Phase" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="1508" source="M Phase" target="Mosaic variegated aneuploidy syndrome 2, 614114 (3)" />
      <edge id="1509" source="M Phase" target="Joubert syndrome 15, 614464 (3)" />
      <edge id="1510" source="M Phase" target="[Premature chromatid separation trait], 176430 (3)" />
      <edge id="1511" source="M Phase" target="Microcephaly 3, primary, autosomal recessive, 604804 (3)" />
      <edge id="1512" source="M Phase" target="Nephronophthisis 15, 614845 (3)" />
      <edge id="1513" source="M Phase" target="Senior-Loken syndrome 7, 613615 (3)" />
      <edge id="1514" source="M Phase" target="Lymphoma, somatic (3)" />
      <edge id="1515" source="M Phase" target="Microcephaly 4, primary, autosomal recessive, 604321 (3)" />
      <edge id="1516" source="M Phase" target="Bardet-Biedl syndrome 14, 209900 (3)" />
      <edge id="1517" source="M Phase" target="Lissencephaly 1, 607432 (3)" />
      <edge id="1518" source="M Phase" target="Meckel syndrome 10, 614175 (3)" />
      <edge id="1519" source="GP1b-IX-V activation signalling" target="von Willebrand disease, platelet-type, 177820 (3)" />
      <edge id="1520" source="GP1b-IX-V activation signalling" target="Terminal osseous dysplasia, 300244 (3)" />
      <edge id="1521" source="GP1b-IX-V activation signalling" target="LEOPARD syndrome 2, 611554 (3)" />
      <edge id="1522" source="GP1b-IX-V activation signalling" target="Heterotopia, periventricular, 300049 (3)" />
      <edge id="1523" source="GP1b-IX-V activation signalling" target="von Willebrand disease, type 1, 193400 (3)" />
      <edge id="1524" source="GP1b-IX-V activation signalling" target="Heterotopia, periventricular, ED variant, 300537 (3)" />
      <edge id="1525" source="GP1b-IX-V activation signalling" target="Intestinal pseudoobstruction, neuronal, 300048 (3)" />
      <edge id="1526" source="GP1b-IX-V activation signalling" target="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" />
      <edge id="1527" source="Cornelia de Lange syndrome 3, 610759 (3)" target="Mitotic Prometaphase" />
      <edge id="1528" source="Cornelia de Lange syndrome 3, 610759 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1529" source="Cornelia de Lange syndrome 3, 610759 (3)" target="DNA Replication" />
      <edge id="1530" source="{Rheumatoid arthritis, susceptibility to}, 180300 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1531" source="[Blood group, OK], 111380 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1532" source="Prostate cancer, progression and metastasis of, 603688 (3)" target="L1CAM interactions" />
      <edge id="1533" source="Oculopharyngeal muscular dystrophy, 164300 (3)" target="Post-Elongation Processing of Intronless pre-mRNA" />
      <edge id="1534" source="Oculopharyngeal muscular dystrophy, 164300 (3)" target="Post-Elongation Processing of Intron-Containing pre-mRNA" />
      <edge id="1535" source="Oculopharyngeal muscular dystrophy, 164300 (3)" target="mRNA 3'-end processing" />
      <edge id="1536" source="Oculopharyngeal muscular dystrophy, 164300 (3)" target="Processing of Intronless Pre-mRNAs" />
      <edge id="1537" source="Lissencephaly, X-linked, 300067 (3)" target="Neurofascin interactions" />
      <edge id="1538" source="Lissencephaly, X-linked, 300067 (3)" target="L1CAM interactions" />
      <edge id="1539" source="Krabbe disease, atypical, 611722 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1540" source="Subcortical laminar heterotopia, 607432 (3)" target="Mitotic Prometaphase" />
      <edge id="1541" source="Subcortical laminar heterotopia, 607432 (3)" target="DNA Replication" />
      <edge id="1542" source="Subcortical laminar heterotopia, 607432 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1543" source="Subcortical laminar heterotopia, 607432 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1544" source="Mosaic variegated aneuploidy syndrome 2, 614114 (3)" target="DNA Replication" />
      <edge id="1545" source="Mosaic variegated aneuploidy syndrome 2, 614114 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1546" source="Mosaic variegated aneuploidy syndrome 2, 614114 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1547" source="Aplasia of lacrimal and salivary glands, 180920 (3)" target="Regulation of beta-cell development" />
      <edge id="1548" source="Aplasia of lacrimal and salivary glands, 180920 (3)" target="Regulation of gene expression in early pancreatic precursor cells" />
      <edge id="1549" source="Integrin alphaIIb beta3 signaling" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="1550" source="Integrin alphaIIb beta3 signaling" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1551" source="Integrin alphaIIb beta3 signaling" target="{Insulin resistance, susceptibility to}, 125853 (3)" />
      <edge id="1552" source="Integrin alphaIIb beta3 signaling" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1553" source="Integrin alphaIIb beta3 signaling" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="1554" source="{Diabetes mellitus, noninsulin-dependent}, 125853 (3)" target="Regulation of beta-cell development" />
      <edge id="1555" source="Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1556" source="Nephronophthisis 15, 614845 (3)" target="DNA Replication" />
      <edge id="1557" source="Nephronophthisis 15, 614845 (3)" target="Mitotic M-M/G1 phases" />
      <edge id="1558" source="Nephronophthisis 15, 614845 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1559" source="{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)" target="Neuronal System" />
      <edge id="1560" source="{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)" target="TWIK-related spinal cord K+ channel (TRESK)" />
      <edge id="1561" source="APC-Cdc20 mediated degradation of Nek2A" target="[Premature chromatid separation trait], 176430 (3)" />
      <edge id="1562" source="DNA Replication" target="Lissencephaly 4 (with microcephaly), 614019 (3)" />
      <edge id="1563" source="DNA Replication" target="Alstrom syndrome, 203800 (3)" />
      <edge id="1564" source="DNA Replication" target="Thyroid carcinoma, papillary, 188550 (3)" />
      <edge id="1565" source="DNA Replication" target="Microcephaly 8, primary, autosomal recessive, 614673 (3)" />
      <edge id="1566" source="DNA Replication" target="Meier-Gorlin syndrome 5, 613805 (3)" />
      <edge id="1567" source="DNA Replication" target="Microcephaly 4, primary, autosomal recessive, 604321 (3)" />
      <edge id="1568" source="DNA Replication" target="Advanced sleep-phase syndrome, 604348 (3)" />
      <edge id="1569" source="DNA Replication" target="Seckel syndrome 4, 613676 (3)" />
      <edge id="1570" source="DNA Replication" target="Joubert syndrome 5, 610188 (3)" />
      <edge id="1571" source="DNA Replication" target="Senior-Loken syndrome 6, 610189 (3)" />
      <edge id="1572" source="DNA Replication" target="Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6, 615156 (3)" />
      <edge id="1573" source="DNA Replication" target="?N syndrome, 310465 (1)" />
      <edge id="1574" source="DNA Replication" target="Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)" />
      <edge id="1575" source="DNA Replication" target="Cortical dysplasia, complex, with other brain malformations, 614039 (3)" />
      <edge id="1576" source="DNA Replication" target="Meier-Gorlin syndrome 1, 224690 (3)" />
      <edge id="1577" source="DNA Replication" target="Seckel syndrome 5, 613823 (3)" />
      <edge id="1578" source="DNA Replication" target="Joubert syndrome 10, 300804 (3)" />
      <edge id="1579" source="DNA Replication" target="{Colorectal cancer, susceptibiliyt to, 10}, 612591 (3)" />
      <edge id="1580" source="DNA Replication" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="1581" source="DNA Replication" target="Joubert syndrome 15, 614464 (3)" />
      <edge id="1582" source="DNA Replication" target="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" />
      <edge id="1583" source="DNA Replication" target="[Premature chromatid separation trait], 176430 (3)" />
      <edge id="1584" source="DNA Replication" target="Microcephaly 3, primary, autosomal recessive, 604804 (3)" />
      <edge id="1585" source="DNA Replication" target="Senior-Loken syndrome 7, 613615 (3)" />
      <edge id="1586" source="DNA Replication" target="Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)" />
      <edge id="1587" source="DNA Replication" target="Lymphoma, somatic (3)" />
      <edge id="1588" source="DNA Replication" target="Seckel syndrome 6, 614728 (3)" />
      <edge id="1589" source="DNA Replication" target="Meier-Gorlin syndrome 4, 613804 (3)" />
      <edge id="1590" source="DNA Replication" target="Bardet-Biedl syndrome 14, 209900 (3)" />
      <edge id="1591" source="DNA Replication" target="Meier-Gorlin syndrome 3, 613803 (3)" />
      <edge id="1592" source="DNA Replication" target="Lissencephaly 1, 607432 (3)" />
      <edge id="1593" source="DNA Replication" target="Meckel syndrome 10, 614175 (3)" />
      <edge id="1594" source="[Kininogen deficiency], 228960 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1595" source="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1596" source="Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1597" source="{Nevus sebaceous, somatic}, 162900 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1598" source="{Nevus sebaceous, somatic}, 162900 (3)" target="Neuronal System" />
      <edge id="1599" source="{Nevus sebaceous, somatic}, 162900 (3)" target="Post NMDA receptor activation events" />
      <edge id="1600" source="{Nevus sebaceous, somatic}, 162900 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1601" source="{Nevus sebaceous, somatic}, 162900 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1602" source="Mitotic M-M/G1 phases" target="Lissencephaly 4 (with microcephaly), 614019 (3)" />
      <edge id="1603" source="Mitotic M-M/G1 phases" target="Alstrom syndrome, 203800 (3)" />
      <edge id="1604" source="Mitotic M-M/G1 phases" target="Thyroid carcinoma, papillary, 188550 (3)" />
      <edge id="1605" source="Mitotic M-M/G1 phases" target="Microcephaly 8, primary, autosomal recessive, 614673 (3)" />
      <edge id="1606" source="Mitotic M-M/G1 phases" target="Meier-Gorlin syndrome 5, 613805 (3)" />
      <edge id="1607" source="Mitotic M-M/G1 phases" target="Microcephaly 4, primary, autosomal recessive, 604321 (3)" />
      <edge id="1608" source="Mitotic M-M/G1 phases" target="Advanced sleep-phase syndrome, 604348 (3)" />
      <edge id="1609" source="Mitotic M-M/G1 phases" target="Seckel syndrome 4, 613676 (3)" />
      <edge id="1610" source="Mitotic M-M/G1 phases" target="Joubert syndrome 5, 610188 (3)" />
      <edge id="1611" source="Mitotic M-M/G1 phases" target="Senior-Loken syndrome 6, 610189 (3)" />
      <edge id="1612" source="Mitotic M-M/G1 phases" target="?N syndrome, 310465 (1)" />
      <edge id="1613" source="Mitotic M-M/G1 phases" target="Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)" />
      <edge id="1614" source="Mitotic M-M/G1 phases" target="Cortical dysplasia, complex, with other brain malformations, 614039 (3)" />
      <edge id="1615" source="Mitotic M-M/G1 phases" target="Meier-Gorlin syndrome 1, 224690 (3)" />
      <edge id="1616" source="Mitotic M-M/G1 phases" target="Seckel syndrome 5, 613823 (3)" />
      <edge id="1617" source="Mitotic M-M/G1 phases" target="Joubert syndrome 10, 300804 (3)" />
      <edge id="1618" source="Mitotic M-M/G1 phases" target="Seckel syndrome 6, 614728 (3)" />
      <edge id="1619" source="Mitotic M-M/G1 phases" target="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" />
      <edge id="1620" source="Mitotic M-M/G1 phases" target="Joubert syndrome 15, 614464 (3)" />
      <edge id="1621" source="Mitotic M-M/G1 phases" target="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" />
      <edge id="1622" source="Mitotic M-M/G1 phases" target="[Premature chromatid separation trait], 176430 (3)" />
      <edge id="1623" source="Mitotic M-M/G1 phases" target="Microcephaly 3, primary, autosomal recessive, 604804 (3)" />
      <edge id="1624" source="Mitotic M-M/G1 phases" target="Senior-Loken syndrome 7, 613615 (3)" />
      <edge id="1625" source="Mitotic M-M/G1 phases" target="Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)" />
      <edge id="1626" source="Mitotic M-M/G1 phases" target="Lymphoma, somatic (3)" />
      <edge id="1627" source="Mitotic M-M/G1 phases" target="Meier-Gorlin syndrome 4, 613804 (3)" />
      <edge id="1628" source="Mitotic M-M/G1 phases" target="Bardet-Biedl syndrome 14, 209900 (3)" />
      <edge id="1629" source="Mitotic M-M/G1 phases" target="Meier-Gorlin syndrome 3, 613803 (3)" />
      <edge id="1630" source="Mitotic M-M/G1 phases" target="Lissencephaly 1, 607432 (3)" />
      <edge id="1631" source="Mitotic M-M/G1 phases" target="Meckel syndrome 10, 614175 (3)" />
      <edge id="1632" source="{Esophageal cancer, alcohol-related, susceptibility to} (3)" target="Neuronal System" />
      <edge id="1633" source="{Esophageal cancer, alcohol-related, susceptibility to} (3)" target="Transmission across Chemical Synapses" />
      <edge id="1634" source="{Esophageal cancer, alcohol-related, susceptibility to} (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1635" source="Thrombophilia, dysfibrinogenemic (3)" target="Formation of Fibrin Clot (Clotting Cascade)" />
      <edge id="1636" source="Formation of Fibrin Clot (Clotting Cascade)" target="Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)" />
      <edge id="1637" source="Formation of Fibrin Clot (Clotting Cascade)" target="Alpha-2-macroglobulin deficiency, 614036 (1)" />
      <edge id="1638" source="Formation of Fibrin Clot (Clotting Cascade)" target="Thrombophilia due to thrombomodulin defect, 614486 (3)" />
      <edge id="1639" source="Formation of Fibrin Clot (Clotting Cascade)" target="von Willebrand disease, platelet-type, 177820 (3)" />
      <edge id="1640" source="Formation of Fibrin Clot (Clotting Cascade)" target="Factor V deficiency, 227400 (3)" />
      <edge id="1641" source="Formation of Fibrin Clot (Clotting Cascade)" target="{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)" />
      <edge id="1642" source="Formation of Fibrin Clot (Clotting Cascade)" target="Amyloidosis, hereditary renal, 105200 (3)" />
      <edge id="1643" source="Formation of Fibrin Clot (Clotting Cascade)" target="{Myocardial infarction, decreased susceptibility to}, 608446 (3)" />
      <edge id="1644" source="Formation of Fibrin Clot (Clotting Cascade)" target="Factor XI deficiency, autosomal recessive, 612416 (3)" />
      <edge id="1645" source="Formation of Fibrin Clot (Clotting Cascade)" target="Dysfibrinogenemia, gamma type (3)" />
      <edge id="1646" source="Formation of Fibrin Clot (Clotting Cascade)" target="Acid-labile subunit, deficiency of (3)" />
      <edge id="1647" source="Formation of Fibrin Clot (Clotting Cascade)" target="Factor X deficiency, 227600 (3)" />
      <edge id="1648" source="Formation of Fibrin Clot (Clotting Cascade)" target="Angioedema, hereditary, type III, 610618 (3)" />
      <edge id="1649" source="Formation of Fibrin Clot (Clotting Cascade)" target="Factor XIIIB deficiency, 613235 (3)" />
      <edge id="1650" source="Formation of Fibrin Clot (Clotting Cascade)" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="1651" source="Formation of Fibrin Clot (Clotting Cascade)" target="Hypoprothrombinemia, 613679 (3)" />
      <edge id="1652" source="Formation of Fibrin Clot (Clotting Cascade)" target="von Willebrand disease, type 1, 193400 (3)" />
      <edge id="1653" source="Formation of Fibrin Clot (Clotting Cascade)" target="Thrombophilia due to antithrombin III deficiency, 613118 (3)" />
      <edge id="1654" source="Formation of Fibrin Clot (Clotting Cascade)" target="{Deep venous thrombosis, protection against}, 300807 (3)" />
      <edge id="1655" source="Formation of Fibrin Clot (Clotting Cascade)" target="Fletcher factor deficiency, 612423 (3)" />
      <edge id="1656" source="Formation of Fibrin Clot (Clotting Cascade)" target="Hemophilia A, 306700 (3)" />
      <edge id="1657" source="Formation of Fibrin Clot (Clotting Cascade)" target="Thrombophilia, X-linked, due to factor IX defect, 300807 (3)" />
      <edge id="1658" source="Formation of Fibrin Clot (Clotting Cascade)" target="Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)" />
      <edge id="1659" source="Formation of Fibrin Clot (Clotting Cascade)" target="{Myocardial infarction, protection against}, 608446 (3)" />
      <edge id="1660" source="Formation of Fibrin Clot (Clotting Cascade)" target="Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)" />
      <edge id="1661" source="Seckel syndrome 6, 614728 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1662" source="Activation of Na-permeable Kainate Receptors" target="Mental retardation, autosomal recessive, 6, 611092 (3)" />
      <edge id="1663" source="Pseudohypoparathyroidism Ib, 603233 (3)" target="Platelet homeostasis" />
      <edge id="1664" source="Pseudohypoparathyroidism Ib, 603233 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="1665" source="{Insulin resistance, susceptibility to}, 125853 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1666" source="Nasu-Hakola disease, 221770 (3)" target="Other semaphorin interactions" />
      <edge id="1667" source="GRB2:SOS provides linkage to MAPK signaling for Intergrins" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="1668" source="GRB2:SOS provides linkage to MAPK signaling for Intergrins" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1669" source="GRB2:SOS provides linkage to MAPK signaling for Intergrins" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1670" source="GRB2:SOS provides linkage to MAPK signaling for Intergrins" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="1671" source="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" target="Mitotic Prometaphase" />
      <edge id="1672" source="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" target="Rev-mediated nuclear export of HIV-1 RNA" />
      <edge id="1673" source="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1674" source="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" target="Host Interactions of HIV factors" />
      <edge id="1675" source="{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)" target="Vpr-mediated nuclear import of PICs" />
      <edge id="1676" source="Cardiomyopathy, dilated, 1AA, 612158 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1677" source="Cardiomyopathy, dilated, 1AA, 612158 (3)" target="Neuronal System" />
      <edge id="1678" source="Cardiomyopathy, dilated, 1AA, 612158 (3)" target="Post NMDA receptor activation events" />
      <edge id="1679" source="Cardiomyopathy, dilated, 1AA, 612158 (3)" target="CREB phosphorylation through the activation of CaMKII" />
      <edge id="1680" source="Cardiomyopathy, dilated, 1AA, 612158 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1681" source="Cardiomyopathy, dilated, 1AA, 612158 (3)" target="Unblocking of NMDA receptor, glutamate binding and activation" />
      <edge id="1682" source="Cardiomyopathy, dilated, 1AA, 612158 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1683" source="Gaucher disease, atypical, 610539 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1684" source="Vpu mediated degradation of CD4" target="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" />
      <edge id="1685" source="Vpu mediated degradation of CD4" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="1686" source="Gerstmann-Straussler disease, 137440 (3)" target="NCAM1 interactions" />
      <edge id="1687" source="Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1688" source="Regulation of gene expression in early pancreatic precursor cells" target="LADD syndrome, 149730 (3)" />
      <edge id="1689" source="Regulation of gene expression in early pancreatic precursor cells" target="Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)" />
      <edge id="1690" source="Joubert syndrome 15, 614464 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1691" source="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" target="RNA Polymerase II HIV-1 Promoter Escape" />
      <edge id="1692" source="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" target="RNA Pol II CTD phosphorylation and interaction with CE" />
      <edge id="1693" source="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1694" source="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" target="HIV-1 Transcription Initiation" />
      <edge id="1695" source="Cerebrooculofacioskeletal syndrome 2, 610756 (3)" target="Formation of HIV-1 elongation complex containing HIV-1 Tat" />
      <edge id="1696" source="Hypoprothrombinemia, 613679 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1697" source="Hypoprothrombinemia, 613679 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1698" source="Senior-Loken syndrome 6, 610189 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1699" source="Myasthenia, limb-girdle, familial, 254300 (3)" target="NCAM1 interactions" />
      <edge id="1700" source="Activation of G protein gated Potassium channels" target="{Nicotine dependence, susceptibility to}, 188890 (3)" />
      <edge id="1701" source="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1702" source="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" target="Neuronal System" />
      <edge id="1703" source="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" target="Post NMDA receptor activation events" />
      <edge id="1704" source="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" target="CREB phosphorylation through the activation of CaMKII" />
      <edge id="1705" source="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1706" source="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" target="Unblocking of NMDA receptor, glutamate binding and activation" />
      <edge id="1707" source="Charcot-Marie-Tooth disease, type 1F, 607734 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1708" source="Heterotopia, periventricular, 300049 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1709" source="Intestinal pseudoobstruction, neuronal, 300048 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1710" source="Regulation of beta-cell development" target="Diabetes mellitus, insulin-dependent, 2, 125852 (3)" />
      <edge id="1711" source="Regulation of beta-cell development" target="Diamond-Blackfan anemia 5, 612528 (3)" />
      <edge id="1712" source="Regulation of beta-cell development" target="Diabetes mellitus, type 1, 125852 (3)" />
      <edge id="1713" source="Regulation of beta-cell development" target="Diamond-Blackfan anemia 4, 612527 (3)" />
      <edge id="1714" source="Regulation of beta-cell development" target="{Diabetes mellitus, noninsulin-dependent} (3)" />
      <edge id="1715" source="Regulation of beta-cell development" target="Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)" />
      <edge id="1716" source="Regulation of beta-cell development" target="LADD syndrome, 149730 (3)" />
      <edge id="1717" source="Regulation of beta-cell development" target="Maturity-onset diabetes of the young 6, 606394 (3)" />
      <edge id="1718" source="Regulation of beta-cell development" target="Maturity-onset diabetes of the young, type 10, 613370 (3)" />
      <edge id="1719" source="Regulation of beta-cell development" target="Hyperproinsulinemia, familial, with or without diabetes (3)" />
      <edge id="1720" source="{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1721" source="SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion" target="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" />
      <edge id="1722" source="Neurofascin interactions" target="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" />
      <edge id="1723" source="Neurofascin interactions" target="Hydrocephalus with Hirschsprung disease, 307000 (3)" />
      <edge id="1724" source="Neurofascin interactions" target="Subcortical laminal heteropia, X-linked, 300067 (3)" />
      <edge id="1725" source="Neurofascin interactions" target="MASA syndrome, 303350 (3)" />
      <edge id="1726" source="Neurofascin interactions" target="Hydrocephalus due to aqueductal stenosis, 307000 (3)" />
      <edge id="1727" source="Neurofascin interactions" target="Spherocytosis, type 1, 182900 (3)" />
      <edge id="1728" source="Trichothiodystrophy, 601675 (3)" target="RNA Polymerase II HIV-1 Promoter Escape" />
      <edge id="1729" source="Trichothiodystrophy, 601675 (3)" target="RNA Pol II CTD phosphorylation and interaction with CE" />
      <edge id="1730" source="Trichothiodystrophy, 601675 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1731" source="Trichothiodystrophy, 601675 (3)" target="HIV-1 Transcription Initiation" />
      <edge id="1732" source="Trichothiodystrophy, 601675 (3)" target="Formation of HIV-1 elongation complex containing HIV-1 Tat" />
      <edge id="1733" source="Pleuropulmonary blastoma, 601200 (3)" target="MicroRNA (miRNA) Biogenesis" />
      <edge id="1734" source="Pleuropulmonary blastoma, 601200 (3)" target="Regulatory RNA pathways" />
      <edge id="1735" source="Prion disease with protracted course, 606688 (3)" target="NCAM1 interactions" />
      <edge id="1736" source="Binding and entry of HIV virion" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="1737" source="Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)" target="Insulin receptor recycling" />
      <edge id="1738" source="Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)" target="Signal attenuation" />
      <edge id="1739" source="MASA syndrome, 303350 (3)" target="Signal transduction by L1" />
      <edge id="1740" source="MASA syndrome, 303350 (3)" target="Interaction between L1 and Ankyrins" />
      <edge id="1741" source="MASA syndrome, 303350 (3)" target="L1CAM interactions" />
      <edge id="1742" source="MASA syndrome, 303350 (3)" target="Recycling pathway of L1" />
      <edge id="1743" source="PECAM1 interactions" target="Metachondromatosis, 156250 (3)" />
      <edge id="1744" source="PECAM1 interactions" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1745" source="PECAM1 interactions" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1746" source="Signal transduction by L1" target="Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <edge id="1747" source="Signal transduction by L1" target="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" />
      <edge id="1748" source="Signal transduction by L1" target="Hydrocephalus with Hirschsprung disease, 307000 (3)" />
      <edge id="1749" source="Signal transduction by L1" target="{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)" />
      <edge id="1750" source="Signal transduction by L1" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="1751" source="Signal transduction by L1" target="Hydrocephalus due to aqueductal stenosis, 307000 (3)" />
      <edge id="1752" source="Diabetes mellitus, insulin-dependent, 2, 125852 (3)" target="Insulin receptor recycling" />
      <edge id="1753" source="Diabetes mellitus, insulin-dependent, 2, 125852 (3)" target="Signal attenuation" />
      <edge id="1754" source="Other semaphorin interactions" target="[Blood group, John-Milton-Hagen system], 614745 (3)" />
      <edge id="1755" source="LEOPARD syndrome 2, 611554 (3)" target="SOS-mediated signalling" />
      <edge id="1756" source="LEOPARD syndrome 2, 611554 (3)" target="MEK activation" />
      <edge id="1757" source="LEOPARD syndrome 2, 611554 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1758" source="LEOPARD syndrome 2, 611554 (3)" target="Neuronal System" />
      <edge id="1759" source="LEOPARD syndrome 2, 611554 (3)" target="Post NMDA receptor activation events" />
      <edge id="1760" source="LEOPARD syndrome 2, 611554 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1761" source="LEOPARD syndrome 2, 611554 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1762" source="LEOPARD syndrome 2, 611554 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1763" source="{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)" target="L1CAM interactions" />
      <edge id="1764" source="[Blood group, Yt system], 112100 (3)" target="Neuronal System" />
      <edge id="1765" source="[Blood group, Yt system], 112100 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1766" source="[Blood group, Yt system], 112100 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1767" source="L1CAM interactions" target="Hydrocephalus due to aqueductal stenosis, 307000 (3)" />
      <edge id="1768" source="L1CAM interactions" target="Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)" />
      <edge id="1769" source="L1CAM interactions" target="Lissencephaly 5, 615191 (3)" />
      <edge id="1770" source="L1CAM interactions" target="Spherocytosis, type 1, 182900 (3)" />
      <edge id="1771" source="L1CAM interactions" target="Hydrocephalus with Hirschsprung disease, 307000 (3)" />
      <edge id="1772" source="L1CAM interactions" target="Subcortical laminal heteropia, X-linked, 300067 (3)" />
      <edge id="1773" source="L1CAM interactions" target="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" />
      <edge id="1774" source="L1CAM interactions" target="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" />
      <edge id="1775" source="L1CAM interactions" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1776" source="L1CAM interactions" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1777" source="Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components" target="[Premature chromatid separation trait], 176430 (3)" />
      <edge id="1778" source="Bleeding disorder due to P2RX1 defect (3)" target="Platelet homeostasis" />
      <edge id="1779" source="Bleeding disorder due to P2RX1 defect (3)" target="Elevation of cytosolic Ca2+ levels" />
      <edge id="1780" source="Pancreatic cancer (3)" target="Signaling by NODAL" />
      <edge id="1781" source="Myhre syndrome, 139210 (3)" target="Signaling by NODAL" />
      <edge id="1782" source="Hydrocephalus with Hirschsprung disease, 307000 (3)" target="Interaction between L1 and Ankyrins" />
      <edge id="1783" source="Hydrocephalus with Hirschsprung disease, 307000 (3)" target="Recycling pathway of L1" />
      <edge id="1784" source="[Premature chromatid separation trait], 176430 (3)" target="Mitotic Prometaphase" />
      <edge id="1785" source="[Premature chromatid separation trait], 176430 (3)" target="Inactivation of APC/C via direct inhibition of the APC/C complex" />
      <edge id="1786" source="Interaction between L1 and Ankyrins" target="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" />
      <edge id="1787" source="Interaction between L1 and Ankyrins" target="Hydrocephalus due to aqueductal stenosis, 307000 (3)" />
      <edge id="1788" source="Plasminogen Tochigi disease (3)" target="Dissolution of Fibrin Clot" />
      <edge id="1789" source="{Nicotine dependence, susceptibility to}, 188890 (3)" target="Activation of GABAB receptors" />
      <edge id="1790" source="{Nicotine dependence, susceptibility to}, 188890 (3)" target="Neuronal System" />
      <edge id="1791" source="{Nicotine dependence, susceptibility to}, 188890 (3)" target="GABA B receptor activation" />
      <edge id="1792" source="{Nicotine dependence, susceptibility to}, 188890 (3)" target="Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits" />
      <edge id="1793" source="{Nicotine dependence, susceptibility to}, 188890 (3)" target="G protein gated Potassium channels" />
      <edge id="1794" source="{Nicotine dependence, susceptibility to}, 188890 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1795" source="Cardiomyopathy, dilated, 1O, 608569 (3)" target="Neuronal System" />
      <edge id="1796" source="Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)" target="Neuronal System" />
      <edge id="1797" source="Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1798" source="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" target="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" />
      <edge id="1799" source="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" target="Host Interactions of HIV factors" />
      <edge id="1800" source="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" target="Nef Mediated CD4 Down-regulation" />
      <edge id="1801" source="Hypocalciuric hypercalcemia, familial, type III, 600740 (3)" target="Recycling pathway of L1" />
      <edge id="1802" source="Heterotopia, periventricular, ED variant, 300537 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1803" source="Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)" target="Recycling pathway of L1" />
      <edge id="1804" source="CREB phosphorylation through the activation of CaMKII" target="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" />
      <edge id="1805" source="Microcephaly 4, primary, autosomal recessive, 604321 (3)" target="Mitotic Prometaphase" />
      <edge id="1806" source="Meckel syndrome 10, 614175 (3)" target="Mitotic Prometaphase" />
      <edge id="1807" source="Ionotropic activity of Kainate Receptors" target="Mental retardation, autosomal recessive, 6, 611092 (3)" />
      <edge id="1808" source="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal" target="Lymphoma, somatic (3)" />
      <edge id="1809" source="Acid-labile subunit, deficiency of (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1810" source="Acid-labile subunit, deficiency of (3)" target="Dissolution of Fibrin Clot" />
      <edge id="1811" source="Costello syndrome, 218040 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1812" source="Costello syndrome, 218040 (3)" target="Neuronal System" />
      <edge id="1813" source="Costello syndrome, 218040 (3)" target="Post NMDA receptor activation events" />
      <edge id="1814" source="Costello syndrome, 218040 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1815" source="Costello syndrome, 218040 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1816" source="Microcephaly 8, primary, autosomal recessive, 614673 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1817" source="{Kuru, susceptibility to}, 245300 (3)" target="NCAM1 interactions" />
      <edge id="1818" source="Host Interactions of HIV factors" target="Mental retardation, autosomal dominant 17, 615009 (3)" />
      <edge id="1819" source="Host Interactions of HIV factors" target="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" />
      <edge id="1820" source="Host Interactions of HIV factors" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="1821" source="Host Interactions of HIV factors" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="1822" source="Host Interactions of HIV factors" target="Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)" />
      <edge id="1823" source="Advanced sleep-phase syndrome, 604348 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1824" source="Joubert syndrome 5, 610188 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1825" source="{Transcription of plasminogen activator inhibitor, modulator of} (3)" target="Dissolution of Fibrin Clot" />
      <edge id="1826" source="Mental retardation, autosomal dominant 11, 614257 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1827" source="Mental retardation, autosomal dominant 11, 614257 (3)" target="Neuronal System" />
      <edge id="1828" source="Mitotic Prometaphase" target="Lymphoma, somatic (3)" />
      <edge id="1829" source="Mitotic Prometaphase" target="Lissencephaly 1, 607432 (3)" />
      <edge id="1830" source="Mitotic Prometaphase" target="Lissencephaly 4 (with microcephaly), 614019 (3)" />
      <edge id="1831" source="GABA-transaminase deficiency, 613163 (3)" target="Neuronal System" />
      <edge id="1832" source="GABA-transaminase deficiency, 613163 (3)" target="GABA synthesis, release, reuptake and degradation" />
      <edge id="1833" source="GABA-transaminase deficiency, 613163 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1834" source="Lissencephaly 4 (with microcephaly), 614019 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1835" source="Dystonia-Parkinsonism, X-linked, 314250 (3)" target="RNA Polymerase II HIV-1 Promoter Escape" />
      <edge id="1836" source="Dystonia-Parkinsonism, X-linked, 314250 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1837" source="Dystonia-Parkinsonism, X-linked, 314250 (3)" target="HIV-1 Transcription Initiation" />
      <edge id="1838" source="Joubert syndrome 10, 300804 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1839" source="Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)" target="Platelet activation, signaling and aggregation" />
      <edge id="1840" source="Netrin mediated repulsion signals" target="Metachondromatosis, 156250 (3)" />
      <edge id="1841" source="Netrin mediated repulsion signals" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1842" source="Netrin mediated repulsion signals" target="Colorectal cancer (3)" />
      <edge id="1843" source="Netrin mediated repulsion signals" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1844" source="Senior-Loken syndrome 7, 613615 (3)" target="Golgi Cisternae Pericentriolar Stack Reorganization" />
      <edge id="1845" source="Hypogonadotropic hypogonadism 16 with or without anosmia, 614897 (3)" target="Sema3A PAK dependent Axon repulsion" />
      <edge id="1846" source="Mental retardation, autosomal dominant 17, 615009 (3)" target="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" />
      <edge id="1847" source="Platelet activation, signaling and aggregation" target="Terminal osseous dysplasia, 300244 (3)" />
      <edge id="1848" source="Platelet activation, signaling and aggregation" target="Combined SAP deficiency, 611721 (3)" />
      <edge id="1849" source="Platelet activation, signaling and aggregation" target="von Willebrand disease, platelet-type, 177820 (3)" />
      <edge id="1850" source="Platelet activation, signaling and aggregation" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="1851" source="Platelet activation, signaling and aggregation" target="von Willebrand disease, type 1, 193400 (3)" />
      <edge id="1852" source="Platelet activation, signaling and aggregation" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1853" source="Platelet activation, signaling and aggregation" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="1854" source="Platelet activation, signaling and aggregation" target="Familial cold autoinflammatory syndrome 3, 614468 (3)" />
      <edge id="1855" source="Platelet activation, signaling and aggregation" target="Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)" />
      <edge id="1856" source="Platelet activation, signaling and aggregation" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="1857" source="Platelet activation, signaling and aggregation" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1858" source="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" target="Activation of NMDA receptor upon glutamate binding and postsynaptic events" />
      <edge id="1859" source="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" target="Neuronal System" />
      <edge id="1860" source="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" target="Post NMDA receptor activation events" />
      <edge id="1861" source="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1862" source="Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1863" source="LIG4 syndrome, 606593 (3)" target="Early Phase of HIV Life Cycle" />
      <edge id="1864" source="Pancreatic cancer, somatic (3)" target="Signaling by NODAL" />
      <edge id="1865" source="Hyperproinsulinemia, familial, with or without diabetes (3)" target="Insulin receptor recycling" />
      <edge id="1866" source="Hyperproinsulinemia, familial, with or without diabetes (3)" target="Signal attenuation" />
      <edge id="1867" source="Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="1868" source="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" target="Rev-mediated nuclear export of HIV-1 RNA" />
      <edge id="1869" source="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" target="Late Phase of HIV Life Cycle" />
      <edge id="1870" source="Achalasia-addisonianism-alacrimia syndrome, 231550 (3)" target="Vpr-mediated nuclear import of PICs" />
      <edge id="1871" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Alstrom syndrome, 203800 (3)" />
      <edge id="1872" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Thyroid carcinoma, papillary, 188550 (3)" />
      <edge id="1873" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Seckel syndrome 4, 613676 (3)" />
      <edge id="1874" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)" />
      <edge id="1875" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Cortical dysplasia, complex, with other brain malformations, 614039 (3)" />
      <edge id="1876" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Seckel syndrome 5, 613823 (3)" />
      <edge id="1877" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Microcephaly 3, primary, autosomal recessive, 604804 (3)" />
      <edge id="1878" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Bardet-Biedl syndrome 14, 209900 (3)" />
      <edge id="1879" source="Golgi Cisternae Pericentriolar Stack Reorganization" target="Lissencephaly 1, 607432 (3)" />
      <edge id="1880" source="Diabetes mellitus, type 1, 125852 (3)" target="Insulin receptor recycling" />
      <edge id="1881" source="Diabetes mellitus, type 1, 125852 (3)" target="Signal attenuation" />
      <edge id="1882" source="Early Phase of HIV Life Cycle" target="OKT4 epitope deficiency, 613949 (3)" />
      <edge id="1883" source="Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1884" source="Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)" target="Neuronal System" />
      <edge id="1885" source="Dissolution of Fibrin Clot" target="Thrombophilia due to elevated HRG, 613116 (1)" />
      <edge id="1886" source="Dissolution of Fibrin Clot" target="Thrombophilia due to HRG deficiency, 613116 (3)" />
      <edge id="1887" source="Dissolution of Fibrin Clot" target="{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)" />
      <edge id="1888" source="Dissolution of Fibrin Clot" target="Conjunctivitis, ligneous, 217090 (3)" />
      <edge id="1889" source="Dissolution of Fibrin Clot" target="Alpha-2-plasmin inhibitor deficiency, 262850 (3)" />
      <edge id="1890" source="Dissolution of Fibrin Clot" target="Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)" />
      <edge id="1891" source="Pseudohypoparathyroidism Ic, 612462 (3)" target="Platelet homeostasis" />
      <edge id="1892" source="Pseudohypoparathyroidism Ic, 612462 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="1893" source="Signaling by NODAL" target="Polyposis, juvenile intestinal, 174900 (3)" />
      <edge id="1894" source="Signaling by NODAL" target="Heterotaxy, visceral, 4, autosomal, 613751 (3)" />
      <edge id="1895" source="Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)" target="Platelet homeostasis" />
      <edge id="1896" source="Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1897" source="{Schizophrenia, susceptibility to}, 181500 (3)" target="Neuronal System" />
      <edge id="1898" source="{Schizophrenia, susceptibility to}, 181500 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1899" source="{Schizophrenia, susceptibility to}, 181500 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1900" source="Rev-mediated nuclear export of HIV-1 RNA" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="1901" source="Hydrocephalus due to aqueductal stenosis, 307000 (3)" target="Recycling pathway of L1" />
      <edge id="1902" source="{Panic disorder, susceptibility to}, 167870 (3)" target="Neuronal System" />
      <edge id="1903" source="{Panic disorder, susceptibility to}, 167870 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1904" source="{Panic disorder, susceptibility to}, 167870 (3)" target="Transmission across Chemical Synapses" />
      <edge id="1905" source="Signal attenuation" target="Maturity-onset diabetes of the young, type 10, 613370 (3)" />
      <edge id="1906" source="Signal attenuation" target="Noonan syndrome 4, 610733 (3)" />
      <edge id="1907" source="Signal attenuation" target="Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)" />
      <edge id="1908" source="Signal attenuation" target="Fibromatosis, gingival, 135300 (3)" />
      <edge id="1909" source="OKT4 epitope deficiency, 613949 (3)" target="Nef Mediated CD4 Down-regulation" />
      <edge id="1910" source="Late Phase of HIV Life Cycle" target="Spinocerebellar ataxia 17, 607136 (3)" />
      <edge id="1911" source="Late Phase of HIV Life Cycle" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="1912" source="Lipodystrophy, congenital generalized, type 3, 612526 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1913" source="Spinocerebellar ataxia 17, 607136 (3)" target="HIV-1 Transcription Initiation" />
      <edge id="1914" source="Spinocerebellar ataxia 17, 607136 (3)" target="RNA Polymerase II HIV-1 Promoter Escape" />
      <edge id="1915" source="Transmission across Chemical Synapses" target="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" />
      <edge id="1916" source="Transmission across Chemical Synapses" target="Congenital myopathy with excess of muscle spindles, 218040 (3)" />
      <edge id="1917" source="Transmission across Chemical Synapses" target="Succinic semialdehyde dehydrogenase deficiency, 271980 (3)" />
      <edge id="1918" source="Transmission across Chemical Synapses" target="{Sublingual nitroglycerin, susceptibility to poor response to} (3)" />
      <edge id="1919" source="Transmission across Chemical Synapses" target="Mental retardation, autosomal recessive, 6, 611092 (3)" />
      <edge id="1920" source="Transmission across Chemical Synapses" target="Brunner syndrome, 300615 (3)" />
      <edge id="1921" source="Noonan syndrome 4, 610733 (3)" target="SOS-mediated signalling" />
      <edge id="1922" source="Noonan syndrome 4, 610733 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1923" source="Noonan syndrome 4, 610733 (3)" target="Tie2 Signaling" />
      <edge id="1924" source="Recycling pathway of L1" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1925" source="Recycling pathway of L1" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1926" source="Insulin receptor recycling" target="Maturity-onset diabetes of the young, type 10, 613370 (3)" />
      <edge id="1927" source="Insulin receptor recycling" target="Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)" />
      <edge id="1928" source="Fibromatosis, gingival, 135300 (3)" target="SOS-mediated signalling" />
      <edge id="1929" source="Fibromatosis, gingival, 135300 (3)" target="Cell surface interactions at the vascular wall" />
      <edge id="1930" source="Fibromatosis, gingival, 135300 (3)" target="Tie2 Signaling" />
      <edge id="1931" source="Cell surface interactions at the vascular wall" target="Thrombophilia due to thrombomodulin defect, 614486 (3)" />
      <edge id="1932" source="Cell surface interactions at the vascular wall" target="Metachondromatosis, 156250 (3)" />
      <edge id="1933" source="Cell surface interactions at the vascular wall" target="Thrombophilia due to thrombin defect, 188050 (3)" />
      <edge id="1934" source="Cell surface interactions at the vascular wall" target="Leukocyte adhesion deficiency, 116920 (3)" />
      <edge id="1935" source="Cell surface interactions at the vascular wall" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1936" source="Cell surface interactions at the vascular wall" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1937" source="Activation of NMDA receptor upon glutamate binding and postsynaptic events" target="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" />
      <edge id="1938" source="Activation of NMDA receptor upon glutamate binding and postsynaptic events" target="Congenital myopathy with excess of muscle spindles, 218040 (3)" />
      <edge id="1939" source="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" target="Neuronal System" />
      <edge id="1940" source="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" target="Post NMDA receptor activation events" />
      <edge id="1941" source="{Thyroid carcinoma, follicular, somatic}, 188470 (3)" target="CREB phosphorylation through the activation of Ras" />
      <edge id="1942" source="Diabetes mellitus, noninsulin-dependent, 125853 (3)" target="Neuronal System" />
      <edge id="1943" source="GABA synthesis, release, reuptake and degradation" target="Succinic semialdehyde dehydrogenase deficiency, 271980 (3)" />
      <edge id="1944" source="Tie2 Signaling" target="Metachondromatosis, 156250 (3)" />
      <edge id="1945" source="Metachondromatosis, 156250 (3)" target="SOS-mediated signalling" />
      <edge id="1946" source="Metachondromatosis, 156250 (3)" target="Platelet homeostasis" />
      <edge id="1947" source="ACTH-independent macronodular adrenal hyperplasia, 219080 (3)" target="Platelet homeostasis" />
      <edge id="1948" source="ACTH-independent macronodular adrenal hyperplasia, 219080 (3)" target="Prostacyclin signalling through prostacyclin receptor" />
      <edge id="1949" source="Succinic semialdehyde dehydrogenase deficiency, 271980 (3)" target="Neuronal System" />
      <edge id="1950" source="CREB phosphorylation through the activation of Ras" target="Congenital myopathy with excess of muscle spindles, 218040 (3)" />
      <edge id="1951" source="Vpr-mediated nuclear import of PICs" target="Striatonigral degeneration, infantile, 271930 (3)" />
      <edge id="1952" source="Brunner syndrome, 300615 (3)" target="Neuronal System" />
      <edge id="1953" source="Brunner syndrome, 300615 (3)" target="Neurotransmitter Clearance In The Synaptic Cleft" />
      <edge id="1954" source="Neuronal System" target="Congenital myopathy with excess of muscle spindles, 218040 (3)" />
      <edge id="1955" source="Neuronal System" target="{Sublingual nitroglycerin, susceptibility to poor response to} (3)" />
      <edge id="1956" source="Neuronal System" target="Atrial fibrillation, familial, 12, 614050 (3)" />
      <edge id="1957" source="Neuronal System" target="Mental retardation, autosomal recessive, 6, 611092 (3)" />
      <edge id="1958" source="Neurotransmitter Clearance In The Synaptic Cleft" target="{Sublingual nitroglycerin, susceptibility to poor response to} (3)" />
      <edge id="1959" source="Congenital myopathy with excess of muscle spindles, 218040 (3)" target="Post NMDA receptor activation events" />
      <edge id="1960" source="p130Cas linkage to MAPK signaling for integrins" target="Thrombocytopenia, neonatal alloimmune (3)" />
      <edge id="1961" source="p130Cas linkage to MAPK signaling for integrins" target="Glanzmann thrombasthenia, 273800 (3)" />
      <edge id="1962" source="Activation of Kainate Receptors upon glutamate binding" target="Mental retardation, autosomal recessive, 6, 611092 (3)" />
    </edges>
  </graph>
</gexf>
